ࡱ> `//  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_/bcdefghijklmnopqrstuvwxyz{|}~Root Entry@n/~PageMakerap^      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~                            ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~        !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  !!!!!!!!! ! ! ! ! !!!!!!!!!!!!!!!!!!! !!!"!#!$!%!&!'!(!)!*!+!,!-!.!/!0!1!2!3!4!5!6!7!8!9!:!;!!?!@!A!B!C!D!E!F!G!H!I!J!K!L!M!N!O!P!Q!R!S!T!U!V!W!X!Y!Z![!\!]!^!_!`!a!b!c!d!e!f!g!h!i!j!k!l!m!n!o!p!q!r!s!t!u!v!w!x!y!z!{!|!}!~!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!""""""""" " " " " """"""""""""""""""" "!"""#"$"%"&"'"(")"*"+","-"."/"0"1"2"3"4"5"6"7"8"9":";"<"=">"?"@"A"B"C"D"E"F"G"H"I"J"K"L"M"N"O"P"Q"R"S"T"U"V"W"X"Y"Z"["\"]"^"_"`"a"b"c"d"e"f"g"h"i"j"k"l"m"n"o"p"q"r"s"t"u"v"w"x"y"z"{"|"}"~""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""######### # # # # ################### #!#"###$#%#&#'#(#)#*#+#,#-#.#/#0#1#2#3#4#5#6#7#8#9#:#;#<#=#>#?#@#A#B#C#D#E#F#G#H#I#J#K#L#M#N#O#P#Q#R#S#T#U#V#W#X#Y#Z#[#\#]#^#_#`#a#b#c#d#e#f#g#h#i#j#k#l#m#n#o#p#q#r#s#t#u#v#w#x#y#z#{#|#}#~##################################################################################################################################$$$$$$$$$ $ $ $ $ $$$$$$$$$$$$$$$$$$$ $!$"$#$$$%$&$'$($)$*$+$,$-$.$/$0$1$2$3$4$5$6$7$8$9$:$;$<$=$>$?$@$A$B$C$D$E$F$G$H$I$J$K$L$M$N$O$P$Q$R$S$T$U$V$W$X$Y$Z$[$\$]$^$_$`$a$b$c$d$e$f$g$h$i$j$k$l$m$n$o$p$q$r$s$t$u$v$w$x$y$z${$|$}$~$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$%%%%%%%%% % % % % %%%%%%%%%%%%%%%%%%% %!%"%#%$%%%&%'%(%)%*%+%,%-%.%/%0%1%2%3%4%5%6%7%8%9%:%;%<%=%>%?%@%A%B%C%D%E%F%G%H%I%J%K%L%M%N%O%P%Q%R%S%T%U%V%W%X%Y%Z%[%\%]%^%_%`%a%b%c%d%e%f%g%h%i%j%k%l%m%n%o%p%q%r%s%t%u%v%w%x%y%z%{%|%}%~%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%&&&&&&&&& & & & & &&&&&&&&&&&&&&&&&&& &!&"&#&$&%&&&'&(&)&*&+&,&-&.&/&0&1&2&3&4&5&6&7&8&9&:&;&<&=&>&?&@&A&B&C&D&E&F&G&H&I&J&K&L&M&N&O&P&Q&R&S&T&U&V&W&X&Y&Z&[&\&]&^&_&`&a&b&c&d&e&f&g&h&i&j&k&l&m&n&o&p&q&r&s&t&u&v&w&x&y&z&{&|&}&~&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&''''''''' ' ' ' ' ''''''''''''''''''' '!'"'#'$'%'&'''(')'*'+','-'.'/'0'1'2'3'4'5'6'7'8'9':';'<'='>'?'@'A'B'C'D'E'F'G'H'I'J'K'L'M'N'O'P'Q'R'S'T'U'V'W'X'Y'Z'['\']'^'_'`'a'b'c'd'e'f'g'h'i'j'k'l'm'n'o'p'q'r's't'u'v'w'x'y'z'{'|'}'~''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''((((((((( ( ( ( ( ((((((((((((((((((( (!("(#($(%(&('((()(*(+(,(-(.(/(0(1(2(3(4(5(6(7(8(9(:(;(<(=(>(?(@(A(B(C(D(E(F(G(H(I(J(K(L(M(N(O(P(Q(R(S(T(U(V(W(X(Y(Z([(\(](^(_(`(a(b(c(d(e(f(g(h(i(j(k(l(m(n(o(p(q(r(s(t(u(v(w(x(y(z({(|(}(~(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((())))))))) ) ) ) ) ))))))))))))))))))) )!)")#)$)%)&)')()))*)+),)-).)/)0)1)2)3)4)5)6)7)8)9):);)<)=)>)?)@)A)B)C)D)E)F)G)H)I)J)K)L)M)N)O)P)Q)R)S)T)U)V)W)X)Y)Z)[)\)])^)_)`)a)b)c)d)e)f)g)h)i)j)k)l)m)n)o)p)q)r)s)t)u)v)w)x)y)z){)|)})~))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))))********* * * * * ******************* *!*"*#*$*%*&*'*(*)***+*,*-*.*/*0*1*2*3*4*5*6*7*8*9*:*;*<*=*>*?*@*A*B*C*D*E*F*G*H*I*J*K*L*M*N*O*P*Q*R*S*T*U*V*W*X*Y*Z*[*\*]*^*_*`*a*b*c*d*e*f*g*h*i*j*k*l*m*n*o*p*q*r*s*t*u*v*w*x*y*z*{*|*}*~**********************************************************************************************************************************+++++++++ + + + + +++++++++++++++++++ +!+"+#+$+%+&+'+(+)+*+++,+-+.+/+0+1+2+3+4+5+6+7+8+9+:+;+<+=+>+?+@+A+B+C+D+E+F+G+H+I+J+K+L+M+N+O+P+Q+R+S+T+U+V+W+X+Y+Z+[+\+]+^+_+`+a+b+c+d+e+f+g+h+i+j+k+l+m+n+o+p+q+r+s+t+u+v+w+x+y+z+{+|+}+~++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, ,!,",#,$,%,&,',(,),*,+,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?,@,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,[,\,],^,_,`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,--------- - - - - ------------------- -!-"-#-$-%-&-'-(-)-*-+-,---.-/-0-1-2-3-4-5-6-7-8-9-:-;-<-=->-?-@-A-B-C-D-E-F-G-H-I-J-K-L-M-N-O-P-Q-R-S-T-U-V-W-X-Y-Z-[-\-]-^-_-`-a-b-c-d-e-f-g-h-i-j-k-l-m-n-o-p-q-r-s-t-u-v-w-x-y-z-{-|-}-~----------------------------------------------------------------------------------------------------------------------------------......... . . . . ................... .!.".#.$.%.&.'.(.).*.+.,.-.../.0.1.2.3.4.5.6.7.8.9.:.;.<.=.>.?.@.A.B.C.D.E.F.G.H.I.J.K.L.M.N.O.P.Q.R.S.T.U.V.W.X.Y.Z.[.\.].^._.`.a.b.c.d.e.f.g.h.i.j.k.l.m.n.o.p.q.r.s.t.u.v.w.x.y.z.{.|.}.~..................................................................................................................................///////// / / / / /////////////////// /!/"/#/$/%/&/'/(/)/*/+/,/-/.///0/1/2/3/4/5/6/7/8/9/:/;//?/@/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z/[/\/]/^/_/`/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z/{/|/}/~///////////////////////////  dfl^l^3l^l^T+MP2t688 88 hL&  , kZ 4&@ } @ Pd 0  @@ L4  & ^U N & &4   9 $7( MS6  B@ & >  ; G3Ld 26 kZ 3L  1 @ @  @   @} .+@EPSG:\mm Setup\logos\Cdc.eps.eps`F'l5(KL EPSG:\mm Setup\logos\Logoblack.eps.epsu;(u;(M DOCG:\MM\Mm 50 series (2001)\Mm5048\Original Text\Text.doc+,+$+DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 1.docm+n+n+!DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2a.docm+n+n+"DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2b.docm+n+n+#DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2c.docm+n+n+$DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2d.docm+n+n+%DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 3a.docm+n+n+V&DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 3b.doc n+n+n+'DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 4.docn+n+n+(EPSG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Fig1vp.epsHɃ+Ƀ+ +/1  ;5j!DISPLAYDISPLAYNone``@@<<GMMd(_<PddP2   jContents^tIndex ,^>;^>^=.^>  D:\Program Files\Adobe\PM65\RSRC\USENGLSH:\Program Files\Adobe\PM65\RSRC\USENGLSH\PM65.HLPxdd;P[ P  db ..--__ 9;[;P[ P  :?;P[ P  ;[?;P[ P ;[;P[ P ;[;P[ P ;[;P[ P ;[;P[ P ;[;P[ P ;[;P[ P ;[;P[ P ;[;P[ P  ?;P[ P  (;[?;P[ P );[;P[ P *[;P[ P +;[;P[ P ,;[;P[ P -;[;P[ P .;[;P[ P  /?;P[ P ! ;[?;P[ P *;P[ P + ;[?;P[ P T;[;P[ P U;[;P[ P  @/>! !?@ABCD!EFGHIJ!NOPQRS! VWXYZ[! \]^_`a! bcdefg!hijklm!tuvwxy!z{|}~!!!!!!!!!!! nopqrs!K!"#$%&!L-./012!N'()*+,!O345678!P!Q!R!S!T!! !    !234567!89:;<=!>?@ABC!WXYZ[\!^_`abc!pqrstu!!!!!! ! !!)*+,-.!/01234!56789:!fghijk!!!!DEFGHI!JKLMNO!PQRSTU!!!!!!!"defghi!jklmno!vwxyz{!|}~!!#!!!!!$!!!!!%;<=>?@!ABCDEF!GHIJKL!MNOPQR!STUVWX!YZ[\]^!&`abcde!    !!!"#$%&'!'lmnopq! rstuvw! xyz{|}! ~! ! !!!!!!(! !01]_!!!!Univers 45 Light"$Univers 55"$ZapfDingbatsR$Symbol$Times New Roman$" NMpON"E$POi&u)QP (xKddddGMMdCaption(xKdddxGMMdHanging indentU(xKdddGMMdSubhead 1U(xKdddxGMMdSubhead 2 (xKdddPGMMdZ Header(xKdddZnGMMdDate!h! h(xKddd!AAGMMdTable of Content-Cover Page  (xKddd"PZGMMdU.S. Depart  (xKdddZmGMMdBody Text  (xKdddFOGMMdEnd Disclaimer (xKdddFOGMMdReturn Address (xKdddFZGMMdRotated 1st Class Mailer s { 1<(_<PddAFGMMdDirect 2 s { 1<(_<PddAFGMMdDirect 2 Center&i](xKdddCdnGMMdHeadline!!x$(xKdddZdGMMdHeadline2Z[(xKdddQPZGMMd*Footnote w/RuleVV(xKdddZdGMMdFigure Title $$(xKddd$PGMMdContinued<(xKddd/PZGMMdReported by((xKdddZnGMMdEditorial Note<(xKdddPZGMMdReferences;;(xKdddPdGMMdReference Text 10L(xKdddtPdGMMdReference Text(xKdddZmGMMdBulleted Body Text 1 Ht`c(_<dPddGZdGMMdArticle Table TitleHt`(_<dPddcZGMMdTable Titler(((dKdddcPZGMMdColumn Headings TopN o !3' 4(dKddd<FPGMMdArticle Table 1 CH Bottom N o w'!(dKdddFPGMMdArticle Table 1 CH !$ d%("(xKdddFPGMMdArticle Table 1 Text"Z#[(xKdddQPZGMMd*Footnote No Rule#  { 1$(_<PdddnGMMdKicker$%(xKdddQPZGMMd**Footnote w/Rule%Ht`&(_<dPddcZGMMdZTable Title&T(y(dKdddFFGMMdTable Footnote 7pt(T)y(dKddd<<GMMdTable Footnote 6pt((),(xKddd<(GMMdZ Table Blank Line,Wv W-(_<dddW<<GMMdTbl 2a Col Head 1st Line-WW j?W.(_<dddW<<GMMdTbl 2 Col Head Center.W R m  {zW/(_<dddW<AGMMdTbl 2a Col Head 2nd/3rd Line/W W0(_<dddW<<GMMdTbl 2b Col Head 1st Line copy0W sm YzW1(_<dddW<AGMMdTbl 2b Col Head 2nd/3rd Line1D sm YzD2(_<ddd><AGMMdTbl 2b Col Head 3rd Line//2W* W3(_<dddW<AGMMdTbl 2b/c/d Col Head 1st Line3W@ =7W4(_<dddW<AGMMdTbl 2b/c/d Col Head 2nd/3rd Lin4W@ =7W7(_<dddW<FGMMdTbl 3 Col Head Center7W ;b= { T,^W8(_<dddW<AGMMdTbl 3a Col Head 2nd/3rd Line8W^W:(_<dddW<AGMMdTbl 3b Col Head 1st Line:W ]O @ \ SW;(_<dddW<AGMMdTbl 3b Col Head 2nd/3rd Line;h>(dKdddFFGMMd****Table Footnote 7pt(>?L(dKdddFFGMMd**Table Footnote 7pt(?@(dKdddFFGMMd***Table Footnote 7pt?@A(xKdddZmGMMda1) indent A+B*(xKddd~ZmGMMda1) indent (b)AAB `O(dKdddPZGMMdArticle Table 4 TextO `P((dKdddPZGMMdArticle Table 4 BoldOPh QG(dKdddGPZGMMdArticle Table 4 CH BottomQh R(dKdddPZGMMdArticle Table 4 CH TopR&i]V(xKdddCZnGMMdBox HeadlineVLW(xKdddPZGMMdBox Text WX(xKdddZmGMMdBulleted Body Text 2XY(xKdddPGMMdContinued RYZP(xKdddZnGMMdErratumZ&i[(xKdddCdnGMMdHead w/Kicker[ \(xKddd"GMMdProof\H]$(dKddd+PZGMMdSource:]H^y(dKdddPZGMMdTable Footnote 8pt^  ` )p)0@ " %`'_(xKdddPZGMMdTable Text_Z`[((dKddcdPZGMMdTable Footnote Top_`K  >2%  #%'a((xKdddQFPGMMdTable Text Bold_a p@ 0!$(bXG(xKdddGFPGMMdTable Total Line"bh c(xKddddnGMMdTOC Headlinec d(xKdddZdGMMdTOC Headline2dZs[x(xKdddQPZGMMdFootnote Topst(xKdddFPGMMdInside Back Cover Box TexttHu.(dKddd<<GMMdfootnotes tables uWI Wv(_<dddW<AGMMdTbl 3a Col Head 1st LinevW]Ww(_<dddW<FGMMdTbl 4 Col Head AgeswW@ =7Wx(_<dddW<FGMMdTbl 4 Col Head Center7xWW j?W(_<dddW<AGMMdTable 1 Text 'm  ,^.(_<Pdd<<GMMdTable 2a Text _  ,^.(_<Pdd<<GMMdTable 2b Text'~  ).(_<Pdd<<GMMdTable 2c TextT  &(_<Pdd<<GMMdTable 2d Text _   {SB(_<Pdd<<GMMdTable 3a Text  \ 7o(_<Pdd<<GMMdTable 3b Text5   j(_<Pdd<<GMMdTable 4 Text(_<PddxGMMdReference`~ @NoneRegistrationPaperBlackRedGreenBlueCyanMagentaYellowPANTONE 286 CVU\\\ = =Dark MagentaPANTONE 286 CVC\\\ = =d< xh# uD ]xh  DAdobe Compatibility CMSAdobe Compatibility CMSPageMaker 5.0 RGBDAdobe Compatibility CMS Adobe Compatibility CMSPageMaker 5.0 CMYKDefaultDocument Master;[;P[ P Document Master_;[;P[ P Bbyy@ hee@ dedf@4LK eg@ heh@ 2211@ 2d1d@  SR10@ 2212@s433@sd3d@RQ3@s434@g 655@g d5d@TS5@g 656 @`h b : Ad  MMWR December 7, 2001PGMMd(xKddd :@p:b ::Ah:Vol. 50/No. 48 MMWR PGMMd(xKddd  #  K5B @B GBd BP5 %B] B]  BP5 `]* @]HF  `] @]8  `] @]e  `]* @]e `] @]  `] @]  `]  @]e `]e @]  `]  @] @] @B<  B]  @B< b] B]  @B< `] `] @], Contributors to the Production of the MMWR (Weekly) Weekly Notifiable Disease Morbidity Data and 122 Cities Mortality Data Samuel L. Groseclose, D.V.M., M.P.H. Wayne S. Brathwaite State Support Team CDC Operations Team Robert Fagan Carol M. Knowles Jose Aponte Deborah A. Adams Gerald Jones Willie J. Anderson David Nitschke Lateka M. Dammond Scott Noldy Patsy A. Hall Jim Vaughan Mechele A. Hester Carol A. Worsham Felicia J. Connor Pearl Sharp Informatics T. Demetri Vacalis, Ph.D. Michele D. Renshaw Erica R. Shaver&__GMMd__GMMd __GMMdGKKGMMdAFGMMdA(GMMd9AFGMMdA(GMMd&AFGMMdAFGMMd KFGMMd?AFGMMd5(_<Pdd(_<Pdd'*(_<Pdd(_<Pdd'<(_<Pdd#<(_<Pdd s { 1'H' s { 1#, NA (Continued on page 751)PGMMdY(xKddd MZ3  *Cx[? *All MMWR references are available on the Internet at . Use the search function to find specific articles.PZGMMdPZGMMd{PZGMMds[x(xKdddQZ OY3  *Cx[? *All MMWR references are available on the Internet at . Use the search function to find specific articles.PZGMMdPZGMMdzPZGMMds[x(xKdddQZdd[n nGG;<d zz=>d S  { {{d:t  II*0p(~>,,????????????????????????????????    ????>>???????????????????????????????8?0?8~~??0??|????~????~?|??|???>?<??|???<??|??????|x??????|x??????||?Ǐ~?????q?<|?Ǐ>?????p?<~??>?<???p?<????|????p?<??<???q?<??????|???????|q???<G???|q????<G???|p???|???x??|??|??>??~???~?~x???`0?`0??????????Lj???ǏÈ???Ǐ??Ǐ??~?Ǐ>??>?㏏?㏏q??Ǐq?ϟ?Ǐ1??Ǐ???ǏÏ???Ǐx???x???x????8??zO%,( { Z  CorelDRAW!CDC.EPS from CorelDRAW!Tue Apr 26 08:04:11 1994  II*v88uuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuvogaZUPKHGHLQV[bhouMg|9L|GGYhGwwwwLPS_,GGGGGGEGGGGG{GLTgxJGttL|lXHxGUULfxIrAGLHx}IbGUUL\txGL_~xjjtGLOK~xHĄGffLH}xGLfHxrb|G__LlbGxHGNNLlgxϦHGLxz[G{H{HLQIxBGLKP|xGKGjjL}RUxG]^La{xGLxJPGMML^}l|x>HHL]TuvLHopLHHLHUULm[[UULoLwLQxLT``L~GMffLLVMHHL_ehMNLqcklLz{LHLKNNLoUt\]LSvwwLLSkolHHLYVVLHooLcLGL`N^HUULjaaLeLH|LNHHLoNefLyRu[HllLKĥkStLSgkSMML`YÊXNOLHʋGyzL|axyLGdLbVgb\\LHeaWWLHJHLI[sHHLKjLquIdiooLsbbLGfLUG`VQTULUHHLVbL|xmnLoGILbQeeL`WPPL_pLJkdRMzMzLRHLsGMyyLjmXYL[~LUYVu[\}LPV|L|LMv|HbH{cLYi{LcdKnozL[IyILxLKbSToTwoLGVluvLtJkvLgaPuQL_|WtLVSPd{dt|L{LTIsLrLnuLYMrYLHxGqLeHJxypLZVQOHoLUNoLLt[\V[d[ndLtV_nLuPimLybNKtHIHlJLH~lLWUMnonkpLIqjLojLfoLSQSiQLhLf|g|LRnfLQMfLLU~JbcZdf[Lik|}eLvU|dLq]kHL|LcL{bLXHHwyexbfLMGdYxbLwbLc_jg[vJ[aJL|t`LgHHKtq_qL|NrHsH_Lr_LMIPydmpRm^SLHo]Lx^G_o}\~LiYSnS[Lzl[LYGb{l[[[LkZLHjYLGWetchGcYGLYgSXLh_jffWfLttKLfLWLMdnVLNJsdwcKwVKLbHULzP|||[IbrUsLUbUbZa[ULg`\UL[nt_STSLGG_HSLYQi]zSLGQ`Rl\mRLZYb[NQLjPb{[\zQ]LlHk\SYSQL{hVt_YKf_PJLOGmVXGPGLP7JWIOL{|HfVgNhLZPbUbNLlLTUVVNVL[|GULMLLHbwKcSLcMLy`SttrLttLGL[~vMRwMLL_QGQKILKLlIPTKULIdGJYPZKLuyOd`JdLP]gIiNiJLSObGMGIL|yQM^~QI^LTLNJlLlILprILVPHUL]GuKGHGLIoMxRJRHLXwRoJitjoHisLHHVOIHLH[[bsolUHJGUHJLHHLHML]K_ybGHbGLfY_HtbYGubLbXVHGLV{lƠXQKuGKtGL빁SKGUuGULNIIߪtKGuZGvZGLu޸kMGUKULoȰpQHHLLfh¨wbOYYLHJrbrLRHnV||LffGJGIL~Hw__LGVellLJbSJbL]GbLZrQRL`nLIGbLzeTHdTLjYLO_fbNbNLHp\pLNVSLl~KIKILyvGzLHPuxukujLYOaMaLYLRRL^jG}YYLZfLGgLtGSGSLeGpoLSYWklLVoUVoLKZMLounQGHQGHLsIqLIKzthLSv`Iv_LUO]SLbbSb[b[LJ]_LkHHLJRKRL`HH}LUSt|t|LnOnPnLH]a`LtmVXXHYHLmKjKLLH~HcLG_GG^LPRoLf[kkL|}f~Ye~LofLxQNQQNQL[HRuLYMLmKlLGaLzeIalHblHLgzbLNQSSLaJ]J]LLU[LkUMttLuf|S|LHsqqLosXPXPLVJWnVL^HrLGGlHGGlLf[L~^jHjGLaGIw[wLRL|P\\Q[[LH[JyLoO~HHLllS|M{LI}LhU]`~Oa}OLNRfLbGibbLwJjJjLquLKLVtGtGLVJULUqLsW[W[Le^fqfLtJLaGNGGPzHGOzLKLaLiNjNLH[_LfULGlPliPlhLG}`}LGQj}TG~SGLGNRlPLYGWLGkxy`Y`YLHpIjLyHGsrLHVJIxGJxLNHXXLHYsMsMLHewGXGLjHHLIvabVgWgLGINySxLIKRGLJH[WG]G]L]JGLKblbiIYiHXLK|L~LoLLNQPwP~vLQLo|LMSx}bM}bLLMp\LoNLLLNnVJM_f`fLHNLOHLPeHIILbPhgLQ\b}PrWsWLQPPLQhYLRzHZVuVuLUSVeLSMlLKLT|HqnmLtULUfOQhUehUdLKULUxLVpuOPLeVLWUWJb|tV}sVLWLXQJYYLYqd_t_tLYYGRHGLZHb|KKL[HIbIbO֤lUGGUj޾voo}}tlt~ump{|tks}筐t[HOb|ڼ~unp~Jla|_IPeLH{w[HUw`cHlXx\HG]~LRy\HSHNGG|bIGYGh|`MPXH~SvMGUSMNuo~bOYG|`HpXXHXIGMSXtN[XGO^bUYGt|`UlSXHSQNRbYG|`_IXHWPrSN|b[YG|`_I~XH[_SNouHbxYG|`bHXHt[SJ_HNQzGQbfYG|`i]XHShSNKlrѸ|xbȱrMYGQgįG|`WXHVoӾmz]tؿHuSƯjNKGh_IbwYGbG|`QHtMwr?NrXH|nHSSUMoOQNOdU[HHbw{UYGbs|`mlvXHUKxrHSgfftQNoVZKbwUnYGb|`mlgH]XHF5GLScft~NoK^UmbwdHKYGbIP|`mlGlXXH_h_XxjSUTft[NoeKyV_bwYGb|`mlMJbCLXHbXSHftH_NoKHxHGxbwWYGb|`mlHVXHgrHSKftHNou\MNHtVyobwtfHYGbG}|`mlqcGXHe]}|Y|YSbzftofNoVaTHHhHJbwOYGbH|`mlgoV_G͗IXH\{YI[SGftTNo[IgJ_bwKYGb|`mlsMXHHOISftmNo~|dtsLUJbwNNNJYGb|`mlIMp|QXHJHfg^uSftHtNonHNNfYbwbUYGb|`ml<eKUXHGP_orS[MftbvNoBxjPHQlbOtUUYGbM|`mlPawkZXHO|mceS[qSftMNoHHgSHobNYGbY|`mlP~`XH\GUYYS\ftNoKqgUSWbXYGbi|`mlYvHu[fXHl|PPSftsSHNoZtWWbHbYGbb|`mlgoQlXHfGIzHHSftNoVgZtgbtYGbU|`mlbvNrXHWjpHmHVS~ft[Not[Gp]JbYGbJ|`mlNXHLH}bQ`SftQNoeQnK]I`mbPUU^QHYGb|`mloM>1vUXHHW[lS_ftKANoHbZbPhyYGb|`mlУXHSUNfwS_ftNotfKbHHiHYGb|`mlX}wkXHc[tiHtu_SHHeHft[NoHHj`bwlHYGbH|`mlYvXHow|GIPSftVNoHubTqwcYbwlUSYGbf|`mlplXHnKS[eftNoHbbw`YGb|`mlcjXHIbSHQ]HHMSftfNoHbw`YGbSp|`mlidXH~U[z+KwYQxSftfNoHPdvmbwV`YGb|`mlbQXH[LdPSgftNoHzPbwi`YGbG|`mlobXHLGoRUIIdSYfttNoHHoZGbwYGb|`ml{biXHz[[zSftwNoHNXdAbw{\IYGbo|`mlGfPbXH]aHSftGiMNoHU[[ImbwQJYYGb|`ml}bXHkNIgURSGVftNoH~_SVèbw`YG?˹fH|`mlHbXHfƳ[HnNP˱LHSqftHkNoHphNKtbwP[ix`HRYG|`mlPIbXHwuSftMKkNoHcsGgIbwjYG|`ml|ubMXH|dS}ftrkNoHW~hbwXYGw|`mlNbXHtrSKKftPkNoHNHNbwYG|`ml]bcXH[YfS{ftZkNoHH}YobwyHYG|`mlXbbXH[GSft[_kNoHHGMbwYGK|`mlWbXHjgRbaSLftZkNoHvKPbwwGuYG|`mlmbXHPwGJReSeftjkNoHTQ_NyDw|y>lY$GYY|`ml9bX$H_pjttfGW;oft7kNoHHYs[JHtwGپc[UMHHMUQsYͲ|bZSMHKYl|m3lb74˯g_XQKHM[m^bbNKbLfofzuom颾컵ĤdLKbjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjظvYGK_xjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjҷgSLl}QO{ίoUNcjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjLagxuYGRJ]|iQlnLalGxJHd_mrxSw{M[LalGxGH_mGbJVLal|xcLRHc_mMwUevLalxMH_mpHGPLalUxfkH^_my|bLalqxYH]_mXSVLalxH]_mGMeLalxfPH\_mPyHYrLalflxH_m]QMkLalHxtlRNH_mcdLalxH}_mH_HaLal^xofH_mnvvGHLalxHʹP_mvݫxXeĤSZŭGSNnt)PPPPPPPPPPPPPPPPPPPPPPPPPPPPPP/PPPPPPPPPPPPPPPPPPPPPPPPPPPPPPlXxHwyU_KPPPPPPPPPPPPPPPPPPPPPPPPPPPPPPmLwsLqJflUxVGHw_mLSbSEflxHw_mLuKcmLflxItYLHwU_mLLqhL|flNoxHww\_mLHJ[|aHiflJxSxbHwK_mLGL_lcGHflxHHw_mLGcQZ;QflHx_HwH_mLQbX{flx_THwY_mLpplG[Ufl[xnHwk_mLPUqKeflx{IHwU_mLUvQPgGWflvx}HwHH_mLflx_HwU_mLp\`YyflHtxNSHw_mLWaQN`flLx{Hw_mLHPmJfGb_flxkzHwN_mLWUWt]L:GlZxGHw_ymLbz`glxHHw__mL|Ikl_xNSHwe_mLlHSGMmflgx[Hwd_mLJ_ZjMnlxYHTlJP_mLopSYjx_kt[OlxvHg_mLH[HNT_GlexfHH_m.˫}U}fPnlxHH_mrX`YlGxuGHg_m~b_lxH_mJgIGiIlxWH_m]m_eLvlbxHy_msUVNlxrH_mfLilGxHL_mk\HYJuNlxH_m[JSHTlxIH_mUZHOdTdfl`Gax}H_m[btU|fyLflGx}HL_mkqeJ|TflXx}Hh_mkxպeyXflx}HwNY_mGGGUvHNflrx}Hw_m]HpwMlflw_x}HwgX_mԿtflNuoSxZflUx}HwH_mLKH`Yflx}Hw_mLHmGflx}Hw]O_mLHiLHifN]flSx}Hw_mLvHbfl]x}Hw_mLxhfhfljx}Hw]H_mLPOH^YEflx}Hw_mLgh\5I-flx}Hw_mLniflx}Hw^x_mLHfl[x}HwI_mLxv`_flMx}Hw_mLoxdTGazlU}Hw_mLIUqlb}Hwbj_mLJ߈Jl}Hw_mLqPgåfNxvUlY}Hw_mLGLVJl}Hw_mLwG~zl}Hwb\_mL;J|flH}Hw_mL|wJl}Hw_mLHPl[V}Hw_mLlQl}HwbS_mLJnPtlv}Hw_mLUGyl~}Hw_mL_|Ul}Hwo|_mLfTblGU}Hw_mL}UbKl}HwG_mLs_llU}BwxQ_cLGo\&aaaaaaaaaaaaaaaaaaaGaaaaaaaaaaaaaaaaaa-aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa5aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaalUaaaaaaaaaaaaaaaaa4aaaaaaaaaaaaaaaaaaaa2aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa4aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaawaaaaaaaaaaaaaaaaaaax_YaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaLxGHaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaYBaaaaaaaaaaaaaaaaa׶ufYNHHR_m}''''''''''''''''''''''''''''''''''''''''''''''''''''''''OFwt.=e\D,S{r,ZBjΑB0pX*XFn@n (5\V#>Krl&9Taj8 8(÷@÷@b÷@÷@÷@÷@B÷@÷@÷@j÷@"÷@÷@ z$%,(X CorelDRAW 8$G:\mm Setup\logos\Logoblack.eps.epsThu Jan 27 14:46:25 2000  #x#Q^ xDecember 7, 2001/Vol. 50/No. 48#ZnGMMd#(xKddd#gQ  `W,Q & Wh Q $@WhQ Q @BQ `W,Q % Wh Q @WhaQ @BQ `W,Q $ WhQ !WhQ &0Wh Q @WhQ @BQ `W,Q $ WhQ @Wh Q @BQ `W,Q @WhQ 1077 Update: Investigation of Bioterrorism-Related Anthrax Connecticut, 2001 1080 Update: Unexplained Deaths Following Knee Surgery Minnesota, 2001 1081 Septic Arthritis Following Anterior Cruciate Ligament ReconstructionUsing Tendon Allografts Florida and Louisiana, 2000 1084 Influenza Activity United States, 200102 Season 1087 Notices to ReadersAAGMMdKAAGMMdAAGMMdAAGMMdDAAGMMdAAGMMdAAGMMd{AAGMMdAAGMMd4AAGMMdAAGMMdAAGMMdU h(xKddd h(xKdddghO%!PS-Adobe-2.0 EPSF-2.0 %%BoundingBox: 2292 2323 2427 2394 %%Creator: CorelDRAW! %%Title: CDC.EPS from CorelDRAW! %%CreationDate: Tue Apr 26 08:04:11 1994 %%DocumentProcessColors: Cyan Magenta Yellow Black %%DocumentFonts: %%EndComments %%BeginSetup /AutoFlatness true def % Options: Emulsion Up % Options: Print Positive Output /SepsColor false def /ATraps false def %%EndSetup %%BeginProlog /Corelreg true def % Copyright (c)1992, 1993 Corel Corporation. All rights reserved. /wCorel4Dict 300 dict def wCorel4Dict begin/bd{bind def}bind def/ld{load def} bd/xd{exch def}bd/_ null def/rp{{pop}repeat}bd/@cp/closepath ld/@gs/gsave ld /@gr/grestore ld/@np/newpath ld/Tl/translate ld/$sv 0 def/@sv{/$sv save def}bd /@rs{$sv restore}bd/spg/showpage ld/showpage{}bd currentscreen/@dsp xd/$dsp /@dsp def/$dsa xd/$dsf xd/$sdf false def/$SDF false def/$Scra 0 def/SetScr /setscreen ld/setscreen{3 rp}bd/@ss{2 index 0 eq{$dsf 3 1 roll 4 -1 roll pop} if exch $Scra add exch load SetScr}bd/SepMode where{pop}{/SepMode 0 def}ifelse /CurrentInkName where{pop}{/CurrentInkName(Composite)def}ifelse/$ink where {pop}{/$ink -1 def}ifelse/$c 0 def/$m 0 def/$y 0 def/$k 0 def/$t 1 def/$n _ def /$o 0 def/$fil 0 def/$C 0 def/$M 0 def/$Y 0 def/$K 0 def/$T 1 def/$N _ def/$O 0 def/$PF false def/s1c 0 def/s1m 0 def/s1y 0 def/s1k 0 def/s1t 0 def/s1n _ def /$bkg false def/SK 0 def/SM 0 def/SY 0 def/SC 0 def/$op false def matrix currentmatrix/$ctm xd/$ptm matrix def/$ttm matrix def/$stm matrix def/$fst 128 def/$pad 0 def/$rox 0 def/$roy 0 def/$ffpnt true def/CorelDrawReencodeVect[ 16#0/grave 16#5/breve 16#6/dotaccent 16#8/ring 16#A/hungarumlaut 16#B/ogonek 16#C/caron 16#D/dotlessi 16#82/quotesinglbase/florin/quotedblbase/ellipsis/dagger/daggerdbl 16#88/circumflex/perthousand/Scaron/guilsinglleft/OE 16#91/quoteleft/quoteright/quotedblleft/quotedblright/bullet/endash/emdash 16#98/tilde/trademark/scaron/guilsinglright/oe 16#9F/Ydieresis 16#A1/exclamdown/cent/sterling/currency/yen/brokenbar/section 16#a8/dieresis/copyright/ordfeminine/guillemotleft/logicalnot/minus/registered/macron 16#b0/degree/plusminus/twosuperior/threesuperior/acute/mu/paragraph/periodcentered 16#b8/cedilla/onesuperior/ordmasculine/guillemotright/onequarter/onehalf/threequarters/questiondown 16#c0/Agrave/Aacute/Acircumflex/Atilde/Adieresis/Aring/AE/Ccedilla 16#c8/Egrave/Eacute/Ecircumflex/Edieresis/Igrave/Iacute/Icircumflex/Idieresis 16#d0/Eth/Ntilde/Ograve/Oacute/Ocircumflex/Otilde/Odieresis/multiply 16#d8/Oslash/Ugrave/Uacute/Ucircumflex/Udieresis/Yacute/Thorn/germandbls 16#e0/agrave/aacute/acircumflex/atilde/adieresis/aring/ae/ccedilla 16#e8/egrave/eacute/ecircumflex/edieresis/igrave/iacute/icircumflex/idieresis 16#f0/eth/ntilde/ograve/oacute/ocircumflex/otilde/odieresis/divide 16#f8/oslash/ugrave/uacute/ucircumflex/udieresis/yacute/thorn/ydieresis]def AutoFlatness{/@ifl{dup currentflat exch sub 10 gt{ ([Error: PathTooComplex; OffendingCommand: AnyPaintingOperator]\n)print flush @np exit}{currentflat 2 add setflat}ifelse}bd/@fill/fill ld/fill{currentflat{ {@fill}stopped{@ifl}{exit}ifelse}bind loop setflat}bd/@eofill/eofill ld/eofill {currentflat{{@eofill}stopped{@ifl}{exit}ifelse}bind loop setflat}bd/@clip /clip ld/clip{currentflat{{@clip}stopped{@ifl}{exit}ifelse}bind loop setflat} bd/@eoclip/eoclip ld/eoclip{currentflat{{@eoclip}stopped{@ifl}{exit}ifelse} bind loop setflat}bd/@stroke/stroke ld/stroke{currentflat{{@stroke}stopped {@ifl}{exit}ifelse}bind loop setflat}bd}if/d/setdash ld/j/setlinejoin ld/J /setlinecap ld/M/setmiterlimit ld/w/setlinewidth ld/O{/$o xd}bd/R{/$O xd}bd/W /eoclip ld/c/curveto ld/C/c ld/l/lineto ld/L/l ld/rl/rlineto ld/m/moveto ld/n /newpath ld/N/newpath ld/P{11 rp}bd/u{}bd/U{}bd/A{pop}bd/q/@gs ld/Q/@gr ld/` {}bd/~{}bd/@{}bd/&{}bd/@j{@sv @np}bd/@J{@rs}bd/g{1 exch sub/$k xd/$c 0 def/$m 0 def/$y 0 def/$t 1 def/$n _ def/$fil 0 def}bd/G{1 sub neg/$K xd _ 1 0 0 0/$C xd /$M xd/$Y xd/$T xd/$N xd}bd/k{1 index type/stringtype eq{/$t xd/$n xd}{/$t 0 def/$n _ def}ifelse/$k xd/$y xd/$m xd/$c xd/$fil 0 def}bd/K{1 index type /stringtype eq{/$T xd/$N xd}{/$T 0 def/$N _ def}ifelse/$K xd/$Y xd/$M xd/$C xd }bd/x/k ld/X/K ld/sf{1 index type/stringtype eq{/s1t xd/s1n xd}{/s1t 0 def/s1n _ def}ifelse/s1k xd/s1y xd/s1m xd/s1c xd}bd/i{dup 0 ne{setflat}{pop}ifelse}bd /v{4 -2 roll 2 copy 6 -2 roll c}bd/V/v ld/y{2 copy c}bd/Y/y ld/@w{matrix rotate /$ptm xd matrix scale $ptm dup concatmatrix/$ptm xd 1 eq{$ptm exch dup concatmatrix/$ptm xd}if 1 w}bd/@g{1 eq dup/$sdf xd{/$scp xd/$sca xd/$scf xd}if }bd/@G{1 eq dup/$SDF xd{/$SCP xd/$SCA xd/$SCF xd}if}bd/@D{2 index 0 eq{$dsf 3 1 roll 4 -1 roll pop}if 3 copy exch $Scra add exch load SetScr/$dsp xd/$dsa xd /$dsf xd}bd/$ngx{$SDF{$SCF SepMode 0 eq{$SCA}{$dsa}ifelse $SCP @ss}if}bd/p{ /$pm xd 7 rp/$pyf xd/$pxf xd/$pn xd/$fil 1 def}bd/@MN{2 copy le{pop}{exch pop} ifelse}bd/@MX{2 copy ge{pop}{exch pop}ifelse}bd/InRange{3 -1 roll @MN @MX}bd /wDstChck{2 1 roll dup 3 -1 roll eq{1 add}if}bd/@dot{dup mul exch dup mul add 1 exch sub}bd/@lin{exch pop abs 1 exch sub}bd/cmyk2rgb{3{dup 5 -1 roll add 1 exch sub dup 0 lt{pop 0}if exch}repeat pop}bd/rgb2cmyk{3{1 exch sub 3 1 roll}repeat 3 copy @MN @MN 3{dup 5 -1 roll sub neg exch}repeat}bd/rgb2g{2 index .299 mul 2 index .587 mul add 1 index .114 mul add 4 1 roll 3 rp}bd/WaldoColor where{pop} {/SetRgb/setrgbcolor ld/GetRgb/currentrgbcolor ld/SetGry/setgray ld/GetGry /currentgray ld/SetRgb2 systemdict/setrgbcolor get def/GetRgb2 systemdict /currentrgbcolor get def/SetHsb systemdict/sethsbcolor get def/GetHsb systemdict/currenthsbcolor get def/rgb2hsb{SetRgb2 GetHsb}bd/hsb2rgb{3 -1 roll dup floor sub 3 1 roll SetHsb GetRgb2}bd/setcmykcolor where{pop/SetCmyk /setcmykcolor ld}{/SetCmyk{cmyk2rgb SetRgb}bd}ifelse/currentcmykcolor where{ pop/GetCmyk/currentcmykcolor ld}{/GetCmyk{GetRgb rgb2cmyk}bd}ifelse /setoverprint where{pop}{/setoverprint{/$op xd}bd}ifelse/currentoverprint where {pop}{/currentoverprint{$op}bd}ifelse/@tc{5 -1 roll dup 1 ge{pop}{4{dup 6 -1 roll mul exch}repeat pop}ifelse}bd/@trp{exch pop 5 1 roll @tc}bd /setprocesscolor{SepMode 0 eq{SetCmyk}{0 4 $ink sub index exch pop 5 1 roll 4 rp SepsColor true eq{$ink 3 gt{1 sub neg SetGry}{0 0 0 4 $ink roll SetCmyk} ifelse}{1 sub neg SetGry}ifelse}ifelse}bd/findcmykcustomcolor where{pop}{ /findcmykcustomcolor{5 array astore}bd}ifelse/setcustomcolor where{pop}{ /setcustomcolor{exch aload pop SepMode 0 eq{pop @tc setprocesscolor}{ CurrentInkName eq{4 index}{0}ifelse 6 1 roll 5 rp 1 sub neg SetGry}ifelse}bd} ifelse/@scc{dup type/booleantype eq{setoverprint}{1 eq setoverprint}ifelse dup _ eq{pop setprocesscolor pop}{findcmykcustomcolor exch setcustomcolor}ifelse SepMode 0 eq{true}{GetGry 1 eq currentoverprint and not}ifelse}bd/colorimage where{pop/ColorImage/colorimage ld}{/ColorImage{/ncolors xd pop/dataaq xd{ dataaq ncolors dup 3 eq{/$dat xd 0 1 $dat length 3 div 1 sub{dup 3 mul $dat 1 index get 255 div $dat 2 index 1 add get 255 div $dat 3 index 2 add get 255 div rgb2g 255 mul cvi exch pop $dat 3 1 roll put}for $dat 0 $dat length 3 idiv getinterval pop}{4 eq{/$dat xd 0 1 $dat length 4 div 1 sub{dup 4 mul $dat 1 index get 255 div $dat 2 index 1 add get 255 div $dat 3 index 2 add get 255 div $dat 4 index 3 add get 255 div cmyk2rgb rgb2g 255 mul cvi exch pop $dat 3 1 roll put}for $dat 0 $dat length ncolors idiv getinterval}if}ifelse}image}bd }ifelse/setcmykcolor{1 5 1 roll _ currentoverprint @scc/$ffpnt xd}bd /currentcmykcolor{0 0 0 0}bd/setrgbcolor{rgb2cmyk setcmykcolor}bd /currentrgbcolor{currentcmykcolor cmyk2rgb}bd/sethsbcolor{hsb2rgb setrgbcolor} bd/currenthsbcolor{currentrgbcolor rgb2hsb}bd/setgray{dup dup setrgbcolor}bd /currentgray{currentrgbcolor rgb2g}bd}ifelse/WaldoColor true def/@sft{$tllx $pxf add dup $tllx gt{$pwid sub}if/$tx xd $tury $pyf sub dup $tury lt{$phei add}if/$ty xd}bd/@stb{pathbbox/$ury xd/$urx xd/$lly xd/$llx xd}bd/@ep{{cvx exec }forall}bd/@tp{@sv/$in true def 2 copy dup $lly le{/$in false def}if $phei sub $ury ge{/$in false def}if dup $urx ge{/$in false def}if $pwid add $llx le{/$in false def}if $in{@np 2 copy m $pwid 0 rl 0 $phei neg rl $pwid neg 0 rl 0 $phei rl clip @np $pn cvlit load aload pop 7 -1 roll 5 index sub 7 -1 roll 3 index sub Tl matrix currentmatrix/$ctm xd @ep 4 rp}{2 rp}ifelse @rs}bd/@th{@sft 0 1 $tly 1 sub{dup $psx mul $tx add{dup $llx gt{$pwid sub}{exit}ifelse}loop exch $phei mul $ty exch sub 0 1 $tlx 1 sub{$pwid mul 3 copy 3 -1 roll add exch @tp pop}for 2 rp}for}bd/@tv{@sft 0 1 $tlx 1 sub{dup $pwid mul $tx add exch $psy mul $ty exch sub{dup $ury lt{$phei add}{exit}ifelse}loop 0 1 $tly 1 sub{$phei mul 3 copy sub @tp pop}for 2 rp}for}bd/@pf{@gs $ctm setmatrix $pm concat @stb eoclip Bburx Bbury $pm itransform/$tury xd/$turx xd Bbllx Bblly $pm itransform/$tlly xd/$tllx xd/$wid $turx $tllx sub def/$hei $tury $tlly sub def @gs $vectpat{1 0 0 0 0 _ $o @scc{eofill}if}{$t $c $m $y $k $n $o @scc{SepMode 0 eq $pfrg or{ $tllx $tlly Tl $wid $hei scale <00> 8 1 false[8 0 0 1 0 0]{}imagemask}{/$bkg true def}ifelse}if}ifelse @gr $wid 0 gt $hei 0 gt and{$pn cvlit load aload pop /$pd xd 3 -1 roll sub/$phei xd exch sub/$pwid xd $wid $pwid div ceiling 1 add /$tlx xd $hei $phei div ceiling 1 add/$tly xd $psx 0 eq{@tv}{@th}ifelse}if @gr @np/$bkg false def}bd/@dlt{$fse $fss sub/nff xd $frb dup 1 eq exch 2 eq or{ $frt dup $frc $frm $fry $frk @tc 4 copy cmyk2rgb rgb2hsb 3 copy/myb xd/mys xd /myh xd $tot $toc $tom $toy $tok @tc cmyk2rgb rgb2hsb 3 1 roll 4 1 roll 5 1 roll sub neg nff div/kdb xd sub neg nff div/kds xd sub neg dup 0 eq{pop $frb 2 eq{.99}{-.99}ifelse}if dup $frb 2 eq exch 0 lt and{1 add}if dup $frb 1 eq exch 0 gt and{1 sub}if nff div/kdh xd}{$frt dup $frc $frm $fry $frk @tc 5 copy $tot dup $toc $tom $toy $tok @tc 5 1 roll 6 1 roll 7 1 roll 8 1 roll 9 1 roll sub neg nff dup 1 gt{1 sub}if div/$dk xd sub neg nff dup 1 gt{1 sub}if div/$dy xd sub neg nff dup 1 gt{1 sub}if div/$dm xd sub neg nff dup 1 gt{1 sub}if div/$dc xd sub neg nff dup 1 gt{1 sub}if div/$dt xd}ifelse}bd/ffcol{5 copy $fsit 0 eq{ setcmykcolor pop}{SepMode 0 ne{$frn findcmykcustomcolor exch setcustomcolor}{4 rp $frc $frm $fry $frk $frn findcmykcustomcolor exch setcustomcolor}ifelse} ifelse}bd/@ftl{1 index 4 index sub dup $pad mul dup/$pdw xd 2 mul sub $fst div /$wid xd 2 index sub/$hei xd pop Tl @dlt $fss 0 eq{ffcol n 0 0 m 0 $hei l $pdw $hei l $pdw 0 l @cp $ffpnt{fill}{@np}ifelse}if $fss $wid mul $pdw add 0 Tl nff {ffcol n 0 0 m 0 $hei l $wid $hei l $wid 0 l @cp $ffpnt{fill}{@np}ifelse $wid 0 Tl $frb dup 1 eq exch 2 eq or{4 rp myh mys myb kdb add 3 1 roll kds add 3 1 roll kdh add 3 1 roll 3 copy/myb xd/mys xd/myh xd hsb2rgb rgb2cmyk}{$dk add 5 1 roll $dy add 5 1 roll $dm add 5 1 roll $dc add 5 1 roll $dt add 5 1 roll} ifelse}repeat 5 rp $tot dup $toc $tom $toy $tok @tc ffcol n 0 0 m 0 $hei l $pdw $hei l $pdw 0 l @cp $ffpnt{fill}{@np}ifelse 5 rp}bd/@ftr{1 index 4 index sub dup $rox mul/$row xd 2 div 1 index 4 index sub dup $roy mul/$roh xd 2 div 2 copy dup mul exch dup mul add sqrt $row dup mul $roh dup mul add sqrt add dup /$hei xd $fst div/$wid xd 4 index add $roh add exch 5 index add $row add exch Tl 4 rp @dlt $fss 0 eq{ffcol $wid 0 m 0 0 $hei 0 360 arc $ffpnt{fill}{@np} ifelse}if 1.0 $pad 2 mul sub dup scale $hei $fss $wid mul sub/$hei xd nff{ ffcol n $wid 0 m 0 0 $hei 0 360 arc $ffpnt{fill}{@np}ifelse/$hei $hei $wid sub def $frb dup 1 eq exch 2 eq or{4 rp myh mys myb kdb add 3 1 roll kds add 3 1 roll kdh add 3 1 roll 3 copy/myb xd/mys xd/myh xd hsb2rgb rgb2cmyk}{$dk add 5 1 roll $dy add 5 1 roll $dm add 5 1 roll $dc add 5 1 roll $dt add 5 1 roll} ifelse}repeat 5 rp}bd/@ftc{1 index 4 index sub dup $rox mul/$row xd 2 div 1 index 4 index sub dup $roy mul/$roh xd 2 div 2 copy dup mul exch dup mul add sqrt $row dup mul $roh dup mul add sqrt add dup/$hei xd $fst div/$wid xd 4 index add $roh add exch 5 index add $row add exch Tl 4 rp @dlt $fss 0 eq{ffcol $ffpnt{fill}{@np}ifelse}{n}ifelse/$dang 180 $fst 1 sub div def/$sang $dang -2 div 180 add def/$eang $dang 2 div 180 add def/$sang $sang $dang $fss mul add def/$eang $eang $dang $fss mul add def/$sang $eang $dang sub def nff{ffcol n $wid 0 m 0 0 $hei $sang $fan add $eang $fan add arc $ffpnt{fill}{@np}ifelse $wid 0 m 0 0 $hei $eang neg $fan add $sang neg $fan add arc $ffpnt{fill}{@np} ifelse/$sang $eang def/$eang $eang $dang add def $frb dup 1 eq exch 2 eq or{4 rp myh mys myb kdb add 3 1 roll kds add 3 1 roll kdh add 3 1 roll 3 copy/myb xd /mys xd/myh xd hsb2rgb rgb2cmyk}{$dk add 5 1 roll $dy add 5 1 roll $dm add 5 1 roll $dc add 5 1 roll $dt add 5 1 roll}ifelse}repeat 5 rp}bd/@ff{/$fss 0 def $o 1 eq setoverprint 1 1 $fsc 1 sub{dup 1 sub $fsit 0 eq{$fsa exch 5 mul 5 getinterval aload 2 rp/$frk xd/$fry xd/$frm xd/$frc xd/$frn _ def/$frt 1 def $fsa exch 5 mul 5 getinterval aload pop $fss add/$fse xd/$tok xd/$toy xd/$tom xd/$toc xd/$ton _ def/$tot 1 def}{$fsa exch 7 mul 7 getinterval aload 2 rp /$frt xd/$frn xd/$frk xd/$fry xd/$frm xd/$frc xd $fsa exch 7 mul 7 getinterval aload pop $fss add/$fse xd/$tot xd/$ton xd/$tok xd/$toy xd/$tom xd/$toc xd} ifelse $fsit 0 eq SepMode 0 eq or dup not CurrentInkName $frn eq and or{@sv $ctm setmatrix eoclip Bbllx Bblly Bburx Bbury $fty 2 eq{@ftc}{$fty 1 eq{1 index 3 index m 2 copy l 3 index 1 index l 3 index 3 index l @cp @ftr}{1 index 3 index m 2 copy l 3 index 1 index l 3 index 3 index l @cp 4 rp $fan rotate pathbbox @ftl}ifelse}ifelse @rs/$fss $fse def}{1 0 0 0 0 _ $o @scc{fill}if} ifelse}for @np}bd/@Pf{@sv SepMode 0 eq $ink 3 eq or{0 J 0 j[]0 d $t $c $m $y $k $n $o @scc pop $ctm setmatrix 72 1000 div dup matrix scale dup concat dup Bburx exch Bbury exch itransform ceiling cvi/Bbury xd ceiling cvi/Bburx xd Bbllx exch Bblly exch itransform floor cvi/Bblly xd floor cvi/Bbllx xd $Prm aload pop $Psn load exec}{1 SetGry eofill}ifelse @rs @np}bd/F{matrix currentmatrix $sdf{$scf $sca $scp @ss}if $fil 1 eq{@pf}{$fil 2 eq{@ff}{$fil 3 eq{@Pf}{$t $c $m $y $k $n $o @scc{eofill}{@np}ifelse}ifelse}ifelse}ifelse $sdf{$dsf $dsa $dsp @ss}if setmatrix}bd/f{@cp F}bd/S{matrix currentmatrix $ctm setmatrix $SDF{$SCF $SCA $SCP @ss}if $T $C $M $Y $K $N $O @scc{matrix currentmatrix $ptm concat stroke setmatrix}{@np}ifelse $SDF{$dsf $dsa $dsp @ss}if setmatrix}bd/s{@cp S}bd/B{@gs F @gr S}bd/b{@cp B}bd/E{5 array astore exch cvlit xd}bd/@cc{currentfile $dat readhexstring pop}bd/@sm{/$ctm $ctm currentmatrix def}bd/@E{/Bbury xd/Bburx xd /Bblly xd/Bbllx xd}bd/@c{@cp}bd/@p{/$fil 1 def 1 eq dup/$vectpat xd{/$pfrg true def}{@gs $t $c $m $y $k $n $o @scc/$pfrg xd @gr}ifelse/$pm xd/$psy xd/$psx xd /$pyf xd/$pxf xd/$pn xd}bd/@P{/$fil 3 def/$Psn xd array astore/$Prm xd}bd/@k{ /$fil 2 def/$roy xd/$rox xd/$pad xd/$fty xd/$fan xd $fty 1 eq{/$fan 0 def}if /$frb xd/$fst xd/$fsc xd/$fsa xd/$fsit 0 def}bd/@x{/$fil 2 def/$roy xd/$rox xd /$pad xd/$fty xd/$fan xd $fty 1 eq{/$fan 0 def}if/$frb xd/$fst xd/$fsc xd/$fsa xd/$fsit 1 def}bd/@ii{concat 3 index 3 index m 3 index 1 index l 2 copy l 1 index 3 index l 3 index 3 index l clip 4 rp}bd/tcc{@cc}def/@i{@sm @gs @ii 6 index 1 ne{/$frg true def 2 rp}{1 eq{s1t s1c s1m s1y s1k s1n $O @scc/$frg xd}{ /$frg false def}ifelse 1 eq{@gs $ctm setmatrix F @gr}if}ifelse @np/$ury xd /$urx xd/$lly xd/$llx xd/$bts xd/$hei xd/$wid xd/$dat $wid $bts mul 8 div ceiling cvi string def $bkg $frg or{$SDF{$SCF $SCA $SCP @ss}if $llx $lly Tl $urx $llx sub $ury $lly sub scale $bkg{$t $c $m $y $k $n $o @scc pop}if $wid $hei abs $bts 1 eq{$bkg}{$bts}ifelse[$wid 0 0 $hei neg 0 $hei 0 gt{$hei}{0}ifelse]/tcc load $bts 1 eq{imagemask}{image}ifelse $SDF{$dsf $dsa $dsp @ss}if}{$hei abs{tcc pop}repeat}ifelse @gr $ctm setmatrix}bd/@M{@sv}bd/@N {/@cc{}def 1 eq{12 -1 roll neg 12 1 roll @I}{13 -1 roll neg 13 1 roll @i} ifelse @rs}bd/@I{@sm @gs @ii @np/$ury xd/$urx xd/$lly xd/$llx xd/$ncl xd/$bts xd/$hei xd/$wid xd/$dat $wid $bts mul $ncl mul 8 div ceiling cvi string def $ngx $llx $lly Tl $urx $llx sub $ury $lly sub scale $wid $hei abs $bts[$wid 0 0 $hei neg 0 $hei 0 gt{$hei}{0}ifelse]/@cc load false $ncl ColorImage $SDF{$dsf $dsa $dsp @ss}if @gr $ctm setmatrix}bd/z{exch findfont exch scalefont setfont} bd/ZB{9 dict dup begin 4 1 roll/FontType 3 def/FontMatrix xd/FontBBox xd /Encoding 256 array def 0 1 255{Encoding exch/.notdef put}for/CharStrings 256 dict def CharStrings/.notdef{}put/Metrics 256 dict def Metrics/.notdef 3 -1 roll put/BuildChar{exch dup/$char exch/Encoding get 3 index get def dup /Metrics get $char get aload pop setcachedevice begin Encoding exch get CharStrings exch get end exec}def end definefont pop}bd/ZBAddChar{findfont begin dup 4 1 roll dup 6 1 roll Encoding 3 1 roll put CharStrings 3 1 roll put Metrics 3 1 roll put end}bd/Z{findfont dup maxlength 2 add dict exch dup{1 index/FID ne{3 index 3 1 roll put}{2 rp}ifelse}forall pop dup dup/Encoding get 256 array copy dup/$fe xd/Encoding exch put dup/Fontname 3 index put 3 -1 roll dup length 0 ne{0 exch{dup type 0 type eq{exch pop}{$fe exch 2 index exch put 1 add}ifelse}forall pop}if dup 256 dict dup/$met xd/Metrics exch put dup /FontMatrix get 0 get 1000 mul 1 exch div 3 index length 256 eq{0 1 255{dup $fe exch get dup/.notdef eq{2 rp}{5 index 3 -1 roll get 2 index mul $met 3 1 roll put}ifelse}for}if pop definefont pop pop}bd/@ftx{{currentpoint 3 -1 roll(0)dup 3 -1 roll 0 exch put dup @gs true charpath $ctm setmatrix @@txt @gr @np stringwidth pop 3 -1 roll add exch moveto}forall}bd/@ft{matrix currentmatrix exch $sdf{$scf $sca $scp @ss}if $fil 1 eq{/@@txt/@pf ld @ftx}{$fil 2 eq{/@@txt /@ff ld @ftx}{$fil 3 eq{/@@txt/@Pf ld @ftx}{$t $c $m $y $k $n $o @scc{show} {pop}ifelse}ifelse}ifelse}ifelse $sdf{$dsf $dsa $dsp @ss}if setmatrix}bd/@st{ matrix currentmatrix exch $SDF{$SCF $SCA $SCP @ss}if $T $C $M $Y $K $N $O @scc {{currentpoint 3 -1 roll(0)dup 3 -1 roll 0 exch put dup @gs true charpath $ctm setmatrix $ptm concat stroke @gr @np stringwidth pop 3 -1 roll add exch moveto }forall}{pop}ifelse $SDF{$dsf $dsa $dsp @ss}if setmatrix}bd/@te{@ft}bd/@tr{@st }bd/@ta{dup @gs @ft @gr @st}bd/@t@a{dup @gs @st @gr @ft}bd/@tm{@sm concat}bd/e {/t{@te}def}bd/r{/t{@tr}def}bd/o{/t{pop}def}bd/a{/t{@ta}def}bd/@a{/t{@t@a}def} bd/t{@te}def/T{@np $ctm setmatrix/$ttm matrix def}bd/ddt{t}def/@t{/$stm $stm currentmatrix def 3 1 roll moveto $ttm concat ddt $stm setmatrix}bd/@n{/$ttm exch matrix rotate def}bd/@s{}bd/@l{}bd/@B{@gs S @gr F}bd/@b{@cp @B}bd/@sep{ CurrentInkName(Composite)eq{/$ink -1 def}{CurrentInkName(Cyan)eq{/$ink 0 def}{ CurrentInkName(Magenta)eq{/$ink 1 def}{CurrentInkName(Yellow)eq{/$ink 2 def}{ CurrentInkName(Black)eq{/$ink 3 def}{/$ink 4 def}ifelse}ifelse}ifelse}ifelse} ifelse}bd/@whi{@gs -72000 dup moveto -72000 72000 lineto 72000 dup lineto 72000 -72000 lineto @cp 1 SetGry fill @gr}bd/@neg{[{1 exch sub}/exec cvx currenttransfer/exec cvx]cvx settransfer @whi}bd/currentscale{1 0 dtransform matrix defaultmatrix idtransform dup mul exch dup mul add sqrt 0 1 dtransform matrix defaultmatrix idtransform dup mul exch dup mul add sqrt}bd/@unscale{ currentscale 1 exch div exch 1 exch div exch scale}bd/@square{dup 0 rlineto dup 0 exch rlineto neg 0 rlineto @cp}bd/corelsym{@gs @np Tl -90 rotate 7{45 rotate -.75 2 moveto 1.5 @square fill}repeat @gr}bd/@reg Corelreg{{@gs @np Tl -6 -6 moveto 12 @square @gs 1 GetGry sub SetGry fill @gr 4{90 rotate 0 4 m 0 4 rl} repeat stroke 0 0 corelsym @gr}bd}{{@gs @np Tl .3 setlinewidth 0 0 5 0 360 arc @cp @gs 1 GetGry sub SetGry fill @gr 4{90 rotate 0 0 m 0 8 rl}repeat stroke @gr }bd}ifelse/$corelmeter[1 .95 .75 .50 .25 .05 0]def/@colormeter{@gs @np 0 SetGry 0.3 setlinewidth/Courier findfont 5 scalefont setfont/yy xd/xx xd 0 1 6{xx 20 sub yy m 20 @square @gs $corelmeter exch get dup SetGry fill @gr stroke xx 2 add yy 8 add moveto 100 mul 100 exch sub cvi 20 string cvs show/yy yy 20 add def}for @gr}bd/@crop{@gs .3 setlinewidth 0 SetGry Tl rotate 0 0 m 0 -24 rl -4 -24 m 8 @square -4 -20 m 8 0 rl stroke @gr}bd/@colorbox{@gs @np Tl 100 exch sub 100 div SetGry -8 -8 moveto 16 @square fill 0 SetGry 10 -2 moveto show @gr}bd /deflevel 0 def/@sax{/deflevel deflevel 1 add def}bd/@eax{/deflevel deflevel dup 0 gt{1 sub}if def deflevel 0 gt{/eax load}{eax}ifelse}bd/eax{{exec}forall} bd/@rax{deflevel 0 eq{@rs @sv}if}bd/@daq{dup type/arraytype eq{{}forall}if}bd /@BMP{/@cc xd 11 index 1 eq{12 -1 roll pop @i}{7 -2 roll 2 rp @I}ifelse}bd end %%EndProlog wCorel4Dict begin %%BeginSetup 11.4737 setmiterlimit 1.00 setflat /$fst 256 def %%EndSetup %StartPage @sv /$ctm matrix currentmatrix def @sv %StartColorLayer (COMPOSITE) %StartTile /$ctm matrix currentmatrix def @sv @sv @rax %%Note: Object 2296.87 2324.88 2425.32 2339.57 @E 0 O 0 @g 0.00 0.00 0.00 1.00 k 2301.62 2337.77 m 2301.55 2338.70 2300.83 2339.57 2299.39 2339.57 c 2297.81 2339.57 2296.87 2338.42 2296.87 2336.69 c 2296.87 2334.60 2298.10 2333.74 2299.32 2333.74 c 2299.75 2333.74 2301.41 2333.81 2301.70 2335.97 C 2300.98 2335.97 L 2300.76 2334.67 2299.90 2334.46 2299.39 2334.46 c 2298.10 2334.46 2297.59 2335.46 2297.59 2336.76 c 2297.59 2338.20 2298.38 2338.92 2299.39 2338.92 c 2299.90 2338.92 2300.76 2338.78 2300.90 2337.77 C 2301.62 2337.77 L @c 2306.59 2334.60 m 2303.28 2334.60 L 2303.28 2336.47 L 2306.30 2336.47 L 2306.30 2337.12 L 2303.28 2337.12 L 2303.28 2338.78 L 2306.59 2338.78 L 2306.59 2339.42 L 2302.56 2339.42 L 2302.56 2333.95 L 2306.59 2333.95 L 2306.59 2334.60 L @c 2311.13 2335.03 m 2311.06 2335.03 L 2308.32 2339.42 L 2307.46 2339.42 L 2307.46 2333.95 L 2308.18 2333.95 L 2308.18 2338.34 L 2308.18 2338.34 L 2310.98 2333.95 L 2311.78 2333.95 L 2311.78 2339.42 L 2311.13 2339.42 L 2311.13 2335.03 L @c 2312.35 2338.78 m 2314.22 2338.78 L 2314.22 2333.95 L 2315.02 2333.95 L 2315.02 2338.78 L 2316.82 2338.78 L 2316.82 2339.42 L 2312.35 2339.42 L 2312.35 2338.78 L @c 2321.50 2334.60 m 2318.18 2334.60 L 2318.18 2336.47 L 2321.21 2336.47 L 2321.21 2337.12 L 2318.18 2337.12 L 2318.18 2338.78 L 2321.50 2338.78 L 2321.50 2339.42 L 2317.46 2339.42 L 2317.46 2333.95 L 2321.50 2333.95 L 2321.50 2334.60 L @c 2323.22 2336.33 m 2325.02 2336.33 l 2325.89 2336.33 2325.96 2335.75 2325.96 2335.32 c 2325.96 2335.10 2325.96 2334.31 2326.10 2333.95 C 2327.04 2333.95 L 2327.04 2334.10 L 2326.75 2334.17 2326.75 2334.31 2326.75 2334.60 c 2326.68 2335.61 l 2326.68 2336.40 2326.32 2336.54 2326.03 2336.62 C 2326.39 2336.83 2326.82 2337.12 2326.82 2337.98 c 2326.82 2339.14 2325.89 2339.42 2325.02 2339.42 c 2322.43 2339.42 L 2322.43 2333.95 L 2323.22 2333.95 L 2323.22 2336.33 L @c 2323.22 2338.78 m 2325.02 2338.78 l 2325.38 2338.78 2326.03 2338.70 2326.03 2337.91 c 2326.03 2337.05 2325.46 2336.90 2324.88 2336.90 c 2323.22 2336.90 L 2323.22 2338.78 L @c 2331.79 2337.84 m 2331.72 2338.42 2331.58 2339.57 2329.63 2339.57 c 2328.26 2339.57 2327.76 2338.70 2327.76 2337.91 c 2327.76 2336.90 2328.55 2336.69 2328.91 2336.62 c 2330.06 2336.33 l 2330.93 2336.11 2331.22 2335.97 2331.22 2335.39 c 2331.22 2334.60 2330.28 2334.46 2329.78 2334.46 c 2329.06 2334.46 2328.26 2334.74 2328.26 2335.75 C 2327.54 2335.75 L 2327.54 2335.18 2327.62 2334.74 2328.12 2334.31 c 2328.34 2334.10 2328.77 2333.74 2329.78 2333.74 c 2330.71 2333.74 2331.94 2334.17 2331.94 2335.46 c 2331.94 2336.33 2331.36 2336.76 2330.64 2336.90 c 2329.13 2337.26 l 2328.77 2337.34 2328.48 2337.55 2328.48 2337.98 c 2328.48 2338.85 2329.27 2338.92 2329.70 2338.92 c 2330.35 2338.92 2331.00 2338.70 2331.07 2337.84 C 2331.79 2337.84 L @c 2336.54 2336.47 m 2339.28 2336.47 L 2339.28 2337.12 L 2336.54 2337.12 L 2336.54 2338.78 L 2339.64 2338.78 L 2339.64 2339.42 L 2335.82 2339.42 L 2335.82 2333.95 L 2336.54 2333.95 L 2336.54 2336.47 L @c 2344.61 2336.69 m 2344.61 2335.39 2343.89 2334.46 2342.66 2334.46 c 2341.51 2334.46 2340.79 2335.39 2340.79 2336.69 c 2340.79 2337.98 2341.51 2338.92 2342.66 2338.92 c 2343.89 2338.92 2344.61 2337.98 2344.61 2336.69 c @c 2345.33 2336.69 m 2345.33 2337.84 2344.75 2339.57 2342.66 2339.57 c 2340.65 2339.57 2340.00 2337.84 2340.00 2336.69 c 2340.00 2335.54 2340.65 2333.74 2342.66 2333.74 c 2344.75 2333.74 2345.33 2335.54 2345.33 2336.69 c @c 2346.91 2336.33 m 2348.71 2336.33 l 2349.58 2336.33 2349.65 2335.75 2349.65 2335.32 c 2349.65 2335.10 2349.65 2334.31 2349.79 2333.95 C 2350.73 2333.95 L 2350.73 2334.10 L 2350.44 2334.17 2350.44 2334.31 2350.44 2334.60 c 2350.37 2335.61 l 2350.37 2336.40 2350.01 2336.54 2349.72 2336.62 C 2350.08 2336.83 2350.51 2337.12 2350.51 2337.98 c 2350.51 2339.14 2349.58 2339.42 2348.71 2339.42 c 2346.12 2339.42 L 2346.12 2333.95 L 2346.91 2333.95 L 2346.91 2336.33 L @c 2346.91 2338.78 m 2348.71 2338.78 l 2349.07 2338.78 2349.72 2338.70 2349.72 2337.91 c 2349.72 2337.05 2349.14 2336.90 2348.57 2336.90 c 2346.91 2336.90 L 2346.91 2338.78 L @c 2354.54 2333.95 m 2356.70 2333.95 l 2358.50 2333.95 2359.01 2335.54 2359.01 2336.76 c 2359.01 2338.34 2358.14 2339.42 2356.70 2339.42 c 2354.54 2339.42 L 2354.54 2333.95 L @c 2355.26 2338.78 m 2356.63 2338.78 l 2357.64 2338.78 2358.29 2338.13 2358.29 2336.69 c 2358.29 2335.32 2357.64 2334.60 2356.70 2334.60 c 2355.26 2334.60 L 2355.26 2338.78 L @c 2360.74 2339.42 m 2360.02 2339.42 L 2360.02 2333.95 L 2360.74 2333.95 L 2360.74 2339.42 L @c 2365.85 2337.84 m 2365.78 2338.42 2365.63 2339.57 2363.69 2339.57 c 2362.32 2339.57 2361.82 2338.70 2361.82 2337.91 c 2361.82 2336.90 2362.61 2336.69 2362.97 2336.62 c 2364.12 2336.33 l 2364.98 2336.11 2365.27 2335.97 2365.27 2335.39 c 2365.27 2334.60 2364.34 2334.46 2363.83 2334.46 c 2363.11 2334.46 2362.32 2334.74 2362.32 2335.75 C 2361.60 2335.75 L 2361.60 2335.18 2361.67 2334.74 2362.18 2334.31 c 2362.39 2334.10 2362.82 2333.74 2363.83 2333.74 c 2364.77 2333.74 2365.99 2334.17 2365.99 2335.46 c 2365.99 2336.33 2365.42 2336.76 2364.70 2336.90 c 2363.18 2337.26 l 2362.82 2337.34 2362.54 2337.55 2362.54 2337.98 c 2362.54 2338.85 2363.33 2338.92 2363.76 2338.92 c 2364.41 2338.92 2365.06 2338.70 2365.13 2337.84 C 2365.85 2337.84 L @c 2370.89 2334.60 m 2367.58 2334.60 L 2367.58 2336.47 L 2370.60 2336.47 L 2370.60 2337.12 L 2367.58 2337.12 L 2367.58 2338.78 L 2370.89 2338.78 L 2370.89 2339.42 L 2366.86 2339.42 L 2366.86 2333.95 L 2370.89 2333.95 L 2370.89 2334.60 L @c 2374.85 2335.54 m 2375.35 2333.95 L 2376.14 2333.95 L 2374.20 2339.42 L 2373.34 2339.42 L 2371.25 2333.95 L 2372.04 2333.95 L 2372.62 2335.54 L 2374.85 2335.54 L @c 2372.83 2336.18 m 2373.70 2338.63 L 2373.77 2338.63 L 2374.56 2336.18 L 2372.83 2336.18 L @c 2380.75 2337.84 m 2380.68 2338.42 2380.54 2339.57 2378.59 2339.57 c 2377.22 2339.57 2376.72 2338.70 2376.72 2337.91 c 2376.72 2336.90 2377.51 2336.69 2377.87 2336.62 c 2379.02 2336.33 l 2379.89 2336.11 2380.18 2335.97 2380.18 2335.39 c 2380.18 2334.60 2379.24 2334.46 2378.74 2334.46 c 2378.02 2334.46 2377.22 2334.74 2377.22 2335.75 C 2376.50 2335.75 L 2376.50 2335.18 2376.58 2334.74 2377.08 2334.31 c 2377.30 2334.10 2377.73 2333.74 2378.74 2333.74 c 2379.67 2333.74 2380.90 2334.17 2380.90 2335.46 c 2380.90 2336.33 2380.32 2336.76 2379.60 2336.90 c 2378.09 2337.26 l 2377.73 2337.34 2377.44 2337.55 2377.44 2337.98 c 2377.44 2338.85 2378.23 2338.92 2378.66 2338.92 c 2379.31 2338.92 2379.96 2338.70 2380.03 2337.84 C 2380.75 2337.84 L @c 2385.79 2334.60 m 2382.48 2334.60 L 2382.48 2336.47 L 2385.50 2336.47 L 2385.50 2337.12 L 2382.48 2337.12 L 2382.48 2338.78 L 2385.79 2338.78 L 2385.79 2339.42 L 2381.76 2339.42 L 2381.76 2333.95 L 2385.79 2333.95 L 2385.79 2334.60 L @c 2394.22 2337.77 m 2394.14 2338.70 2393.42 2339.57 2391.98 2339.57 c 2390.40 2339.57 2389.46 2338.42 2389.46 2336.69 c 2389.46 2334.60 2390.69 2333.74 2391.91 2333.74 c 2392.34 2333.74 2394.00 2333.81 2394.29 2335.97 C 2393.57 2335.97 L 2393.35 2334.67 2392.49 2334.46 2391.98 2334.46 c 2390.69 2334.46 2390.18 2335.46 2390.18 2336.76 c 2390.18 2338.20 2390.98 2338.92 2391.98 2338.92 c 2392.49 2338.92 2393.35 2338.78 2393.50 2337.77 C 2394.22 2337.77 L @c 2399.40 2336.69 m 2399.40 2335.39 2398.68 2334.46 2397.46 2334.46 c 2396.30 2334.46 2395.58 2335.39 2395.58 2336.69 c 2395.58 2337.98 2396.30 2338.92 2397.46 2338.92 c 2398.68 2338.92 2399.40 2337.98 2399.40 2336.69 c @c 2400.12 2336.69 m 2400.12 2337.84 2399.54 2339.57 2397.46 2339.57 c 2395.44 2339.57 2394.79 2337.84 2394.79 2336.69 c 2394.79 2335.54 2395.44 2333.74 2397.46 2333.74 c 2399.54 2333.74 2400.12 2335.54 2400.12 2336.69 c @c 2404.51 2335.03 m 2404.44 2335.03 L 2401.70 2339.42 L 2400.84 2339.42 L 2400.84 2333.95 L 2401.56 2333.95 L 2401.56 2338.34 L 2401.56 2338.34 L 2404.37 2333.95 L 2405.16 2333.95 L 2405.16 2339.42 L 2404.51 2339.42 L 2404.51 2335.03 L @c 2405.74 2338.78 m 2407.61 2338.78 L 2407.61 2333.95 L 2408.40 2333.95 L 2408.40 2338.78 L 2410.20 2338.78 L 2410.20 2339.42 L 2405.74 2339.42 L 2405.74 2338.78 L @c 2411.64 2336.33 m 2413.44 2336.33 l 2414.30 2336.33 2414.38 2335.75 2414.38 2335.32 c 2414.38 2335.10 2414.38 2334.31 2414.52 2333.95 C 2415.46 2333.95 L 2415.46 2334.10 L 2415.17 2334.17 2415.17 2334.31 2415.17 2334.60 c 2415.10 2335.61 l 2415.10 2336.40 2414.74 2336.54 2414.45 2336.62 C 2414.81 2336.83 2415.24 2337.12 2415.24 2337.98 c 2415.24 2339.14 2414.30 2339.42 2413.44 2339.42 c 2410.85 2339.42 L 2410.85 2333.95 L 2411.64 2333.95 L 2411.64 2336.33 L @c 2411.64 2338.78 m 2413.44 2338.78 l 2413.80 2338.78 2414.45 2338.70 2414.45 2337.91 c 2414.45 2337.05 2413.87 2336.90 2413.30 2336.90 c 2411.64 2336.90 L 2411.64 2338.78 L @c 2420.35 2336.69 m 2420.35 2335.39 2419.63 2334.46 2418.41 2334.46 c 2417.26 2334.46 2416.54 2335.39 2416.54 2336.69 c 2416.54 2337.98 2417.26 2338.92 2418.41 2338.92 c 2419.63 2338.92 2420.35 2337.98 2420.35 2336.69 c @c 2421.07 2336.69 m 2421.07 2337.84 2420.50 2339.57 2418.41 2339.57 c 2416.39 2339.57 2415.74 2337.84 2415.74 2336.69 c 2415.74 2335.54 2416.39 2333.74 2418.41 2333.74 c 2420.50 2333.74 2421.07 2335.54 2421.07 2336.69 c @c 2422.51 2339.42 m 2421.79 2339.42 L 2421.79 2333.95 L 2425.32 2333.95 L 2425.32 2334.60 L 2422.51 2334.60 L 2422.51 2339.42 L @c 2331.00 2326.68 m 2331.50 2325.10 L 2332.30 2325.10 L 2330.35 2330.57 L 2329.49 2330.57 L 2327.40 2325.10 L 2328.19 2325.10 L 2328.77 2326.68 L 2331.00 2326.68 L @c 2328.98 2327.33 m 2329.85 2329.78 L 2329.92 2329.78 L 2330.71 2327.33 L 2328.98 2327.33 L @c 2336.54 2326.18 m 2336.47 2326.18 L 2333.74 2330.57 L 2332.87 2330.57 L 2332.87 2325.10 L 2333.59 2325.10 L 2333.59 2329.49 L 2333.59 2329.49 L 2336.40 2325.10 L 2337.19 2325.10 L 2337.19 2330.57 L 2336.54 2330.57 L 2336.54 2326.18 L @c 2338.34 2325.10 m 2340.50 2325.10 l 2342.30 2325.10 2342.81 2326.68 2342.81 2327.90 c 2342.81 2329.49 2341.94 2330.57 2340.50 2330.57 c 2338.34 2330.57 L 2338.34 2325.10 L @c 2339.06 2329.92 m 2340.43 2329.92 l 2341.44 2329.92 2342.09 2329.27 2342.09 2327.83 c 2342.09 2326.46 2341.44 2325.74 2340.50 2325.74 c 2339.06 2325.74 L 2339.06 2329.92 L @c 2347.49 2329.92 m 2349.00 2329.92 l 2349.65 2329.92 2350.08 2329.70 2350.08 2329.06 c 2350.08 2328.26 2349.65 2328.05 2349.00 2328.05 c 2347.49 2328.05 L 2347.49 2329.92 L @c 2347.49 2327.40 m 2349.22 2327.40 l 2350.44 2327.40 2350.87 2328.26 2350.87 2329.06 c 2350.87 2329.92 2350.22 2330.57 2349.22 2330.57 c 2346.77 2330.57 L 2346.77 2325.10 L 2347.49 2325.10 L 2347.49 2327.40 L @c 2352.53 2327.47 m 2354.33 2327.47 l 2355.19 2327.47 2355.26 2326.90 2355.26 2326.46 c 2355.26 2326.25 2355.26 2325.46 2355.41 2325.10 C 2356.34 2325.10 L 2356.34 2325.24 L 2356.06 2325.31 2356.06 2325.46 2356.06 2325.74 c 2355.98 2326.75 l 2355.98 2327.54 2355.62 2327.69 2355.34 2327.76 C 2355.70 2327.98 2356.13 2328.26 2356.13 2329.13 c 2356.13 2330.28 2355.19 2330.57 2354.33 2330.57 c 2351.74 2330.57 L 2351.74 2325.10 L 2352.53 2325.10 L 2352.53 2327.47 L @c 2352.53 2329.92 m 2354.33 2329.92 l 2354.69 2329.92 2355.34 2329.85 2355.34 2329.06 c 2355.34 2328.19 2354.76 2328.05 2354.18 2328.05 c 2352.53 2328.05 L 2352.53 2329.92 L @c 2361.17 2325.74 m 2357.86 2325.74 L 2357.86 2327.62 L 2360.88 2327.62 L 2360.88 2328.26 L 2357.86 2328.26 L 2357.86 2329.92 L 2361.17 2329.92 L 2361.17 2330.57 L 2357.14 2330.57 L 2357.14 2325.10 L 2361.17 2325.10 L 2361.17 2325.74 L @c 2364.05 2325.89 m 2363.98 2325.89 L 2362.46 2330.57 L 2361.60 2330.57 L 2363.62 2325.10 L 2364.41 2325.10 L 2366.42 2330.57 L 2365.56 2330.57 L 2364.05 2325.89 L @c 2371.10 2325.74 m 2367.79 2325.74 L 2367.79 2327.62 L 2370.82 2327.62 L 2370.82 2328.26 L 2367.79 2328.26 L 2367.79 2329.92 L 2371.10 2329.92 L 2371.10 2330.57 L 2367.07 2330.57 L 2367.07 2325.10 L 2371.10 2325.10 L 2371.10 2325.74 L @c 2375.64 2326.18 m 2375.57 2326.18 L 2372.83 2330.57 L 2371.97 2330.57 L 2371.97 2325.10 L 2372.69 2325.10 L 2372.69 2329.49 L 2372.69 2329.49 L 2375.50 2325.10 L 2376.29 2325.10 L 2376.29 2330.57 L 2375.64 2330.57 L 2375.64 2326.18 L @c 2376.86 2329.92 m 2378.74 2329.92 L 2378.74 2325.10 L 2379.53 2325.10 L 2379.53 2329.92 L 2381.33 2329.92 L 2381.33 2330.57 L 2376.86 2330.57 L 2376.86 2329.92 L @c 2382.77 2330.57 m 2382.05 2330.57 L 2382.05 2325.10 L 2382.77 2325.10 L 2382.77 2330.57 L @c 2388.17 2327.83 m 2388.17 2326.54 2387.45 2325.60 2386.22 2325.60 c 2385.07 2325.60 2384.35 2326.54 2384.35 2327.83 c 2384.35 2329.13 2385.07 2330.06 2386.22 2330.06 c 2387.45 2330.06 2388.17 2329.13 2388.17 2327.83 c @c 2388.89 2327.83 m 2388.89 2328.98 2388.31 2330.71 2386.22 2330.71 c 2384.21 2330.71 2383.56 2328.98 2383.56 2327.83 c 2383.56 2326.68 2384.21 2324.88 2386.22 2324.88 c 2388.31 2324.88 2388.89 2326.68 2388.89 2327.83 c @c 2393.28 2326.18 m 2393.21 2326.18 L 2390.47 2330.57 L 2389.61 2330.57 L 2389.61 2325.10 L 2390.33 2325.10 L 2390.33 2329.49 L 2390.33 2329.49 L 2393.14 2325.10 L 2393.93 2325.10 L 2393.93 2330.57 L 2393.28 2330.57 L 2393.28 2326.18 L @c F @rax %%Note: Object 2337.05 2342.95 2426.54 2393.57 @E 0 O 0 @g 0.00 0.00 0.00 1.00 k 2383.06 2372.47 m 2383.49 2375.42 2384.21 2377.80 2385.29 2380.03 c 2387.45 2384.21 2390.54 2387.66 2394.65 2389.90 c 2398.68 2392.27 2403.58 2393.57 2409.12 2393.57 c 2413.08 2393.57 2417.69 2392.78 2422.58 2391.41 C 2422.58 2383.13 L 2417.83 2385.94 2412.94 2387.30 2408.18 2387.16 c 2402.86 2387.02 2398.68 2385.22 2395.73 2381.69 c 2392.78 2378.23 2391.19 2373.98 2391.12 2369.02 c 2391.19 2365.42 2392.06 2362.03 2393.57 2359.01 c 2395.08 2355.98 2397.38 2353.39 2400.34 2351.52 c 2403.36 2349.65 2406.96 2348.78 2410.99 2348.78 c 2415.82 2348.93 2420.93 2350.51 2426.26 2353.39 C 2426.54 2353.39 L 2422.58 2345.11 L 2420.35 2344.18 2418.19 2343.60 2416.25 2343.31 c 2414.30 2343.02 2412.29 2342.95 2410.13 2342.95 c 2402.93 2343.02 2396.66 2345.04 2391.41 2348.78 c 2386.66 2352.17 2383.70 2357.21 2382.91 2363.83 C 2382.41 2361.10 2381.47 2358.58 2379.96 2356.13 c 2377.87 2352.53 2374.70 2349.65 2370.46 2347.49 c 2366.28 2345.33 2360.95 2344.10 2354.69 2344.10 c 2337.05 2344.10 L 2337.05 2344.39 L 2339.35 2345.62 2340.43 2347.99 2340.43 2351.45 c 2340.43 2351.52 L 2340.43 2384.93 l 2340.43 2388.60 2339.35 2390.90 2337.05 2391.62 C 2337.05 2391.84 L 2355.70 2391.84 l 2361.67 2391.84 2366.86 2390.69 2371.03 2388.60 c 2375.35 2386.37 2378.59 2383.49 2380.54 2379.89 c 2381.83 2377.66 2382.62 2375.14 2383.06 2372.47 C @c 2348.28 2349.94 m 2349.29 2349.79 2351.09 2349.50 2353.54 2349.36 c 2359.08 2349.43 2364.05 2350.87 2368.22 2353.46 c 2372.40 2356.20 2374.70 2360.38 2374.92 2365.99 c 2375.21 2371.18 2374.34 2375.35 2372.40 2378.45 c 2370.46 2381.47 2368.01 2383.63 2364.98 2384.86 c 2361.96 2385.94 2358.72 2386.58 2355.12 2386.58 c 2353.18 2386.58 2350.87 2386.22 2348.28 2385.79 C 2348.28 2349.94 L @c F @rax %%Note: Object 2293.34 2342.95 2337.48 2393.57 @E 0 O 0 @g 0.00 0.00 0.00 1.00 k 2293.63 2365.99 m 2293.34 2371.10 2294.21 2375.78 2296.22 2380.03 c 2298.38 2384.21 2301.48 2387.66 2305.58 2389.90 c 2309.62 2392.27 2314.51 2393.57 2320.06 2393.57 c 2324.02 2393.57 2328.62 2392.78 2333.52 2391.41 C 2333.52 2383.13 L 2328.77 2385.94 2323.87 2387.30 2319.12 2387.16 c 2313.79 2387.02 2309.62 2385.22 2306.66 2381.69 c 2303.71 2378.23 2302.13 2373.98 2302.06 2369.02 c 2302.13 2365.42 2302.99 2362.03 2304.50 2359.01 c 2306.02 2355.98 2308.32 2353.39 2311.27 2351.52 c 2314.30 2349.65 2317.90 2348.78 2321.93 2348.78 c 2326.75 2348.93 2331.86 2350.51 2337.19 2353.39 C 2337.48 2353.39 L 2333.52 2345.11 L 2331.29 2344.18 2329.13 2343.60 2327.18 2343.31 c 2325.24 2343.02 2323.22 2342.95 2321.06 2342.95 c 2313.86 2343.02 2307.60 2345.04 2302.34 2348.78 c 2297.09 2352.53 2294.06 2358.29 2293.63 2365.92 c 2293.63 2365.99 l @c F @rs @rs /$ctm matrix currentmatrix def %EndTile %EndColorLayer @rs @rs %EndPage %%Trailer end II*0p(~>,,????????????????????????????????    ????>>???????????????????????????????8?0?8~~??0??|????~????~?|??|???>?<??|???<??|??????|x??????|x??????||?Ǐ~?????q?<|?Ǐ>?????p?<~??>?<???p?<????|????p?<??<???q?<??????|???????|q???<G???|q????<G???|p???|???x??|??|??>??~???~?~x???`0?`0??????????Lj???ǏÈ???Ǐ??Ǐ??~?Ǐ>??>?㏏?㏏q??Ǐq?ϟ?Ǐ1??Ǐ???ǏÏ???Ǐx???x???x????8??8T 8@ 8 8 .fPC ..EPSF.fTPC ..EPSF*M *RxhMU.S. DEPARTMENT OF HEALTH & HUMAN SERVICES*PZGMMd* (xKddd*P 6 xcw cc d eyeed@I@Ibdd@5t @d t[@t@I@PP ;[!0ePy0ePed"3{*dd#S #$.D%  d&] '*dd_ KJ`@0M[@0MP|dd)@u*@+@o[,@0M[BbyBuM[ l#i u#is3io3in;ip3i;Ci.j#i t#il#is3i!Ci%n#i 3Si The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC) and is available free of charge in electronic format and on a paid subscription basis for paper copy. To receive an electronic copy on Friday of each week, send an e-mail message to listserv@listserv.cdc.gov. The body content should read SUBscribe mmwr-toc. Electronic copy also is available from CDCs World-Wide Web server at http://www.cdc.gov/mmwr or from CDCs file transfer protocol server at ftp://ftp.cdc.gov/pub/Publications/mmwr. To subscribe for paper copy, contact Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402; telephone (202) 512-1800. Data in the weekly MMWR are provisional, based on weekly reports to CDC by state health departments. The reporting week concludes at close of business on Friday; compiled data on a national basis are officially released to the public on the following Friday. Address inquiries about the MMWR Series, including material to be considered for publication, to: Editor, MMWR Series, Mailstop C-08, CDC, 1600 Clifton Rd., N.E., Atlanta, GA 30333; telephone (888) 232-3228. All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.FOGMMd,FOGMMdFOGMMdFOGMMd!FOGMMdFOGMMdIFOGMMdFOGMMd0FOGMMd*FOGMMdFOGMMdFOGMMd FOGMMdFOGMMdPFOGMMdFOGMMdvFOGMMdFOGMMdFOGMMd[ (xKddd[\ xx #0i@ @i @i @i UNITED STATES GOVERNMENT PRINTING OFFICE SUPERINTENDENT OF DOCUMENTS Washington, D.C. 20402)FOGMMd3FOGMMd\(xKddd\G@i@i@irOfficial Business Penalty for Private Use $300 Return Service RequestedFOGMMd6FOGMMdG(xKdddG? ?BxF IU.S. Government Printing Office: 2002-733-100/49031 Region IVPZGMMd>PZGMMd? (xKddd?:JBxRx@BxBx  PRESORTED STANDARD POSTAGE & FEES PAID GPO Permit No. G-26:FZGMMd:(xKddd:  ]]d`] @]sD@B<H ! ]% ]]d`]@]sDirector, Centers for Disease Control and Prevention Jeffrey P. Koplan, M.D., M.P.H. Deputy Director for Science and Public Health, Centers for Disease Control and Prevention David W. Fleming, M.D.AFGMMd<(_<Pdd s { 1 ]+]`]`]s A]t5@B<- ](`]@]s@B< ] ]+`]@]se@@<Director,Epidemiology Program Office Stephen B. Thacker, M.D., M.Sc. Editor, MMWR Series John W. Ward, M.D. Acting Managing Editor, MMWR (Weekly) Teresa F. Rutledge (AFGMMd AFGMMd AFGMMdAFGMMd4AFGMMdAFGMMdAFGMMd<(_<Pdd s { 1w  ] `] ]sI `] ]s `] @]s @B<@] `] ]s `] @]s Writers-Editors, MMWR (Weekly) Jill Crane David C. Johnson Desktop Publishing Lynda G. Cupell Morie M. Higgins AFGMMdAFGMMdAFGMMdAF`GMMdQAFGMMdS<(_<Pdd$(_<Pddw s { 1Yl#i u#is3io3in;ip3i;Ci.j#i t#ij#is3i!Ci%n#i 3Si The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC) and is available free of charge in electronic format and on a paid subscription basis for paper copy. To receive an electronic copy on Friday of each week, send an e-mail message to listserv@listserv.cdc.gov. The body content should read SUBscribe mmwr-toc. Electronic copy also is available from CDCs World-Wide Web server at http://www.cdc.gov/mmwr or from CDCs file transfer protocol server at ftp://ftp.cdc.gov/pub/Publications/mmwr. To subscribe for paper copy, contact Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402; telephone (202) 512-1800. Data in the weekly MMWR are provisional, based on weekly reports to CDC by state health departments. The reporting week concludes at close of business on Friday; compiled data on a national basis are officially released to the public on the following Friday. Address inquiries about the MMWR Series, including material to be considered for publication, to: Editor, MMWR Series, Mailstop C-08, CDC, 1600 Clifton Rd., N.E., Atlanta, GA 30333; telephone (888) 232-3228. All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.FOGMMd,FOGMMdFOGMMdFOGMMd!FOGMMdFOGMMdIFOGMMdFOGMMd0FOGMMd*FOGMMdFOGMMdFOGMMd FOGMMdFOGMMdPFOGMMdFOGMMdvFOGMMdFOGMMdFOGMMdY (xKdddY? ?BxF IU.S. Government Printing Office: 2002-733-100/49031 Region IVPZGMMd>PZGMMd? (xKddd?=RxRx@BxIBxVFIRST-CLASS MAIL POSTAGE & FEES PAID PHS/CDC Permit No. G-284=FZGMMd=(xKddd=z @i Pi @i @i @i DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Atlanta, Georgia 30333 FOGMMdFOGMMdFOGMMdPFOGMMdz(xKdddzG@i@i@irOfficial Business Penalty for Private Use $300 Return Service RequestedFOGMMd6FOGMMdG(xKdddG  ]]d`] @]sD@B<H ! ]% ]]d`]@]sDirector, Centers for Disease Control and Prevention Jeffrey P. Koplan, M.D., M.P.H. Deputy Director for Science and Public Health, Centers for Disease Control and Prevention David W. Fleming, M.D.AFGMMd<(_<Pdd s { 19 ]+9]9`]9 @]s9@B<- ](9`]9@]s9@B< ]9 ]+9`]9@]se9@@<- Director,Epidemiology Program Office Stephen B. Thacker, M.D., M.Sc. Editor, MMWR Series John W. Ward, M.D. Acting Managing Editor, MMWR (Weekly) Teresa F. Rutledge 'AFGMMd AFGMMdAFGMMdAFGMMdAFGMMd4AFGMMdAFGMMdAFGMMdH<(_<Pddb<(_<PddH s { 1b s { 1x  ] `] ]sI `] ]s `] @]s @B<@] `] ]s `] @]s Writers-Editors, MMWR (Weekly) Jill Crane David C. Johnson Desktop Publishing Lynda G. Cupell Morie M. Higgins AFGMMdAFGMMdAFGMMdAF`GMMdRAFGMMdS<(_<Pdd%(_<Pddx s { 1,   P[#  Z#x[ Y#x[ Cx[3 *References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites.JPZGMMdPZGMMdPZGMMd,[(xKdddQ,ZD$d 5$;P[:4$mP%;P[a+P)D$d;P['aP (b$'9  9@9 Investigation of Bioterrorism-Related Anthrax Continued9PGMMd9(xKddd9Qk ]-@]O Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.AFGMMd<(_<Pdd s { 1Ri ]@]All MMWR references are available on the Internet at . Use the search function to find specific articles.AFGMMdAFGMMdzAFGMMd<(_<Pdd s { 1+Sl ]j ]PU@]References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites.IAFGMMdAFGMMdAFGMMd+<(_<Pdd+ s { 1$;P[ $ P !h/ );/ [!.!D$d;P[ "hsP##t .C cx- ^3xZ Cx[ cx- U#xZ Y#x[ ]#x[ 4Cx[ cx- d3xZ [#x[ ^3x[ Z#x[ -Sx[ 9 9@9 Investigation of Bioterrorism-Related Anthrax Continued9PGMMd9(xKddd9Resolution% @ Septic Arthritis ContinuedPGMMd(xKddd.wqPC| ..DOC.w$PC) ..DOC.w$PC) ..DOC.wPC ..DOC.wPC ..DOC[P=X\2g1  xcn  ycFcFdzyyd{cFcFd|xxxd}(< << d~  x  d###dddg{ggddYmYYdddg  i1Y  <<dd3100.0 F (>37.8 C) and either cough or sore throat in the absence of a known cause. The national baseline was calculated as the mean percentage of visits for ILI during noninfluenza weeks plus two standard deviations. Because of wide variability in regional level data, to calculate region-specific baselines is not possible and to apply the national baseline to regional level data is not appropriate. Levels of activity: 1) no activity, 2) sporadicsporadically occurring ILI or laboratory-confirmed influenza with no outbreaks detected, 3) regionaloutbreaks of ILI or laboratory-confirmed influenza in counties with a combined population of <50% of the states population, and 4) widespreadoutbreaks of ILI or laboratory-confirmed influenza in counties with a combined population of >50% of the states population.PZGMMdPZGMMdPZGMMdfPZGMMdPZGMMd@PZGMMdPZGMMdPZGMMd PZGMMdPZGMMdPZGMMd]PZGMMd PZGMMdPZGMMd PZGMMd^PZGMMdPZGMMdPZGMMd[(xKdddQg#[(xKdddQ#[(xKdddQZNZ  )c a C c T#? X#x? V#x? X#x? W#x? W#x? X#x? V#x? 9Cxf  ** The expected baseline proportion of P&I deaths reported by the 122 Cities Mortality Reporting System is projected using a robust regression procedure in which a periodic regression model is applied to the observed percentage of deaths from P&I since 1983. The epidemic threshold is 1.654 standard deviations above the seasonal baseline. Before the 19992000 season, a new case definition for a P&I death was introduced. During the summer of 2000, the baseline and epidemic thresholds were adjusted manually to account for these changes in case definition. For the 200102 season, sufficient data have been collected using the new case definition to allow projection of the baseline using the regression procedure employed before the 200001 season. PZGMMdPZGMMdPZGMMd%(xKdddQ%(xKdddQ%(xKdddQ '@ PX,f- .6+d.`X/4U = } d~ |d  `  yyyd d _ s s s d qd s    s  d  &   d ;P[+):'P XO1b hS2PRXc>xd 1d .B..d ..d ..d ..d ..d vvvd w.w.d EI $x 4x x 8 L.8 8.d [ o.[ [.d ` t.` `.d h |.h h.d  . .d mm# d  "-/x 1) '1) d <E I 51 ! .d d# <  <d R , Rd <) =<) )d J^)JJ)d D X :X X :d 0.00.d ##d  & 4 & 4d L `.L L.d  . .d ]q)]])d ~.~~.d  2 SP X,XP,X +/ x d d ,d d 0DDDd d aad  - d { { {d   d X lX Xd ax Uiiid __# d   x d d d dE FY Y Y Fdd   d. B . . dddmmmdCx CWCCd AA# d @E [ &P' T4hNPnT!"L#ElYlEEd$lld%lld&EEd'P111Pd(d)7EKKEKd*d+kkkd, d-'K x. d/d0d1kkkd2d3d4dxddd54H44d6'l'ld7'8 l #9lld:Hi x;lld<GHRII]IIdJdKdLIIdM T  TdN;IOOIOdOIIdPdQdRdSfzffdT  dUzzzdV3G33dW#X|||dYn @r  Septic Arthritis ContinuedPGMMd XXL s G@s_ Figure I. Selected notifiable disease reports, United States, comparison of provisional 4-week totals ending December 1, 2001, with historical data ZGMMdZGMMd&(_<dPddcHt`q cx- ]#xZ Cx[ cx- Z#xZ Y#x[ HCx[ * No measles or rubella cases were reported for the current 4-week period yielding a ratio for week 48 of zero (0). Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week totals.PZGMMdsPZGMMdPZGMMdPZGMMdq#[(xKdddQqZ XXGs DBshP Table I. Summary of provisional cases of selected notifiable diseases,United States, cumulative, week ending December 1, 2001 (48th Week)*ZGMMdZGMMd&(_<dPddcHt` aW BW: Cum. 2001 <AGMMd ;(_<ddd ]O @ \ S aW BW: Cum. 2001 <AGMMd ;(_<ddd ]O @ \ SK `W `WW aW x `Wj AW-  `W `WW aW x  `Wj AWx `W `WW aW <  `Wj AWx `WH `WW aWN `Wj9 AW<  `WI `WW aW < $`WjR AW `W `WW  aWN `Wjr AW< `W `WW aW x )`Wj AW1 `W `WW aW x $`Wj% AWx `W `WWW aW < `Wje AW `W  `WW  aW < `Wj AWx `W `WW aW - `Wj AW `W aW x  `Wjg AWx `Wb aW <  `WjX AWx *`W~ aWN `Wj AW `WF aWN  `Wj AW- `Ww `WW AW < @W Anthrax 15 Poliomyelitis, paralytic  Brucellosis 82 Psittacosis 23 Cholera 3 Q fever 22 Cyclosporiasis 131 Rabies, human 1 Diphtheria 2 Rocky Mountain spotted fever (RMSF) 565 Ehrlichiosis: human granulocytic (HGE) 206 Rubella, congenital syndrome 1 human monocytic (HME) 86 Streptococcal disease, invasive, group A 3,274 Encephalitis: California serogroup viral 99 Streptococcal toxic-shock syndrome 44 eastern equine 8 Syphilis, congenital 190 St. Louis 2 Tetanus 23 western equine  Toxic-shock syndrome 115 Hansen disease (leprosy) 78 Trichinosis 26 Hantavirus pulmonary syndrome 6 Tularemia 98 Hemolytic uremic syndrome, postdiarrheal 139 Typhoid fever 263 HIV infection, pediatric 200 Yellow fever  Plague 2 2<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMdr<AGMMd<AGMMd:<AGMMd<AGMMd[<AGMMd<AGMMd&<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd<AGMMd4<AGMMd<AGMMd0<AGMMd<AGMMd <AGMMd<AGMMd,<AGMMd<AGMMd/<AGMMd<AGMMd<AGMMd(_<dddW j?.wPC ..DOC  `xPK @PZ X@xP9 `xP< @PZ `xPK ~0PZ A@xP[ `xPK @PPZ= -: No reported cases. *Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Not notifiable in all states. Updated monthly from reports to the Division of HIV/AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention (NCHSTP). Last updated November 27, 2001. Updated from reports to the Division of STD Prevention, NCHSTP. o<<GMMd<<GMMd<<GMMd<<GMMd<<GMMd<<GMMdA<<GMMd)[(dKdddZ(xKdddwXXUBs4w@BswTable II. (Contd) Provisional cases of selected notifiable diseases, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)*ZGMMdZGMMd&(_<dPddcHt` `WbW*bW bWBW`WbW*bW BW <AGMMd 3(_<ddd *  xxBxPbH Reporting Area<<GMMd.(_<dddW j?hhcxPcPWCP@  xP@xP[N: Not notifiable. U: Unavailable. - : No reported cases. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). <<GMMd<)y(dKddd)[(dKddd<:[Z\`WbWY,bW,bW5,bW ,bW,bW,bWWJbW ,BW,`WbWwbWbWRbW bWbWbWbW'BW Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2000 2001 2000 2001 2001 2000.<AGMMd<AGMMd,<AGMMd/1(_<ddd-2(_<ddd/ sm Yz- sm YzO `xPbP bPvbPbPPq,`xP bPXX bPJbP  bP+BP5 Hepatitis C; Lyme Gonorrhea Non-A, Non-B Legionellosis Listeriosis DiseaseO<<GMMdO0(_<dddO  ##pxPaP aPaPl aPaP9aPaPaPhAPhCP5 `xPaPaPB aP xaPxaPxaPsxaP xaPAAP`xPhaPaP xaP\ -aP<aP<aP<aPG<aP1-AP-`xPaPaP xaP\ -aP-aPxaP<aPG<aPAPx`xPaP6xaP xaPM <aP<aP<aP<aPG<aPxAPx`xPYaPaPB aP xaPxaPxaPsxaP xaPAP`xPaPaP aP\ -aP<aPxaP<aPG<aPAPk`xPYaPaPB aP\ -aP-aPxaPsxaPG<aPAAPCP5pxPaPFhaPhaPl aPiaP9aP(aP xaPAAP pxPaPaPB aP xaPxaPxaPsxaP xaPAAP pxPaPFhaPhaP\ -aP-aPxaPsxaP xaP"<APk`xPaPaPB aPl aPiaPxaPsxaP xaPAP`xPaPFhaPhaP xaPxaPxaP(aP xaPAAPCP5 `xPWaPFhaPhaP aPiaP9aP(aP xaPAPk`xPaPFhaPhaPM <aPxaP9aP(aP xaPAPx`xPaPaPB aPM <aP-aPxaPsxaPG<aPxAPx`xPaPFhaPhaP xaPxaPxaPsxaP xaPxAPx`xPJaPFhaPhaP aPiaPxaPsxaP xaPxAPx`xPaPaPB aP\ -aP-aPxaPsxaPG<aPAPkCP5 `xPaPFhaPhaP aPiaPxaPsxaP xaPAPk`xPYaPaPB aPM <aP<aP<aP<aPG<aPAPk`xPaPaPB aP\ -aP<aP<aPsxaPG<aPxAPx`xPaPaPB aP aPiaPxaPsxaP xaPxAPx`xPaP6xaP xaP\ -aP-aP<aP-aPV-aP1-AP<`xPaPaP aP\ -aP-aP<aP<aPV-aP1-AP-pxP,aPaPB aPM <aP<aP<aP<aPG<aP"<AP<`xP;aPaPB aP xaP<aP<aP<aPG<aP"<APxCP5 pxPaPFhaPhaP xaPiaP9aP(aP xaPAP`xPaPaPB aP\ -aP<aPxaPsxaPV-aPxAPk`xPaPaPB aP xaPxaPxaPsxaP xaPAPk`xPaPaPB aP\ -aP<aP<aP<aPV-aPxAPxpxPaPaPB aP\ -aP<aPxaPsxaP xaPAPkpxPhaPaP aPM <aPxaPZaPZaPG<aPxAPx`xPaPFhaPhaP xaPxaPxaPsxaPG<aPxAPx`xPaPaPB aPM <aP<aPxaP<aPG<aP"<APx`xPaPFhaPhaPM <aP<aPxaP<aP xaP1-AP-`xPaPFhaPhaP xaPxaPxaPsxaP xaPxAPxCP5 `xPHaPFhaPhaP aPiaPxaPsxaP xaPxAPx`xPaPaPB aPM <aPxaPxaPsxaPG<aPxAPxpxP;aPaPhaP xaPxaPxaPsxaPG<aPxAPx`xPaPFhaPhaPM <aPxaPxaP<aPG<aP"<AP<`xP;aPaPB aP aPiaP<aP<aPV-aP"<AP<CP5 `xPuaPFhaPhaP aPiaPxaPsxaP xaPxAPx`xPaPaPB aPM <aP<aP-aP-aPG<aP"<AP<`xPaPFhaPhaP xaPiaP<aP<aPV-aP"<AP<`xPaPaPB aPM <aPxaP<aP<aPG<aP1-AP<pxPaPFhaPhaP xaPiaP<aPsxaP xaPxAPxCP5 pxPaPaPB aP xaPxaPxaPsxaP xaPxAPx`xPhaP6xaP xaPM <aP<aP-aP<aPV-aP1-AP-`xPJaP6xaP xaPM <aP<aP<aP<aPG<aP"<AP<`xP,aP6xaP xaPM <aP<aP<aP-aPG<aP"<AP<`xP,aPaPB aP xaPxaPxaPsxaP xaP"<AP-`xPaPaPB aP xaPxaP<aP<aPG<aP"<AP-`xPaPaPB aPM <aPxaPxaP<aPG<aP"<AP-`xPaPaP aPM <aP<aP<aPsxaPG<aP"<AP<`xPaPaPB aPM <aPxaP<aP<aPG<aP"<AP<CP5pxPaPFhaPhaP aPiaPxaPsxaPaPAPk`xPhaPaPB aP xaPxaPxaPsxaP xaP"<AP<`xP;aPaP aP xaPxaPZaPZaPG<aPxAPx`xP,aPFhaPhaP xaPiaPxaPsxaPaPxAPx`xPaPaP aP\ -aP-aP-aP-aPV-aP"<AP<`xPaPaP aP\ -aP<aP<aP<aPG<aPZAPZCP5`xPhaP-aP xaP\ -aP<aP-aP-aPV-aP1-AP-pxPaPaP aPM <aP<aP<aP<aPV-aPZAPZpxPaPr<aP2 -aP\ -aP-aP-aP-aPV-aP1-AP- pxPaPTZaP ZaP/ ZaPZaPZaPZaPV-aPZAPZ `xPaP6xaP ZaP\ -aPZaP-aPZaPV-aP1-APZ@xP  UNITED STATES 302,379 327,661 2,957 2,913 962 1,013 464 11,653 15,862 NEW ENGLAND 6,136 6,116 20 29 71 53 40 3,783 5,216 Maine 132 85  2 8 2 2   N.H. 171 97   11 3 4 148 63 Vt. 63 60 7 4 5 5 3 16 40 Mass. 2,868 2,539 13 18 21 17 25 826 1,145 R.I. 776 604  5 12 9 1 453 571 Conn. 2,126 2,731   14 17 5 2,340 3,397 MID. ATLANTIC 38,825 36,211 1,449 641 192 286 66 5,762 8,150 Upstate N.Y. 8,111 6,792 53 37 64 89 27 3,404 3,540 N.Y. City 11,676 10,738   31 46 12 9 177 N.J. 7,426 6,667 1,342 561 13 22 12 927 2,427 Pa. 11,612 12,014 54 43 84 129 15 1,422 2,006 E.N. CENTRAL 56,276 65,648 150 218 280 261 65 656 764 Ohio 12,547 17,796 5 12 126 106 15 111 58 Ind. 6,277 5,869 1  22 36 8 23 22 Ill. 16,776 19,269 13 19 19 31 11 21 35 Mich. 15,797 16,234 131 187 77 48 23 13 23 Wis. 4,879 6,480   36 40 8 488 626 W.N. CENTRAL 14,141 16,483 714 563 47 55 19 380 422 Minn. 2,171 2,944 9 5 9 7 2 314 322 Iowa 1,199 1,142  2 8 13 2 36 33 Mo. 7,273 8,123 688 544 21 25 10 24 45 N. Dak. 37 68   1    1 S. Dak. 262 261   3 2    Nebr. 713 1,385 6 4 4 4 1 4 4 Kans. 2,486 2,560 11 8 1 4 4 2 17 S. ATLANTIC 76,101 85,108 97 101 185 182 70 803 1,051 Del. 1,545 1,598  2 12 10  49 167 Md. 6,205 8,833 16 12 35 65 14 522 607 D.C. 2,465 2,478  3 8 6  16 10 Va. 9,693 9,579  3 23 33 13 116 143 W. Va. 668 609 9 15 N N 5 13 32 N.C. 15,240 16,439 19 17 11 15 5 39 44 S.C. 6,808 7,788 6 3 13 6 5 5 14 Ga. 15,055 16,873 1 3 10 7 14   Fla. 18,422 20,911 46 43 73 40 14 43 34 E.S. CENTRAL 29,240 33,839 172 427 53 37 20 60 49 Ky. 3,168 3,248 9 35 11 20 5 22 12 Tenn. 8,883 10,842 59 94 27 10 8 29 28 Ala. 10,352 11,188 4 10 13 4 7 8 6 Miss. 6,837 8,561 100 288 2 3  1 3 W.S. CENTRAL 46,914 50,865 177 695 11 26 18 82 88 Ark. 3,961 3,529 4 9   1 1 5 La. 10,876 12,406 88 426 2 7  2 7 Okla. 4,371 3,828 4 10 3 5 2  1 Tex. 27,706 31,102 81 250 6 14 15 79 75 MOUNTAIN 9,257 9,733 52 71 56 43 37 13 13 Mont. 98 48 1 5  2    Idaho 70 84 2 3 3 5 1 5 3 Wyo. 77 45 8 2 1  2 1 3 Colo. 2,768 2,964 10 13 17 15 10 1  N. Mex. 882 1,062 11 14 3 1 7 1  Ariz. 3,610 3,893 9 19 22 7 8 2  Utah 125 209 3 1 6 12 2 1 3 Nev. 1,627 1,428 8 14 4 1 7 2 4 PACIFIC 25,489 23,658 126 168 67 70 129 114 109 Wash. 2,763 2,148 23 31 10 17 10 8 9 Oreg. 1,046 937 13 25 N N 9 10 12 Calif. 20,750 19,797 90 110 53 52 104 94 86 Alaska 383 328      2 2 Hawaii 547 448  2 4 1 6 N N Guam  51  3      P.R. 541 479 1 1 2 1  N N V.I. 6         Amer. Samoa U U U U U U  U U C.N.M.I. 14 U  U  U   U F<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMdy<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMdF(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKdddy(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<PddF _  ,^. _  ,^. _  ,^. _  ,^. _  ,^.y _  ,^. _  ,^. _  ,^. _  ,^. _  ,^. _  ,^..wPC ..DOC XXLBs @Bs Table II. Provisional cases of selected notifiable diseases, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)*ZGMMdZGMMd&(_<dPddcHt`f`WbW,bWH,bW,bWl,bW ,bWX ,bW,bWq,bW ,BW,`WbWbWfbW bWbW bWv bWbWbW>BW Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2000 2001 2000 2001 2000 2001 20002<AGMMd<AGMMd<AGMMd<AGMMd-<AGMMdf/(_<dddf R m  {z.xx`xPbP bP]vbP bPBPbJ AIDS Chlamydia Cryptosporidiosis NETSS PHLIS<<GMMd<<GMMd<<GMMd.-(_<ddd.v xxBxPgHReporting Area<<GMMd.(_<dddW j? xxBxP Escherichia coli O157:H7<<GMMd <<GMMd<<GMMd.(_<dddW j?5 ##pxPaPhaP5haP aP? aPaPaPaPaPAAPCP5 `xPaP aPaP haP{ haPiaPaPUaPaPAPk`xPhaPxaP%xaPP aP aPxaP*xaPxaPCxaPxAPx`xPaPxaP%xaPP aP aPxaP*xaPxaPCxaPxAPx`xPaPxaP%xaP aP aPxaP*xaPxaPCxaP"<APx`xPYaPdaPaPP aP aPxaP*xaPUaPaPAPk`xPaPxaP%xaPP aP aP<aPf<aPxaPCxaPxAPx`xPYaPdaPaPP aP aP-aP*xaPxaPCxaPxAPxCP5pxPaP aPaP haP{ haPiaPaPUaPaPAPk pxPaPdaPaP haP aPiaPaPUaPaPAPx pxPaP aPaP haP{ haPxaPaPxaPCxaPxAPx`xPaP aPaP haP aPxaP*xaPxaPaPxAPk`xPaP aPaP haP{ haPxaP*xaPZaPaZaP1-APkCP5 `xPWaP aPaP aP? aPaPaPUaPaPAPk`xPaPdaPaP haP{ haPiaPaPUaPaPAPk`xPaPdaPaP haP{ haPxaP*xaPxaPaPxAPx`xPaP aPaP haP{ haPiaPaPUaPaPAPk`xPJaPdaPaP haP{ haPiaP*xaPxaPaPxAPk`xPaPdaPaP haP{ haPiaPaPUaPaPxAPkCP5 `xPaPdaPaP haP{ haPiaPaPUaPaPAPk`xPYaPdaPaPP aP aPiaPaPUaPaPAPk`xPaPxaP%xaPP aP aPxaP*xaPxaPaPxAPk`xPaPdaPaP haP{ haPxaP*xaPxaPaPxAPx`xPaP<aPa<aP aP aPxaP*xaPxaPCxaPxAPx`xPaPxaPa<aPP aP aP<aP*xaPxaPCxaPxAPxpxP,aPxaP%xaPP aP aPiaP*xaPxaPCxaP1-APx`xP;aPxaPaPP aP aP<aPf<aPxaPCxaPxAPxCP5 pxPaPhaP5haP aP? aPiaPaPUaPaPAPk`xPaPdaPaPP aP aP<aPf<aP<aP<aP"<AP<`xPaP aPaP haP{ haPxaPf<aPxaPCxaP"<AP<`xPaPdaPaPP aP aPxaP*xaP-aP<aPZAPZpxPaPdaPaP haP{ haPxaP*xaPxaPCxaPxAPxpxPhaPxaP%xaPP aP aP<aPf<aPxaPCxaP"<APx`xPaPdaPaP haP{ haPxaP*xaPxaPCxaPxAPx`xPaPdaPaP haP aP<aPu-aPxaPCxaPxAPx`xPaP aPaP haP{ haPiaPaPxaPCxaPxAPx`xPaP aPaP haP{ haPxaPaPxaPCxaPxAPxCP5 `xPHaP aPaP haP{ haPxaP*xaPUaPaPAPk`xPaPdaPaPP aP aP<aPf<aPxaPCxaPxAPxpxP;aPdaPaP haP{ haPxaP*xaPxaPCxaPxAPx`xPaPdaPaP haP{ haPxaP*xaPxaPCxaP"<AP<`xP;aPdaPaP haP{ haPxaP*xaP<aPCxaP"<APxCP5 `xPuaP aPaP haP{ haPiaPaPUaPaPxAPk`xPaPdaPaPP aP aP<aP*xaPxaPCxaP1-APx`xPaPdaPaP haP{ haP<aP*xaP<aPCxaPxAPx`xPaPdaPaPP aP aPxaP*xaPxaPCxaPxAPxpxPaP aPaP haP{ haPxaPaPxaPaPxAPkCP5 pxPaP aPaP haP{ haPiaPaPUaPaPAPk`xPhaPxaP%xaPP aP aPxaP*xaPxaPCxaP1-AP-`xPJaPxaP%xaPP aP aPxaP*xaPxaPCxaP1-APx`xP,aP<aPa<aP aP aP<aPf<aP<aPCxaP"<APx`xP,aPdaPaPP aP aPxaP*xaPxaPaPxAPk`xPaPdaPaPP aP aPxaP*xaPxaPCxaPxAPx`xPaPdaPaP haP{ haP<aP*xaPxaPCxaPxAPx`xPaPdaPaPP aP aPxaP*xaPxaPCxaPxAPx`xPaPdaPaPP aP aP<aPf<aPxaPCxaP"<APxCP5pxPaP aPaP aP? aPiaPaPUaPaPAPk`xPhaPdaPaP haP{ haP-aPHZaPUaPaPxAPk`xP;aPdaPaPP aP aPxaP*xaPxaPaPxAPk`xP,aP aPaP haP{ haPiaPaPUaPaPAPk`xPaPxaP%xaPP aP aP<aPu-aP<aPCxaP"<AP<`xPaPxaP%xaPP aP aP<aPu-aPxaPCxaP"<APxCP5`xPhaPxaP%xaP@ -aP aP-aPu-aPZaPaZaPZAPZpxPaP aPaPP aP ZaP-aPu-aP<aP<aPZAPZpxPaPxaP%xaP xaP -aP-aPu-aP-aP-aPZAPZ pxPaP<aPp-aP ZaP ZaPZaPHZaPZaPaZaPZAPZ `xPaP-aPp-aP aP ZaP-aPHZaP-aPaZaPZAPZ@xP 2 Q UNITED STATES 37,411 35,685 656,773 639,742 3,247 2,829 2,893 4,276 2,156 3,518 NEW ENGLAND 1,403 1,863 21,429 21,706 123 130 224 366 225 371 Maine 44 38 1,239 1,344 18 20 27 31 27 28 N.H. 37 30 1,246 1,032 16 22 35 35 30 38 Vt. 15 37 579 493 31 26 14 35 8 36 Mass. 704 1,128 9,149 9,291 50 34 115 161 112 167 R.I. 95 91 2,719 2,486 8 3 17 20 11 18 Conn. 508 539 6,497 7,060  25 16 84 37 84 MID. ATLANTIC 9,346 7,605 75,103 60,869 270 359 207 420 181 338 Upstate N.Y. 945 676 13,575 3,037 106 120 154 281 136 76 N.Y. City 5,253 3,919 27,353 24,310 99 159 12 23 11 18 N.J. 1,607 1,554 10,980 9,855 13 19 41 116 34 116 Pa. 1,541 1,456 23,195 23,667 52 61 N N  128 E.N. CENTRAL 2,812 3,411 107,979 110,537 1,407 930 752 1,041 495 734 Ohio 538 533 22,404 28,959 161 253 214 255 153 223 Ind. 343 347 13,985 12,499 79 57 81 119 42 83 Ill. 1,255 1,692 30,330 30,660 408 119 153 188 128 156 Mich. 500 648 27,833 23,306 175 91 93 139 82 104 Wis. 176 191 13,427 15,113 584 410 211 340 90 168 W.N. CENTRAL 808 809 33,234 36,363 498 345 540 635 449 605 Minn. 133 160 6,709 7,523 176 123 256 185 212 216 Iowa 85 83 4,558 4,881 78 74 82 179 62 148 Mo. 405 367 11,674 12,392 44 29 61 108 89 96 N. Dak. 2 3 827 810 13 15 18 19 32 21 S. Dak. 23 7 1,682 1,696 7 15 42 55 41 58 Nebr. 68 68 2,206 3,445 177 80 59 61  48 Kans. 92 121 5,578 5,616 3 9 22 28 13 18 S. ATLANTIC 11,517 10,027 123,700 120,423 312 449 227 354 139 280 Del. 231 198 2,511 2,651 6 6 4 3 7 1 Md. 1,698 1,192 11,078 12,700 38 9 28 34 1 2 D.C. 782 784 2,704 2,945 11 17  1 U U Va. 911 745 16,519 14,625 24 18 49 70 39 66 W. Va. 95 57 2,158 1,979 2 3 10 15 8 13 N.C. 845 644 18,949 20,148 27 26 54 87 43 68 S.C. 645 737 10,248 8,991 7  17 21 11 16 Ga. 1,528 1,118 27,394 25,791 128 170 33 40 15 38 Fla. 4,782 4,552 32,139 30,593 69 200 32 83 15 76 E.S. CENTRAL 1,671 1,781 44,785 47,046 46 49 125 141 110 113 Ky. 315 185 7,882 7,431 4 7 58 40 49 32 Tenn. 540 748 13,180 13,609 13 11 42 54 46 52 Ala. 415 455 13,316 14,251 16 15 17 10 6 9 Miss. 401 393 10,407 11,755 13 16 8 37 9 20 W.S. CENTRAL 3,856 3,666 96,125 96,307 112 159 105 222 91 277 Ark. 189 170 6,389 6,031 8 15 13 56  38 La. 806 632 15,893 16,686 7 12 4 15 26 49 Okla. 214 322 9,573 8,617 15 17 32 19 28 17 Tex. 2,647 2,542 64,270 64,973 82 115 56 132 37 173 MOUNTAIN 1,288 1,324 37,747 34,952 227 168 273 411 131 303 Mont. 15 14 1,775 1,265 37 10 20 30   Idaho 19 20 1,788 1,727 22 23 71 72  40 Wyo. 4 9 767 731 7 5 7 19 1 11 Colo. 267 326 8,876 9,015 40 69 86 154 53 110 N. Mex. 137 140 5,313 4,775 27 21 14 22 11 18 Ariz. 502 410 13,216 11,721 7 10 29 51 23 43 Utah 110 133 1,619 2,077 82 26 30 49 42 71 Nev. 234 272 4,393 3,641 5 4 16 14 1 10 PACIFIC 4,710 5,199 116,671 111,539 252 240 440 686 335 497 Wash. 483 463 12,473 11,929  U 123 221 62 203 Oreg. 213 170 6,757 6,397 49 20 65 133 61 114 Calif. 3,898 4,444 91,499 87,601 199 220 230 287 203 163 Alaska 18 23 2,389 2,318 1  4 31 1 6 Hawaii 98 99 3,553 3,294 3  18 14 8 11 Guam 12 13  465   N N U U P.R. 1,113 1,242 2,240 U   1 7 U U V.I. 11 32 53      U U Amer. Samoa 1  U U U U U U U U C.N.M.I.   124 U  U  U U U P<<GMMd<(GMMd8<<GMMd<(GMMd<<GMMd<(GMMd@<<GMMd<(GMMdh<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd <<GMMd<(GMMd<<GMMdP(_<Pdd,(xKddd8(_<Pdd,(xKddd(_<Pdd,(xKddd@(_<Pdd,(xKdddh(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd (_<Pdd,(xKddd(_<PddP 'm  ,^.8 'm  ,^. 'm  ,^.@ 'm  ,^.h 'm  ,^. 'm  ,^. 'm  ,^. 'm  ,^. 'm  ,^.  'm  ,^. 'm  ,^..w~PCs ..DOCcxP`CPcxPaP<#PeCxPcxPaP'-Pe.CxP# cxPaP'-ACP cxPaP'-Pe/CxPA N: Not notifiable. U: Unavailable.-: No reported cases.C.N.M.I.: Commonwealth of Northern Mariana Islands. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the PublicHealth Laboratory Information System (PHLIS). Chlamydia refers to genital infections caused by C. trachomatis. Updated monthly from reports to the Division of HIV/AIDS Prevention Surveillance and Epidemiology, National Center for HIV, STD, andTB Prevention. Last updated November 27, 2001. <<GMMd<<GMMd<<GMMd<<GMMd2<<GMMd<<GMMd<<GMMd<<GMMd<<GMMd)y(dKddds:[dTXXUBs@BsRTable II. (Contd) Provisional cases of selected notifiable diseases, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)* ZGMMdZGMMd&(_<dPddcHt`; `WbW*bW  BW`WbWgbWJbW\  BW Syphilis NETSS PHLIS (Primary & Secondary) Tuberculosis;<AGMMd;3(_<ddd;* Q`WbW ,bWK,bWj,bW ,bW ,bW,bW(,BW,`WbW(bWibWbW bW bWbWFBW Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2000 2001 2000 2001 2000Q<AGMMdQ4(_<dddQ@ =7 xxBxPbH Reporting Area<<GMMd.(_<dddW j?  xx BxP Shigellosis <<GMMd<<GMMd .(_<ddd W j?R f##pxPaPhaPChaP aPhaPaP aPBhAPVhCP5 `xPaPaPaP aP<aPWxaPxaPAP`xPhaP<aP3 xaPl <aPxaP<aP<aPn<APFx`xPaP<aPo <aPl <aP<aP<aP<aP2xAPFx`xPaP<aPo <aPl <aP-aP<aP-aPn<AP<`xPYaPaPaP aP<aPWxaPxaPAP`xPaPxaP3 xaP0 xaPxaP<aP<aP2xAPFx`xPYaPxaP3 xaP0 xaPxaPWxaPxaP2xAPCP5pxPaP7aPaP aPaP aPcaPAP pxPaPaPaP aP<aPWxaPxaPAP pxPaPaPaP aP<aP aPcaPAP`xPaPaPaP aP<aP aPxaPAP`xPaPaPaP0 xaP<aPWxaPxaPAPCP5 `xPWaP7aPaP aPaP aP aPAP`xPaP7aPaP aP<aPWxaPxaPAP`xPaPaPaP0 xaP<aP aPcaPAP`xPaPaPaP aP<aP aPcaPAP`xPJaPaPaP aP<aP aPcaPAP`xPaPaPaP0 xaPxaPWxaPxaP2xAPFxCP5 `xPaP7aPaP aPaPWxaPxaPAP`xPYaPaPaP aP<aPWxaPxaPAP`xPaPaPaP aP<aP<aPxaP2xAPFx`xPaPaPaP aP<aPWxaPxaPAP`xPaPxaP3 xaP0 xaPxaP-aP-aPn<AP<`xPaPaPo <aP aP<aP-aP-aP2xAPFxpxP,aPxaPaP{ -aP<aP<aP<aP2xAPFx`xP;aPxaPaP0 xaP<aPWxaP<aP}-APFxCP5 pxPaP7aPaP aPaPaP aPAP`xPaPxaP3 xaP0 xaPxaPWxaP<aP2xAPFx`xPaPaPaP0 xaP<aP aPcaPAP`xPaPxaP3 xaPN ZaPZaPWxaPxaP2xAPFxpxPaPaPaP aP<aP aPcaPAPpxPhaP<aP3 xaPl <aPxaP<aP<aP2xAPFx`xPaPaPaP aP<aP aPcaPAP`xPaPaPaP aPxaP aPcaPAP`xPaPaPaP aP<aP aPcaPAP`xPaPaPaP0 xaP<aP aPcaPAPCP5 `xPHaP7aPaP aP<aP aPcaPAP`xPaPaPaP aP<aPWxaPxaPAPpxP;aPxaPaP aP<aP aPcaPAP`xPaPaP3 xaP aPxaP aPcaPAP`xP;aPaPaP0 xaP<aP aPcaPAPCP5 `xPuaP7aPaP aPaP aPcaPAP`xPaPaPaP aPxaPWxaPcaPAP`xPaPaPaP aP<aP aPcaP}-AP`xPaPxaPaP0 xaPxaPWxaPcaPAPpxPaP7aPaP aP<aP aPcaPAPCP5 pxPaPaPaP aP<aP aPcaPAP`xPhaP<aPo <aP{ -aP-aP-aP-aP2xAPFx`xPJaPxaP3 xaP{ -aPxaP<aP<aPn<AP<`xP,aP<aPo <aPl <aP<aP<aP<aPn<AP<`xP,aPaPaP aP<aPWxaP<aPAPFx`xPaPaPaP0 xaP<aPWxaPxaP2xAPFx`xPaPaPaP aP<aP aPcaPAP`xPaPxaP3 xaP0 xaPxaP<aP<aP2xAPFx`xPaPxaPaPl <aPxaP<aP<aP2xAPFxCP5pxPaP7aPaP aPaP aPcaPAP`xPhaPaPaP aP<aPWxaPxaPAP`xP;aPxaPaP aP<aPWxaPxaPAPFx`xP,aP7aPaP{ -aPaP aPcaPAP`xPaP<aPo <aPl <aP<aP-aP-aP2xAP`xPaPxaP3 xaP0 xaPxaPWxaP<aPAPCP5`xPhaP'-aP3 xaPN ZaPZaP-aP<aP}-APFxpxPaP<aP3 xaPN ZaPZaP aPcaP2xAPpxPaP'-aP~ -aPN ZaPZaP-aP-aP}-AP- pxPaPZaPQ ZaPN ZaPZaPuZaPZaPPZAPdZ `xPaP<aPQ ZaPN ZaPZaPWxaPZaP2xAPdZ@xP @ r UNITED STATES 16,403 20,887 7,413 11,921 5,380 5,573 11,200 13,217 NEW ENGLAND 257 383 274 362 59 80 373 390 Maine 6 10 3 11 1 1 3 16 N.H. 6 6 4 8 1 2 16 18 Vt. 7 4 5  3  4 4 Mass. 194 268 184 245 35 57 219 222 R.I. 22 30 26 32 9 4 36 30 Conn. 22 65 52 66 10 16 95 100 MID. ATLANTIC 1,157 2,579 713 1,634 444 259 2,137 2,107 Upstate N.Y. 458 726 113 211 24 10 337 300 N.Y. City 329 907 351 612 255 111 1,078 1,111 N.J. 185 489 184 421 129 65 458 501 Pa. 185 457 65 390 36 73 264 195 E.N. CENTRAL 3,996 3,938 1,707 1,220 934 1,129 1,233 1,344 Ohio 2,727 382 1,135 305 71 66 243 254 Ind. 216 1,481 42 151 147 331 100 133 Ill. 497 1,125 288 130 318 394 571 652 Mich. 286 633 215 579 376 294 243 228 Wis. 270 317 27 55 22 44 76 77 W.N. CENTRAL 1,857 2,318 1,255 1,931 80 62 423 484 Minn. 435 752 440 842 28 15 214 153 Iowa 356 508 290 336 4 11 34 33 Mo. 307 631 210 451 20 28 128 182 N. Dak. 21 42 34 49   3 2 S. Dak. 583 7 246 4   12 16 Nebr. 86 143  116 5 2 32 23 Kans. 69 235 35 133 23 6  75 S. ATLANTIC 2,327 2,784 740 1,109 1,826 1,862 2,315 2,658 Del. 15 24 12 21 12 8 15 14 Md. 144 182 91 109 236 291 211 232 D.C. 53 77 U U 34 36 51 35 Va. 440 434 175 339 102 123 241 240 W. Va. 8 18 8 11 4 3 26 28 N.C. 318 363 170 254 414 449 324 362 S.C. 244 134 120 89 212 210 164 238 Ga. 368 247 130 181 348 360 437 561 Fla. 737 1,305 34 105 464 382 846 948 E.S. CENTRAL 1,505 1,126 570 550 607 812 749 834 Ky. 699 488 300 111 43 80 109 113 Tenn. 97 337 110 362 309 485 273 307 Ala. 201 90 130 70 125 115 246 279 Miss. 508 211 30 7 130 132 121 135 W.S. CENTRAL 2,167 3,313 1,146 1,085 694 776 783 1,925 Ark. 531 198 155 58 39 100 146 167 La. 145 277 166 182 160 199  213 Okla. 89 117 36 44 60 112 125 137 Tex. 1,402 2,721 789 801 435 365 512 1,408 MOUNTAIN 906 1,175 675 814 216 215 467 473 Mont. 8 7     14 17 Idaho 40 44  25 1 1 8 8 Wyo. 3 5 5 3 1 1 3 4 Colo. 233 252 255 205 22 8 112 74 N. Mex. 115 157 79 108 17 16 24 40 Ariz. 383 514 275 326 159 183 210 199 Utah 58 76 53 81 8 1 33 41 Nev. 66 120 8 66 8 5 63 90 PACIFIC 2,231 3,271 333 3,216 520 378 2,720 3,002 Wash. 202 434 167 399 43 60 220 235 Oreg. 86 163 104 109 13 11 103 90 Calif. 1,876 2,633  2,673 452 305 2,214 2,451 Alaska 7 7 6 3   47 101 Hawaii 60 34 56 32 12 2 136 125 Guam  38 U U  3  50 P.R. 8 33 U U 249 154 76 152 V.I.   U U     Amer. Samoa U U U U U U U U C.N.M.I. 7 U U U 10 U 32 U C<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMdf<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMdC(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKdddf(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<PddCT  &T  &T  &T  &T  &fT  &T  &T  &T  &T  &T  & cxPcPWCP@ ecxP<aPT#PCxPcxPaP'-P.CxP# CxPN: Not notifiable. U: Unavailable. -: No reported cases. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the PublicHealth Laboratory Information System (PHLIS). <<GMMd<<GMMd<<GMMd)y(dKdddu.(dKddd;:[fTH( `WbW*bW bWBW`WbW_bW9bWBWJ Malaria Rabies, Animal NETSS PHLIS(<AGMMd(3(_<ddd(* R`WbW ,bWK,bWj,bW ,bW ,bW,bW(,BW,`WbW(bWibWbW bW bWbWFBW Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2000 2001 2000 2001 2000 R<AGMMdR4(_<dddR@ =7 xxBxPbH Reporting Area<<GMMd.(_<dddW j? xxBxP9 Salmonellosis <<GMMd<<GMMd.(_<dddW j? f##pxPaP aPaaP aPaPhaPhaP0hAPhCP5 `xPaPxaP xaP aPaP aPcaP{AP`xPhaP<aPB <aP0 xaPaPfaPaPAPx`xPaP<aPB <aP0 xaPZxaPfaPaPAPk`xPaP<aPB <aP0 xaPZxaPxaPaP xAPk`xPYaPxaP xaP aPaP aPcaP{AP`xPaPxaPB <aP0 xaPZxaPfaPaPAPk`xPYaPxaP xaP aPaPfaPaPAPkCP5pxPaPdaPaP aPaP aPcaP{AP pxPaPxaP xaP aPaP aPcaP{AP pxPaPdaPaP0 xaPZxaPfaPcaP{AP`xPaPxaP xaP aPaPfaPcaPAPk`xPaPxaP xaP aPaPfaPcaPAPCP5 `xPWaPdaPaP aPaP aPcaP{AP`xPaPxaP xaP0 xaPZxaP aPcaP{AP`xPaPxaPB <aP0 xaP-aPfaPaPAPk`xPaPxaP xaP0 xaPZxaP aPcaP{APk`xPJaPxaP xaP0 xaPZxaPfaPaPAPk`xPaPxaP xaPl <aPZxaPfaPaPAPkCP5 `xPaPxaP xaP aPaP aPcaP{AP`xPYaP<aP xaP0 xaPZxaPfaPaPAPk`xPaP<aPB <aP0 xaPZxaPfaPaPAPk`xPaPxaP xaP0 xaPZxaPfaPaPAPk`xPaP-aPB <aP0 xaPaPxaPxaP xAPx`xPaP-aPB <aP0 xaPZxaPfaPxaPAPkpxP,aP<aPB <aPl <aP<aPfaPaPk-APk`xP;aP<aPB <aP0 xaPZxaPfaPaPAPkCP5 pxPaPdaPaP aPaP aPcaP{AP`xPaP<aPB <aP0 xaPZxaPxaPaPAPk`xPaPdaPaP aPaPfaPaPAPk`xPaPxaP xaP{ -aP-aPxaPxaP>ZAPZpxPaPxaP xaP aPaP aPaPAPkpxPhaP<aPB <aP aPaPfaPaPAPk`xPaPxaP xaP aPaP aPcaP{AP`xPaP<aPB <aP aPaPfaPaPAPk`xPaPxaP xaP aPaP aPcaP{AP`xPaPxaP xaP aPaP aPcaPAPkCP5 `xPHaPxaP xaP aPaP aPcaP{AP`xPaPxaP xaP0 xaPZxaPfaPaPAPkpxP;aPxaP xaP aPaPfaPaPAPk`xPaP<aP xaP0 xaPZxaPfaPaPAPk`xP;aP<aPB <aPl <aP<aPfaPaPAPkCP5 `xPuaPxaP xaP aPaP aPcaP{AP`xPaP<aPB <aP0 xaPZxaPfaPaP xAPk`xPaP<aP xaPl <aP<aPfaPaPAPk`xPaP<aPB <aP0 xaPZxaPfaPaPAPkpxPaP<aP xaP aPaP aPcaP{APCP5 pxPaPxaP xaP aPaP aPcaP{AP`xPhaP<aPB <aP0 xaPZxaPxaPxaPk-AP-`xPJaP<aPB <aP0 xaP<aPfaPaP\<APk`xP,aP-aPQ -aP0 xaPZxaPxaPxaP xAPx`xP,aPxaP xaP{ -aP-aPfaPaPAPk`xPaP<aPQ -aP0 xaPZxaPfaPaPAPk`xPaPxaPB <aP aPZxaPfaPaPAPk`xPaP<aPB <aP0 xaPZxaPfaPaPAPk`xPaP<aPB <aPl <aP<aPfaPaP xAPkCP5pxPaPdaPaP aPaP aPcaP{AP`xPhaPxaP xaP{ -aP-aPfaPaPAPk`xP;aPxaP xaPl <aP<aPfaPaPAPk`xP,aPdaPaP aPaP aPcaP{AP`xPaP<aPQ -aP0 xaPZxaPxaPxaP xAPx`xPaP<aP xaP{ -aP-aPfaPaPAPkCP5`xPhaP-aPB <aP{ -aP-aP-aPxaP>ZAPZpxPaP<aPB <aP0 xaPZxaPfaPaP>ZAPZpxPaP-aPQ -aP{ -aP-aP-aPS-aP>ZAPZ pxPaPZaP$ ZaPN ZaPxZaPZaP&ZaP>ZAPZ `xPaP-aP$ ZaP{ -aPxZaPxaP&ZaP>ZAPZ@xP @ rUNITED STATES 1,156 1,373 7,218 6,526 33,911 36,341 27,020 30,299 NEW ENGLAND 85 69 686 783 2,220 2,055 2,101 2,110 Maine 4 6 63 127 162 119 151 97 N.H. 2 1 22 21 162 136 149 140 Vt. 1 3 60 57 76 104 63 101 Mass. 38 32 249 262 1,258 1,179 1,115 1,200 R.I. 13 8 67 56 131 124 168 148 Conn. 27 19 225 260 431 393 455 424 MID. ATLANTIC 330 372 1,122 1,233 4,062 4,710 3,588 4,989 Upstate N.Y. 65 73 739 789 1,179 1,158 1,213 1,217 N.Y. City 196 217 29 18 996 1,132 1,297 1,217 N.J. 35 47 180 184 905 1,097 657 975 Pa. 34 35 174 242 982 1,323 421 1,580 E.N. CENTRAL 132 137 142 151 4,450 5,045 3,844 3,435 Ohio 22 20 51 50 1,184 1,459 1,076 1,372 Ind. 16 6 15  494 601 459 576 Ill. 34 64 24 22 1,227 1,428 1,049 231 Mich. 39 31 46 68 768 834 778 886 Wis. 21 16 6 11 777 723 482 370 W.N. CENTRAL 35 66 332 511 2,203 2,255 2,281 2,412 Minn. 6 27 44 87 624 515 665 645 Iowa 9 2 74 74 330 344 301 337 Mo. 13 19 41 50 630 677 906 826 N. Dak.  2 37 113 56 55 80 75 S. Dak.  1 42 90 144 93 118 101 Nebr. 2 8 4 2 144 209  139 Kans. 5 7 90 95 275 362 211 289 S. ATLANTIC 269 309 2,093 2,235 8,130 7,583 5,595 5,617 Del. 2 5 30 49 87 114 104 125 Md. 108 106 332 393 768 711 836 684 D.C. 13 16   79 61 U U Va. 46 49 461 539 1,247 942 958 885 W. Va. 1 4 131 110 131 156 133 144 N.C. 18 34 550 541 1,274 1,076 1,219 1,082 S.C. 7 2 112 149 847 716 677 543 Ga. 30 30 311 302 1,630 1,434 1,210 1,649 Fla. 44 63 166 152 2,067 2,373 458 505 E.S. CENTRAL 33 45 196 196 2,473 2,298 1,735 1,726 Ky. 12 18 27 20 355 360 217 249 Tenn. 11 12 103 100 598 637 758 773 Ala. 6 14 64 75 714 628 474 576 Miss. 4 1 2 1 806 673 286 128 W.S. CENTRAL 12 70 2,082 852 3,607 4,721 2,537 2,892 Ark. 3 3 20 20 866 691 92 563 La. 5 12 3 4 413 851 952 720 Okla. 3 9 59 54 454 369 375 286 Tex. 1 46 2,000 774 1,874 2,810 1,118 1,323 MOUNTAIN 57 50 231 262 2,031 2,579 1,666 2,377 Mont. 3 1 38 64 72 90   Idaho 3 4 28 9 134 121 4 109 Wyo.   20 56 55 67 52 58 Colo. 22 24   552 664 566 646 N. Mex. 3  14 20 270 222 235 201 Ariz. 13 9 115 94 588 701 594 723 Utah 4 6 15 10 209 462 192 459 Nev. 9 6 1 9 151 252 23 181 PACIFIC 203 255 334 303 4,735 5,095 3,673 4,741 Wash. 13 32   505 554 491 630 Oreg. 14 39 3 7 227 276 298 339 Calif. 166 174 294 268 3,617 3,988 2,526 3,511 Alaska 1  37 28 45 56 28 33 Hawaii 9 10   341 221 330 228 Guam  2    26 U U P.R. 4 5 85 74 515 652 U U V.I.       U U Amer. Samoa U U U U U U U U C.N.M.I.  U  U 14 U U U B<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMdw<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd <<GMMd<(GMMd<<GMMd<(GMMd}<<GMMdB(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKdddw(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd (_<Pdd,(xKddd(_<Pdd,(xKddd}(_<PddB'~  ).'~  ).'~  ).'~  ).'~  ).w'~  ).'~  ).'~  ). '~  ).'~  ).}'~  ). XXcxPcPWCP@ ecxPaP<#PCxPcxPaP'-P.CxP# @        @          @                      @  @      @ E m     @            @    q        @         @    @         @       @      K    #    @  $9 $@   @        @      @    @              @        @        @  @    @      \@    @       O    @           @    $9# $#  $  @$  %  @%  %  &  &  f@(  (  )  *  *  +  .+  +  @,  ,  -  -  .  @.  .  /  /  0  @0  0  1  1  @2 @a  5 a  m  @p  w  $9 $    @   @                 @   ;@      @    @  Q    @          @          @      @     R        @   @      @  @   (@      @    @  R    @          @          @      @     " @% , 9 9 N: Not notifiable. U: Unavailable. -: No reported cases. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the PublicHealth Laboratory Information System (PHLIS). <<GMMd<<GMMd<<GMMd)y(dKddd<:[fTXXUBs@BsTable II. (Contd) Provisional cases of selected notifiable diseases, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)*ZGMMdZGMMd&(_<dPddcHt`1 `WbW$WbWBW`WbWbW  bWBW Meningococcal Disease Mumps Pertussis Rubella1<AGMMd1:(_<ddd1^c `WbW,bW,bWbWl,bW ,bW\ bW,bWB,bWbW,BW,`WbWbWbWMbWbW bW bW-bW`bWbWBW/ Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2001 2000 2001 2001 2000 2001 2001 2000c<AGMMdc;(_<dddc ]O @ \ S B]bH Reporting Area<FGMMd7(_<ddd@ =7 Tsq ?sHq!BsK l Table III. (Contd) Provisional cases of selected notifiable diseases preventableby vaccination, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)*ZGMMdZGMMd&(_<dPddcHt`/ ##pxPaPaPaP <aP aPaPIxaPaPcaPB-aPxAPUCP5 `xPaP%aP aP -aP/ -aPi<aP<aPtaPcaPB-aPi-APx`xPhaP<aP<aP -aP/ -aPx-aP-aPxaPxaPB-aPi-AP-`xPaPpxaPkxaP -aP/ -aPx-aP-aPxaPaPB-aPi-AP<`xPaP<aP<aP -aP/ -aPx-aP<aPxaPaPB-aPi-AP-`xPYaPpxaPkxaP -aP/ -aPi<aP-aPtaPcaPB-aPi-AP<`xPaP<aP<aP -aP/ -aPi<aP<aP<aPxaPB-aPi-AP<`xPYaPpxaPkxaP -aP/ -aPi<aP-aPxaPxaPB-aPi-AP<CP5pxPaP%aP aP -aP xaP-xaP<aPtaPaPB-aPZ<AP< pxPaPpxaPkxaP -aP <aP-xaP<aPtaPaPB-aPZ<AP< pxPaPpxaPkxaP -aP xaPi<aP-aPxaPxaPB-aPZ<AP<`xPaPpxaPkxaP -aP <aPi<aP-aPxaPxaPB-aPZ<AP-`xPaPpxaPkxaP -aP <aPi<aP-aPxaPaPB-aPi-AP-CP5 `xPWaP%aP aP -aP xaP-xaP<aPtaPaPB-aPZ<AP<`xPaPpxaPkxaP -aP <aPi<aP<aPtaPaPB-aPi-AP-`xPaPpxaPkxaP -aP <aPi<aP<aPxaPaPB-aPZ<AP-`xPaPpxaPkxaP -aP xaPi<aP<aPxaPaPB-aPZ<AP<`xPJaPpxaP aP -aP <aPi<aP<aPtaPaPB-aPi-AP-`xPaPpxaPkxaP -aP/ -aPi<aP-aPxaPaPB-aPi-AP-CP5 `xPaP%aP aP <aP xaP-xaPIxaPtaPaPB-aPZ<AP<`xPYaPpxaPkxaP -aP <aPx-aPIxaPtaPaPB-aPi-AP<`xPaPpxaPkxaP -aP/ -aPi<aP<aPxaPxaPB-aPZ<AP-`xPaPpxaPkxaP -aP <aPi<aP-aPxaPxaPB-aPZ<AP-`xPaP<aP<aP -aP/ -aPi<aP-aP<aPD<aPB-aPi-AP-`xPaP<aP<aP -aP/ -aPx-aP-aP<aPD<aPB-aPi-AP-pxP,aPpxaP<aP -aP <aPi<aP-aP<aPxaPB-aPi-AP<`xP;aPpxaPkxaP <aP <aPi<aP<aPxaPxaPB-aPZ<AP-CP5 pxPaP%aP aP <aP xaP-xaP<aPtaPaPB-aPZ<APU`xPaP<aP<aP -aP/ -aPx-aP-aP -aPD<aPB-aPZ<AP<`xPaPpxaPkxaP <aP <aPi<aP-aPxaPaPB-aPi-AP-`xPaP-aP-aP -aP/ -aPx-aP-aP<aPD<aPB-aPi-AP-pxPaPpxaPkxaP -aP <aP-xaP<aPxaPaPB-aPi-AP-pxPhaPpxaPkxaP -aP/ -aPx-aP-aP<aPD<aPB-aPi-AP-`xPaPpxaPkxaP -aP <aPi<aP<aPxaPaPB-aPi-APx`xPaPpxaPkxaP -aP <aP-xaP-aPxaPxaPB-aPZ<APx`xPaPpxaPkxaP -aP <aPi<aP-aPxaPxaPB-aPZ<AP-`xPaP%aPkxaP -aP <aPi<aP-aPxaPxaPB-aPZ<AP<CP5 `xPHaP%aP aP -aP <aPi<aP<aPtaPaPB-aPi-AP<`xPaPpxaPkxaP -aP <aPi<aP<aPxaPxaPB-aPi-AP<pxP;aPpxaPkxaP -aP <aPi<aP-aPxaPxaPB-aPi-AP<`xPaPpxaPkxaP -aP/ -aPi<aP-aPxaPxaPB-aPi-AP<`xP;aPpxaPkxaP -aP <aPx-aP-aP<aPD<aPB-aPi-AP-CP5 `xPuaP%aP aP <aP xaP-xaPIxaPtaPaPB-aPZ<AP<`xPaPpxaPkxaP -aP <aPi<aP-aPxaPxaPB-aPi-AP<`xPaPpxaPkxaP -aP <aPi<aP-aP<aPxaPB-aPi-AP<`xPaPpxaPkxaP -aP/ -aPx-aP-aPxaPxaPB-aPi-AP-pxPaP%aP aP <aP xaP-xaPIxaPtaPaPB-aPZ<AP<CP5 pxPaPpxaPkxaP -aP xaP-xaPIxaPaPaPB-aPi-AP<`xPhaP<aP<aP -aP <aPi<aP-aPxaPxaPB-aPi-AP-`xPJaP<aP<aP -aP <aPi<aP-aPtaPxaPB-aPi-AP-`xP,aP<aP<aP -aP <aPi<aP-aP<aPD<aPB-aPi-AP-`xP,aPpxaPkxaP -aP <aPi<aPIxaPtaPaPB-aPi-AP<`xPaPpxaPkxaP -aP <aPi<aP<aPtaPxaPB-aPi-AP-`xPaPpxaPkxaP -aP <aPi<aP-aPtaPxaPB-aPi-AP<`xPaP<aP<aP -aP <aPi<aP-aPxaPxaPB-aPi-AP-`xPaP<aP<aP -aP <aPi<aP<aPxaPxaPB-aPi-AP-CP5pxPaP%aP aP -aP xaPaP<aPtaPcaPB-aPZ<APx`xPhaPpxaPkxaP -aP <aP-xaP<aPtaPaPB-aPi-AP<`xP;aPpxaPkxaP ZaP ZaPKZaP-aPxaPaPB-aPi-AP-`xP,aP%aP aP -aP xaP-xaP-aPtaPaPB-aPi-AP<`xPaP<aP<aP -aP <aPi<aP-aPxaPxaPB-aPi-AP-`xPaPpxaP<aP -aP xaP-xaP-aPxaPxaPB-aPZ<AP-CP5`xPhaP-aP-aP -aP/ -aP-xaP-aP -aPD<aPB-aPi-AP<pxPaP<aPkxaP -aP/ -aPx-aP-aP<aPD<aPB-aPi-AP-pxPaP-aP-aP -aP/ -aPx-aP-aP -aPS-aPB-aPi-AP- pxPaPZaPZaP ZaP ZaPKZaPgZaPZaP&ZaPZaP<ZAPZ `xPaP-aPZaP ZaP/ -aPKZaPgZaP -aP&ZaPZaPi-APZ@xP @] ;|UNITED STATES 2,041 2,009 3 201 299 82 4,394 6,600  20 165 NEW ENGLAND 106 118   4 4 415 1,789   12 Maine 4 8     21 45    N.H. 13 12     38 126   2 Vt. 6 3    3 36 236    Mass. 54 68   1  297 1,318   8 R.I. 6 9   1 1 6 19   1 Conn. 23 18   2  17 45   1 MID. ATLANTIC 203 238  20 26 2 265 654  5 9 Upstate N.Y. 59 72  3 10 2 133 326  1 1 N.Y. City 40 41  10 7  44 82  3 8 N.J. 49 49  3 3  18 30  1  Pa. 55 76  4 6  70 216    E.N. CENTRAL 295 362  19 22 7 605 774  3 1 Ohio 75 87  1 7 2 235 318    Ind. 37 41  3 1 1 80 111  1  Ill. 70 82  11 6 2 71 113  2 1 Mich. 66 110  4 6 2 132 111    Wis. 47 42   2  87 121    W.N. CENTRAL 145 146 1 11 17 23 345 564  3 2 Minn. 22 21  3  21 167 343   1 Iowa 29 34   7 1 43 56  1  Mo. 49 66  2 4  92 85  1  N. Dak. 6 2   1  5 6    S. Dak. 5 5     4 7    Nebr. 20 7  1 2  7 27   1 Kans. 14 11 1 5 3 1 27 40  1  S. ATLANTIC 347 268 1 37 44 9 247 478  7 112 Del. 5 1      9  1 1 Md. 40 26 1 7 9  38 114    D.C.       1 3    Va. 38 39  8 10 8 49 106    W. Va. 13 13     4 1    N.C. 62 36  5 7 1 70 108   82 S.C. 34 22  5 11  32 35  2 27 Ga. 48 45  7 2  27 40  1  Fla. 107 86  5 5  26 62  3 2 E.S. CENTRAL 123 127  9 5 2 149 108   6 Ky. 21 26  3 1 2 52 55   1 Tenn. 56 53  1 2  57 32   1 Ala. 31 34   2  36 18   4 Miss. 15 14  5   4 3    W.S. CENTRAL 322 214 1 14 32 14 470 351  1 8 Ark. 19 13  1 3  45 36   1 La. 65 43  2 5  3 20   1 Okla. 28 27     27 47    Tex. 210 131 1 11 24 14 395 248  1 6 MOUNTAIN 88 94  13 21 19 1,248 755   2 Mont. 4 4  1 1  37 35    Idaho 7 7  1 1  170 61    Wyo. 5 1  1 1  1 4    Colo. 34 32  3 1 11 283 453   1 N. Mex. 10 11  2 1 2 137 88    Ariz. 13 29  1 4  509 75   1 Utah 8 7  1 6  76 24    Nev. 7 3  3 6 6 35 15    PACIFIC 412 442  78 128 2 650 1,127  1 13 Wash. 60 56  2 10 2 161 391   7 Oreg. 41 66 N N N  51 106    Calif. 295 303  39 87  395 569   6 Alaska 3 9  1 8  11 21    Hawaii 13 8  36 23  32 40  1  Guam     16   4   1 P.R. 4 10     2 9    V.I.            Amer. Samoa U U U U U U U U U U U C.N.M.I.  U U  U U  U U  U <<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMdB<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd#<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKdddB(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd#(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd<  \ 7o  \ 7o  \ 7o  \ 7o  \ 7oB  \ 7o  \ 7o  \ 7o#  \ 7o  \ 7o  \ 7o hhcxPcPCP@  xP@xP[N: Not notifiable. U: Unavailable. - : No reported cases. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). <<GMMd<)y(dKddd)[(dKddd<:[Z cxPcPCP@ cxP!PCxPZcxPbAP'cxPjAPqCxPN: Not notifiable. U: Unavailable. - : No reported cases. * Incidence data for reporting year 2001 are provisional and cumulative (year-to-date). Incidence data for reporting year 2000 are finalized and cumulative (year-to-date). For imported measles, cases include only those resulting from importation from other countries. Of 257 cases among children aged <5 years, serotype was reported for 121, and of those, 21 were type b. <<GMMd<<GMMda<<GMMd<<GMMdj<<GMMd;)y(dKddd{)Z(dKddd)y(dKddd;:[|T JBs ?sq !Bsl Table III. Provisional cases of selected notifiable diseases preventable by vaccination, United States, weeks ending December 1, 2001, and December 2, 2000 (48th Week)*ZGMMdZGMMd&(_<dPddcHt`# `WbW*bW BW`WbWZbWK bW v bW :BWm A B Indigenous Imported Total<AGMMd<AGMMd<AGMMd3(_<dddv(_<ddd* I r`WbW,bW,bW!,bWj,bW ,bW ,bWTbW,bWbW^,bW,BW,`WbWbWbW?bWbW bW bW bWbWbW|bWBW/ Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. Cum. 2001 2000 2001 2000 2001 2000 2001 2001 2001 2001 2001 2000:<AGMMd<AGMMd7<AGMMdr8(_<dddr ;b= { T,^ B]bH Reporting Area<FGMMd7(_<ddd@ =7$ xxBxPU$ Hepatitis (Viral), By Type<<GMMd.(_<dddW j?|B]|B]e|H. influenzae, Invasive<FGMMd <FGMMd7(_<ddd@ =7- r##pxPaPaPaPB aP@ haP aPaPu-aPxaP&-aPxaPWxAPxCP5 `xPaPUxaP&aP aP aPyxaPJaPu-aP?<aP&-aP<aP<AP<`xPhaP<aP<aP xaP0 xaP<aP<aPu-aPN-aP&-aP-aP-AP-`xPaP<aPqxaP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP<`xPaP<aP<aP xaP0 xaP<aP<aPu-aP?<aP&-aP-aP<AP<`xPYaPUxaPqxaP aP aPyxaPxaPu-aP?<aP&-aP<aP<AP-`xPaP<aP<aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xPYaPUxaPqxaP aP aPyxaPxaPu-aP?<aP&-aP-aP<AP-CP5pxPaP aP&aP aP aP.aPaPu-aP?<aP&-aPxaPWxAPx pxPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP<aP<APx pxPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP<aP<APx`xPaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP<aP<AP-`xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP<aP<AP<CP5 `xPWaP aP&aPB aP aP.aPJaPu-aPN-aP&-aPxaPWxAP<`xPaPUxaPqxaP aP aPyxaPxaPu-aPN-aP&-aP<aP<AP<`xPaPUxaPqxaP xaP aPyxaPxaPu-aPN-aP&-aP<aP<AP-`xPaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP<aP<AP<`xPJaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP-aP-AP<`xPaPUxaPqxaP xaP0 xaP-aPxaPu-aPN-aP&-aP-aP-AP-CP5 `xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP<aP<AP<`xPYaPUxaPqxaP xaP aPyxaPxaPu-aP?<aP&-aP<aP<AP<`xPaP-aP-aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP-aP<AP-`xPaP<aP<aP# <aPl <aP<aP<aPu-aPN-aP&-aP-aP-AP-`xPaP-aP<aP# <aPl <aP<aP<aPu-aPN-aP&-aP-aP-AP-pxP,aP<aP<aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xP;aP<aP<aP aP aPyxaPxaPu-aPN-aP&-aP-aP-AP<CP5 pxPaP aP&aPB aP aP aPaPu-aP?<aP&-aP<aP<AP<`xPaP-aP-aP2 -aP0 xaP-aPxaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP<aP<AP-`xPaP-aP-aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-pxPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP-aP<AP<pxPhaPUxaP<aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP-aP-AP-`xPaP<aP<aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP-aP<AP-`xPaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP-aP-AP<CP5 `xPHaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP-aP<AP-`xPaP<aPqxaP aP0 xaPyxaPxaPu-aP?<aP&-aP-aP<AP-pxP;aPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP-`xP;aP<aP<aP xaP aPyxaPJaPu-aPN-aP&-aP-aP-AP-CP5 `xPuaPUxaPqxaPB aP aP.aPaPu-aPN-aP&-aP<aP<AP-`xPaP<aP<aP xaP aPyxaPxaPu-aPN-aP&-aP-aP-AP-`xPaP<aPqxaP xaP0 xaPyxaPJaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aPN-aP&-aP-aP-AP-pxPaP<aP<aPB aP aP.aPJaPu-aPN-aP&-aP<aP<AP-CP5 pxPaP aP&aP aP aP.aPJaPu-aP?<aP&-aP-aP<APx`xPhaP-aP<aP xaPl <aP<aP<aPu-aPN-aP&-aP-aP-AP-`xPJaP<aP<aP xaP0 xaPyxaP<aPu-aP?<aP&-aP-aP<AP-`xP,aP-aP<aP# <aPl <aP<aP<aPu-aPN-aP&-aP-aP-AP-`xP,aPUxaPqxaP xaP aPyxaPxaPu-aPN-aP&-aP-aP-AP<`xPaPUxaPqxaP xaP0 xaP.aPJaPu-aPN-aP&-aP-aP-AP-`xPaPUxaPqxaP aP aP.aPJaPu-aP?<aP&-aP-aP<AP-`xPaP<aPqxaP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP<`xPaPUxaP<aP xaP0 xaPyxaPxaPu-aPN-aP&-aP-aP-AP<CP5pxPaPUxaP&aPB aP aP aPaPu-aPxaP&-aPxaPWxAPx`xPhaP<aP<aP aP aP.aPJaPu-aPxaP&-aP<aPWxAP<`xP;aPUxaPqxaP xaP aP.aPJaPu-aP?<aP&-aP-aP<AP-`xP,aPUxaPqxaPB aP aP.aPJaPu-aPxaP&-aPxaPWxAPx`xPaP<aPqxaP xaP0 xaP<aPxaPu-aPN-aP&-aP-aP-AP<`xPaPUxaPqxaP# <aP0 xaPyxaPxaPu-aP?<aP&-aP<aP<AP<CP5`xPhaP-aP<aP2 -aPl <aP-aPxaPu-aPN-aP&-aP-aP-AP-pxPaP<aP<aP aP aP.aPJaPu-aPN-aP&-aP-aP-AP<pxPaP-aP-aP2 -aP{ -aP-aP-aPu-aPN-aP&-aP-aP-AP- pxPaPsZaPZaP ZaPN ZaPZaPZaPHZaP!ZaPZaPZaPuZAPZ `xPaP-aPZaP2 -aPN ZaPyxaPZaPHZaPN-aPZaP-aP-APZ@xP  ~UNITED STATES 1,229 1,194 9,310 12,070 5,962 6,520  52  43 95 75 NEW ENGLAND 88 100 642 368 95 105  4  1 5 6 Maine 2 1 11 21 5 5       N.H. 6 12 18 18 16 16      3 Vt. 4 9 16 10 4 6  1   1 3 Mass. 41 40 307 128 11 15  2  1 3  R.I. 5 4 66 24 28 22       Conn. 30 34 224 167 31 41  1   1  MID. ATLANTIC 179 217 886 1,421 917 1,082  5  11 16 21 Upstate N.Y. 71 93 256 240 121 123  1  4 5 10 N.Y. City 46 59 281 479 397 527  3  1 4 10 N.J. 42 38 159 273 169 168    1 1  Pa. 20 27 190 429 230 264  1  5 6 1 E.N. CENTRAL 202 167 1,086 1,564 833 691    10 10 8 Ohio 56 51 213 245 84 98    3 3 2 Ind. 46 28 95 111 47 46    4 4  Ill. 62 56 403 666 149 108    3 3 3 Mich. 13 11 308 461 553 400      3 Wis. 25 21 67 81  39       W.N. CENTRAL 64 74 385 622 201 274  4  1 5 2 Minn. 39 42 41 171 28 35  2  1 3 1 Iowa   37 63 25 32       Mo. 15 22 103 248 103 134  2   2  N. Dak. 7 2 3 3 1 2       S. Dak.  1 3 2 1 1       Nebr. 2 3 32 32 25 44       Kans. 1 4 166 103 18 26      1 S. ATLANTIC 348 260 2,174 1,341 1,364 1,189  4  1 5 4 Del.    15  14       Md. 84 75 276 186 132 114  2  1 3  D.C.   52 24 11 29       Va. 27 37 127 147 170 156  1   1 2 W. Va. 14 8 25 53 20 19       N.C. 44 23 206 131 200 236       S.C. 9 7 71 77 29 21       Ga. 97 65 865 283 442 220  1   1  Fla. 73 45 552 425 360 380      2 E.S. CENTRAL 70 47 366 369 390 439  2   2  Ky. 2 12 123 47 41 73  2   2  Tenn. 40 21 145 133 216 204       Ala. 26 12 71 48 79 60       Miss. 2 2 27 141 54 102       W.S. CENTRAL 47 63 1,273 2,272 661 1,026    1 1  Ark. 1 2 66 127 95 92       La. 6 16 61 90 45 144       Okla. 39 43 113 245 106 148       Tex. 1 2 1,033 1,810 415 642    1 1  MOUNTAIN 133 123 687 870 449 496  2   2 12 Mont.  1 11 7 3 6       Idaho 2 4 57 33 11 6  1   1  Wyo.  1 7 4 3 3       Colo. 37 31 86 196 99 95      2 N. Mex. 22 24 37 69 128 131       Ariz. 54 45 365 424 136 184  1   1  Utah 8 11 68 59 26 24      3 Nev. 10 6 56 78 43 47      7 PACIFIC 98 143 1,811 3,243 1,052 1,218  31  18 49 22 Wash. 5 7 140 268 133 107  13  2 15 3 Oreg. 19 32 74 161 111 113  4   4  Calif. 44 35 1,580 2,788 782 975  12  11 23 15 Alaska 6 45 14 13 9 11      1 Hawaii 24 24 3 13 17 12  2  5 7 3 Guam  1  1  10       P.R. 1 4 119 234 176 275      2 V.I.             Amer. Samoa U U U U U U U U U U U U C.N.M.I.  U  U 35 U U  U   U C<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd!<<GMMd<(GMMd}<<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMdD<<GMMd<(GMMd<<GMMd<(GMMd<<GMMdC(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd!(_<Pdd,(xKddd}(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKdddD(_<Pdd,(xKddd(_<Pdd,(xKddd(_<PddC _   {SB _   {SB _   {SB _   {SB! _   {SB} _   {SB _   {SB _   {SBD _   {SB _   {SB _   {SB! xxBxP! Measles (Rubeola)<<GMMd.(_<dddW j?N!XX2Rs'Bs } Table IV. Deaths in 122 U.S. cities,* week ending December 1, 2001 (48th Week)ZGMMdIZGMMdN&(_<dPddcNHt`!b `]bb]Zbb]bb]-bb]bB]ub 65 45-64 25-44 1-24 <1<FGMMd<FGMMd<FGMMdw(_<ddd]!  B]bH Reporting Area<FGMMdx(_<ddd@ =7!G xx BxPG All Causes, By Age (Years)<<GMMd.(_<dddW j?! BxPBxPdAll Ages<<GMMd.(_<dddW j? !h BxP<hBxP&hP&I Total<<GMMd<<GMMd<<GMMd .(_<ddd W j?1!`]b] b] b]-w b]YB]9 65 45-64 25-44 1-24 <1<FGMMd<FGMMd<FGMMd*<FGMMd1w(_<ddd1]!-xxBxPsH-Reporting Area<<GMMd.(_<dddW j?!G xxBxPG All Causes, By Age (Years)<<GMMd.(_<dddW j?!/BxP/BxP/All Ages<<GMMd.(_<dddW j? !]BxP7]BxP ]P&I Total<<GMMd<<GMMd<<GMMd .(_<ddd W j?$!*! !   `xPaPaPraPRxaP xaP^ <aP <AP x`xPWaPFZaPZaPpZaP ZaP@ ZaP ZAPZ`xP8aP(xaPxaP<aP <aPm -aP -AP.<`xP8aP(xaPxaP<aP <aPm -aP -AP=-pxPaP(xaPxaP<aP -aPm -aP -AP.<`xPaPFZaPZaPpZaP ZaP@ ZaP ZAPZ`xP*aP(xaPxaP<aP -aP^ <aP -AP=- `xPaP(xaP<aP<aP <aPm -aP -AP.<`xPaP(xaPxaP<aP <aPm -aP -AP.<`xPGaP(xaPxaP<aP <aP^ <aP <AP.<`xPaP(xaPxaPRxaP <aP^ <aP -AP=-`xP)aPd<aP<aP<aP -aPm -aP -AP=-`xPGaP(xaPxaP<aP <aP^ <aP -AP=-`xPaP(xaPxaP<aP <aPm -aP -AP.<pxPaP(xaPxaPRxaP <aP^ <aP <AP.<CP5pxPaPaPaPaPB aP" xaP xAP  pxPaP(xaPxaPRxaP <aP^ <aP <AP.<`xPuaP(xaPxaP<aP -aPm -aP -AP.<pxPaP(xaPxaPRxaP <aP^ <aP <AP.< `xPaP(xaPxaP<aP <aP^ <aP -AP.<`xPWaP(xaPxaP<aP -aPm -aP -AP=- `xPaP(xaPxaP<aP <aPm -aP -AP=-`xPaP(xaPxaP<aP <aPm -aP <AP=-pxPeaPaPraPaPB aP" xaP xAP x `xPaPFZaPZaPpZaP ZaP@ ZaP ZAPZ`xPHaP(xaPxaP<aP <aPm -aP <AP.<`xPaPaPraPRxaP xaP" xaP <AP x`xPaP(xaPxaP<aP <aPm -aP <AP.< `xPaP(xaPxaP<aP -aPm -aP -AP.<pxPuaPaPraPRxaP <aP^ <aP <AP xpxP)aP(xaPxaP<aP <aPm -aP -AP.<`xPfaP(xaPxaP<aP <aPm -aP -AP.<pxPHaP(xaPxaPRxaP <aP^ <aP <AP xpxPaP(xaPxaP<aP <aPm -aP <AP=- pxPgaP(xaPxaP<aP -aPm -aP -AP.<pxPaPFZaPZaPpZaP ZaP@ ZaP ZAPZCP5 `xPWaPaPaPaPB aP" xaP xAP  `xPaP(xaPxaPRxaP <aPm -aP <AP.< `xPaP(xaPxaP<aP <aP^ <aP <AP.<`xPaPFZaPZaPpZaP ZaP@ ZaP ZAPZ`xPaPaPxaPRxaP <aP^ <aP <AP.<`xPaPaPxaPRxaP xaP^ <aP <AP x`xPaPaPraPRxaP xaP^ <aP <AP.< `xPaPaPraPRxaP <aP^ <aP <AP x`xPHaPaPraPRxaP xaP^ <aP xAP x`xPuaP(xaPxaP<aP <aP^ <aP -AP.<`xPaP(xaPxaPRxaP <aP^ <aP <AP.< `xP:aP(xaPxaP<aP <aP^ <aP <AP.<`xPaP(xaPxaPRxaP <aP^ <aP <AP.<`xP aPaPraPRxaP <aP^ <aP <AP x`xPuaP(xaPxaPRxaP <aP^ <aP <AP.<`xPaPaPxaPRxaP <aP^ <aP <AP x `xPIaP(xaPxaPRxaP <aP^ <aP <AP.<`xPaP(xaPxaPRxaP <aP^ <aP -AP.<`xPaP(xaPxaP<aP <aPm -aP -AP.< pxPaP(xaPxaPRxaP <aP^ <aP <AP.<pxPeaP(xaPxaPRxaP <aPm -aP -AP.<CP5 `xPaPaPraPaP xaP" xaP xAP x`xP)aP(xaPxaP<aP -aPm -aP -AP.<`xPHaP(xaPxaP<aP <aPm -aP -AP.<`xP8aP(xaPxaPRxaP <aP^ <aP <AP.<`xPaP(xaPxaP<aP <aP^ <aP <AP.<pxP9aP(xaPxaP<aP <aP^ <aP <AP.<`xPaPaPraPRxaP <aP^ <aP <AP x pxP*aP(xaPxaP<aP <aP^ <aP <AP.<`xPHaPaPxaPRxaP xaP^ <aP <AP=-`xPuaP(xaPxaP<aP <aP^ <aP <AP.<`xPWaPaPxaPRxaP <aP^ <aP <AP.<@Z pxPaPaPraPaPB aP" xaP xAP x `xPaPaPxaPRxaP xaP^ <aP <AP.<`xPaPaPxaPRxaP xaP^ <aP <AP x`xPfaPaPxaPRxaP xaP^ <aP <AP x`xPaPaPraPRxaP xaP^ <aP <AP x `xPaPaPraPRxaP xaP^ <aP <AP x pxPaP(xaPxaPRxaP <aP^ <aP <AP.<pxPWaP(xaPxaPRxaP <aP^ <aP <AP.<`xPHaP(xaPxaP<aP <aP^ <aP <AP.<`xPtaP(xaPxaPRxaP <aP^ <aP <AP.< pxPaPaPraPRxaP xaP^ <aP <AP.<`xPaPaPxaPRxaP <aP^ <aP -AP=-`xPaP(xaP<aP<aP -aPm -aP -AP=-CP5 `xPHaPaPraPaP xaP" xaP xAP x`xPaPaPraPRxaP <aP^ <aP <AP xpxPaP(xaPxaPRxaP <aP^ <aP -AP.<pxPaPaPxaPRxaP <aP^ <aP <AP.<`xPWaPaPxaPRxaP <aPm -aP <AP xpxPaPaPraPRxaP <aP^ <aP <AP x `xPaPaPxaPRxaP xaP^ <aP <AP.<`xPGaP(xaPxaP<aP <aPm -aP -AP.<pxPaPaPraPRxaP <aP^ <aP <AP.<CP5 `xPuaPaPaPaPB aP" xaP xAP  pxPaPaPxaPRxaP xaP^ <aP <AP.<`xPaPaPxaPRxaP <aP^ <aP <AP.<pxPaP(xaPxaPRxaP <aP^ <aP <AP.< pxPaPaPraPRxaP xaP^ <aP xAP xpxPaP(xaPxaPRxaP <aP^ <aP -AP.<pxPfaPaPxaPRxaP <aP^ <aP <AP.<pxP9aPaPraPaP xaP" xaP <AP x`xPaP(xaPxaPRxaP <aP^ <aP <AP.<`xPaPFZaPZaPpZaP ZaP@ ZaP ZAPZpxP)aPaPraPRxaP xaP^ <aP <AP x`xPaP(xaPxaPRxaP <aP^ <aP -AP.< pxPaPaPxaPRxaP xaP^ <aP <AP xCP5 pxPaPaPraPaP xaP" xaP xAP x`xPaPaPraPRxaP xaP^ <aP <AP x `xPaP(xaPxaP<aP <aPm -aP -AP.<`xPaP(xaPxaP<aP <aPm -aP <AP.<pxP aPaPxaPRxaP xaP^ <aP <AP.<pxPaPaPraPRxaP xaP^ <aP -AP x `xPaP(xaPxaP<aP <aPm -aP <AP.<`xPHaPaPxaPRxaP xaP^ <aP <AP.<`xPaP(xaPxaP<aP <aP^ <aP -AP.<`xPaPaPxaPRxaP xaP^ <aP <AP xpxP aPaPraPRxaP <aP^ <aP <AP.<CP5pxPaPaPaPaPB aP" xaP xAP `xPWaP(xaPxaP<aP -aPm -aP -AP.<`xP aPaPxaPRxaP xaPm -aP <AP.<`xPuaP(xaPxaP<aP <aPm -aP -AP.<`xP aP(xaPxaPRxaP <aP^ <aP <AP.<`xP)aP(xaPxaPRxaP <aP^ <aP <AP x`xPGaPaPraPRxaP xaP" xaP <AP x`xPaP(xaPxaP<aP <aPm -aP -AP.<`xPaPaPraPRxaP xaP^ <aP <AP.<`xPGaPaPxaPRxaP <aP^ <aP <AP x`xPaPaPraPRxaP xaP^ <aP <AP x`xPaPFZaPZaPpZaP ZaP@ ZaP ZAPZ`xPaPaPraPRxaP xaP^ <aP <AP x`xPaP(xaPxaP<aP <aPm -aP -AP.<`xPWaPaPraPRxaP <aP^ <aP <AP x`xPaP(xaPxaPRxaP <aP^ <aP <AP.<pxPaPaPxaPRxaP <aP^ <aP <AP xCP5pxPaP aPaPaPB aP aP? AP @xP B b B@NEW ENGLAND 417 327 56 23 8 3 27 Boston, Mass. U U U U U U U Bridgeport, Conn. 34 28 4 2   3 Cambridge, Mass. 18 14 3 1    Fall River, Mass. 30 28 2    2 Hartford, Conn. U U U U U U U Lowell, Mass. 19 12 6  1   Lynn, Mass. 16 9 2 5   1 New Bedford, Mass. 42 38 3 1   4 New Haven, Conn. 54 42 5 4 1 2 4 Providence, R.I. 67 48 12 6 1   Somerville, Mass. 7 6 1     Springfield, Mass. 27 18 4 2 3   Waterbury, Conn. 24 22 1 1   5 Worcester, Mass. 79 62 13 1 2 1 8 MID. ATLANTIC 2,556 1,699 532 227 62 33 123 Albany, N.Y. 51 33 11 5 1 1 8 Allentown, Pa. 21 17 4    1 Buffalo, N.Y. 94 62 23 6 2 1 8 Camden, N.J. 42 28 8 5 1  1 Elizabeth, N.J. 16 11 5     Erie, Pa. 51 40 5 6    Jersey City, N.J. 29 16 8 4  1  New York City, N.Y. 1,449 918 324 149 37 18 51 Newark, N.J. U U U U U U U Paterson, N.J. 19 11 4 3  1 1 Philadelphia, Pa. 364 238 72 35 14 5 21 Pittsburgh, Pa. 42 31 9 1  1 1 Reading, Pa. 23 18 5    2 Rochester, N.Y. 192 149 28 7 6 2 15 Schenectady, N.Y. 27 20 5 2   2 Scranton, Pa. 36 32 3 1   1 Syracuse, N.Y. 66 48 13 2 1 2 10 Trenton, N.J. 15 10 3 1  1  Utica, N.Y. 19 17 2    1 Yonkers, N.Y. U U U U U U U E.N. CENTRAL 2,032 1,423 389 124 41 55 137 Akron, Ohio 63 43 16 3  1 8 Canton, Ohio 47 33 9 1 3 1 5 Chicago, Ill. U U U U U U U Cincinnati, Ohio 119 84 24 8 2 1 9 Cleveland, Ohio 146 96 34 11 3 2 11 Columbus, Ohio 211 139 45 15 4 8 7 Dayton, Ohio 160 127 20 9 3 1 12 Detroit, Mich. 236 135 58 22 5 16 14 Evansville, Ind. 55 42 9 3 1  3 Fort Wayne, Ind. 82 62 11 5 2 2 4 Gary, Ind. 39 21 8 5 4 1 2 Grand Rapids, Mich. 82 55 14 4 1 8 4 Indianapolis, Ind. 239 169 50 9 3 8 18 Lansing, Mich. 62 43 10 6 2 1 5 Milwaukee, Wis. 127 89 23 9 4 2 11 Peoria, Ill. 54 38 11 3 1 1 8 Rockford, Ill. 77 61 10 4 2  6 South Bend, Ind. 75 66 8 1   2 Toledo, Ohio 87 62 18 4 1 2 7 Youngstown, Ohio 71 58 11 2   1 W.N. CENTRAL 797 580 127 42 22 26 46 Des Moines, Iowa 49 42 7    8 Duluth, Minn. 37 32 4 1   4 Kansas City, Kans. 53 30 15 4 2 2 2 Kansas City, Mo. 58 43 7 5 1 2 2 Lincoln, Nebr. 50 38 7 3 1 1 1 Minneapolis, Minn. 149 109 26 8 3 3 12 Omaha, Nebr. 93 73 9 1 5 5 5 St. Louis, Mo. 116 70 24 10 7 5  St. Paul, Minn. 87 76 6 2 1 2 6 Wichita, Kans. 105 67 22 8 2 6 6 S. ATLANTIC 1,304 851 280 115 26 32 84 Atlanta, Ga. 143 79 34 19 4 7 3 Baltimore, Md. 131 83 28 17 1 2 13 Charlotte, N.C. 142 96 29 12 2 3 15 Jacksonville, Fla. 203 132 39 18 8 6 20 Miami, Fla. 163 116 28 17 1 1 12 Norfolk, Va. 61 43 11 3 1 3 1 Richmond, Va. 61 35 16 3 2 5 4 Savannah, Ga. 47 34 8 2 1 2 4 St. Petersburg, Fla. 61 45 10 4 1 1 5 Tampa, Fla. 180 124 40 11 3 2 7 Washington, D.C. 100 55 34 9 2   Wilmington, Del. 12 9 3     E.S. CENTRAL 937 645 200 50 21 20 75 Birmingham, Ala. 162 109 37 8 3 4 18 Chattanooga, Tenn. 73 55 13 3 2  3 Knoxville, Tenn. 107 78 20 5 3 1 7 Lexington, Ky. 101 66 26 3  6 13 Memphis, Tenn. 152 103 32 9 7 1 14 Mobile, Ala. 148 96 34 12 4 2 6 Montgomery, Ala. 40 31 7 2   7 Nashville, Tenn. 154 107 31 8 2 6 7 W.S. CENTRAL 1,794 1,115 412 151 70 46 104 Austin, Tex. 133 79 29 13 5 7 5 Baton Rouge, La. 128 88 26 4 8 2 5 Corpus Christi, Tex. 57 36 16 1 1 3 1 Dallas, Tex. 283 161 77 24 9 12 15 El Paso, Tex. 97 71 16 8 2  6 Ft. Worth, Tex. 121 77 22 9 9 4 5 Houston, Tex. 407 241 101 40 17 8 26 Little Rock, Ark. 65 37 18 4 5 1 2 New Orleans, La. U U U U U U U San Antonio, Tex. 285 184 60 28 7 6 16 Shreveport, La. 65 49 10 3 3  9 Tulsa, Okla. 153 92 37 17 4 3 14 MOUNTAIN 1,203 804 255 87 26 24 84 Albuquerque, N.M. 175 110 40 14 4 3 12 Boise, Idaho 41 33 7 1   3 Colo. Springs, Colo. 51 42 5 3  1 4 Denver, Colo. 100 60 23 11 3 3 9 Las Vegas, Nev. 314 217 79 15 3  19 Ogden, Utah 47 35 9 2  1 6 Phoenix, Ariz. 142 78 36 13 7 5 8 Pueblo, Colo. 31 22 6 2 1  2 Salt Lake City, Utah 141 88 25 17 4 7 14 Tucson, Ariz. 161 119 25 9 4 4 7 PACIFIC 1,922 1,345 354 133 42 48 150 Berkeley, Calif. 12 11 1    2 Fresno, Calif. 131 86 26 17  2 5 Glendale, Calif. 28 20 5 3   3 Honolulu, Hawaii 86 62 15 5 2 2 7 Long Beach, Calif. 77 58 14 1 3 1 13 Los Angeles, Calif. 461 320 89 32 12 8 34 Pasadena, Calif. 20 12 6 2   3 Portland, Oreg. 181 133 25 13 4 6 6 Sacramento, Calif. 142 88 34 7 5 8 10 San Diego, Calif. 176 119 33 15 3 6 15 San Francisco, Calif. U U U U U U U San Jose, Calif. 216 157 36 17 1 5 10 Santa Cruz, Calif. 37 31 4 2   5 Seattle, Wash. 166 113 31 7 9 6 17 Spokane, Wash. 71 52 11 4 2 2 9 Tacoma, Wash. 118 83 24 8 1 2 11 TOTAL 12,962 8,789 2,605 952 318 287 830 <<GMMd<(GMMd<<GMMd<(GMMd<<GMMd<(GMMd+<<GMMd<(GMMd;<<GMMd<(GMMd<<GMMd<(GMMdx<<GMMd<(GMMd_<<GMMd<(GMMd <<GMMd<<GMMd<<GMMd(_<Pdd,(xKddd(_<Pdd,(xKddd(_<Pdd,(xKddd+(_<Pdd,(xKddd;(_<Pdd,(xKddd(_<Pdd,(xKdddx(_<Pdd,(xKddd_(_<Pdd,(xKddd,(_<Pdd5   j5   j5   j+5   j;5   j5   jx5   j_5   j,5   jzqUM%,$y CorelDRAW 9 Fig1vp.epsWed Dec 05 16:30:09 2001 \PANTONE 286 CVCFri Aug 16 16:45:12 1991Thu Mar 15 08:57:55 1990Univers Helvetica SU C"!/cxPcP@ cPcPcPcPCPPcxPaP<#P#CxP"cxPaP'-CPcxPaP'-P#*CxPCcxPaP'-sPccPpcP@ cPcPcPcPcPP#P cxPcPcPcPpCP@ U: Unavailable. -:No reported cases. * Mortality data in this table are reported voluntarily from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not included. Pneumonia and influenza. Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Completecounts will be available in 4 to 6 weeks. Total includes unknown ages. <<GMMd<<GMMd<<GMMd<<GMMd<<GMMd<<GMMd<<GMMd<<GMMd+<<GMMdC)y(dKddd6:[ T `h b : Ad  MMWR December 7, 2001PGMMd(xKddd  `h b : Ad 1100 MMWR December 7, 2001PGMMd(xKddd .fTPC ..EPSFII*aM  !#$')+,/1254769;=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrtuvwx{|}~   !#$')+,/1254769;=>? !!""%'()*@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrtuvwx{|}~+,,-./47778 $')+.32678:;?> !#$')+,/1254769;=>?DIILNSVZ_acffhpwx|~@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrtuvwx{|}~88n^;^0^;^n^;^nn^;^^~^~^^n~;0;0n^^^^nn0000nnn^^^0~0~;;^^0n^~0;^n;~;^n;0n^~~^n~^n~^~;~0n00~;0~;;~000^n;~n000n;~;;^^^;~nn~~;~^^^^^^n~00;~00;^n^^^^~00^;~~;~~~0^0^~0~^^~;~~^~^^n^n~^0000^;^~nn^^~00;ˤ;ˤ~0^0^^^0n0n^^ڰ^;ڰ^;^~^;~0nn;~^^^n^^^^^^00^;^^;^;^^^^^00~~^;^~~~~~~^;~^;~^~^0~^0^00~n^n^^~^^^^0;󻊊󻊊^^nn^;^n00^^;~;~n0^^~;;~^~^^^^n^^^^^~^n~~n^^n;~~n^;^0^~;;^^;;^^0^^^~nn0000^^^^^;;;^nnnn;;nn^~^~^~^;;;~~n^~n^;;;~^^0^^^~^;~^0~^0^0^~~^^^0~^^0^~~^;nn;~^00~0^^00n;^;^000;~;~^^^^;^n0^;^n^^n^;^^~0^;^n^n^;^^~0^;^n0~;n;n0~00~0~0^0;0~;00n^~;0^n^~;0ڤ^00^^~00n^^^n^^^ڤ^00^~^^~^0000n000nnn00^^nnn000~;^0~;~^0~;^n;~0;^n;~~^0~~0n^~~^n~0;^n;~^0n^~~^n~0;^n;~~0~;n00~;~;~00n00~;^;~00n00~;n0n00nn;~;n00^^^n;~;n00~~nn~~;~^nn~^^^;~^nn~n~~00;~00;n~^n^~00;^^^n^~00;;~~0^;~~~00^;~~^0^~00^;~~0~0^^~00;0~~^;^n^~~^;0n~^00n~^0^;^0n~^0n~n~n^^~n;ˤ0;ˤ~00;ˤ^0^~00;ˤ^^0n0n^^^^ڰ^;0n^~^^^ڰ^;0nn;n0nn;;~^0n^n^;~^0n^^^^^0^^^^^;^0^^^^;^^;^^^;^^^^^;^00~0^;^~0~~~~~~~~^;~~~~~^~^~^;~~~~~n;^0^0n;0~n^^0^~^0~n^^0^^󻊊^0;󻊊^^^^n^0;󻊊^;^^^n^0;󻊊;~0^^;~n00^^;~^^n00^^;~;~;~^~;^^^~^~;^n^n^^~^n^0~;;^;^n00^^n0^;;0~;~n;~^;^n;~^;;00;;^^~;;^^0^~;;^^^^0^~;;^^0;n~n~nn~^~n^^^^~n^n~~~;;^n;~nn;^nn~;;^~;^nn^~^;;^~;^nn^^~;;0~;n~n^~n^n;;;~^~n^^;;;~^~n^0~n;0~~^0~^;~^0~~^;~^0^0~^;~^0^0˰n;~~^0~^^0~^^0~~^0~~^~~^~^^0~^^~~^~^^0~n0^~;~;~00;0~00~^^00~^0;^0;;~~0;^0n;^00;~0n;^^0;~0n;^n^~;;;0;n;n00~~0;n^0~~0;n^^~;;^^n^^^^~00n^^^^^ڤ^00^^~00n^^^^0ڤ^00^^~00n^^^^n~00n;;00^^~;;;n^0~;;;ˤ^~n;;0n;0^;;n;;n^^n;^~^^~;^^^~n0;~~0^000~~~^^0n~^0^^~~~󻊊^n;n0n;;~;^0~;;;^~^n;n;;^^;~0;~;;^^~ˊ~~n^~0n;0nnn^0;~n^^^n0~^0^;~~^^0^n^00;^^~~;;n^~;~;n^^^g_cT@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@#ALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALALAL^^;AL^^AL^^~0AL~^^n~^^n~^^^^AL~0~0~0^^nAL00;^^0AL~~~n^n^nAL~0;^;^n00ALnڰ~nڰ~~ڤ^^^^AL0;;0;;^^^nAL;;^~^^nAL~;~;;^n^^~AL;~^;~^~0^^;0AL^^^^^^^^^ALˊ^;^~^^~ˊ^;^0^^^^^0^^^^^~^0n~nAL00n000^^^^~0;ALnnnn00n;~0^^^^;;AL^^;;^^^^^00AL;0;0^^0ڤ;^~ڰn~00ڰn;;^;^0ˊ0;~AL00^0;00n^^^^^~~^nnALڰ;ڰ;~;0;~~0^~^^^^~nnn0AL^^00^^^^0AL~~^;^~00^^^^~0ALnn;;ˊ0^n0^^^^^nALnn;^^^^^^^;0nAL^^;;~0~ڤ~^^^^^~^^ALˤ^ˤ^0^^~^^^^0;~AL00^^^^^0n00AL~~0;^n^;^^^^~AL^;^;~^^^^^00^AL00^^~^^^^^~;AL^^n;^;^^^^~0^AL0^n^^^^^;AL^n^^^^^~^AL00;n^^^^^^^^^^AL;n^;n^;0^0^^^^^0nALn0n0;~0~^^^^^n0ALnn~^~;0^000^0^;0AL;~;~~^0n;00^^;^~~AL;ڤn0;ڤn0nڻ~;0ڰn0ˊ00~ڤ;^^;^^;^~ڤn^AL^^0^^^;^AL;;;;^0^;^;^^0AL000^^~~^^^^000nAL~0~00^0;^^^^~;0^~;0^^~;0^^ˊ^^n^AL~^^~~^^~ˊ^0^^AL^AL^AL^AL^AL^AL^AL^AL^AL^AL^AL^ALALALALjl@Eqd8  Lx\0'ST(.ZxL  5 a p D  !W>\>0>>?2?^?T?(?? @9@xe@L@ @@A@AplADAAABGBhsBGljG@GGGHEHdqH8H HH ILI\xI0III'JSJTJ(JJK.KxZKLK KK L5LpaLDLLLM7>7@?7G@7A7A7@B7DC7D7D7@E7AF7G7G7@H7>I7I7J7@|K7;L7L7M7@yN78O7O7P7@vQ75R7R7S7@sT72U7U7V7@pW7/X7X7Y7@mZ7,[7[\ $ W. $4$ 4 R&%P7 ++u5 ))_2 A('F (( ' o $  * 6 !I ( h" * z$## 1 ))+JBD @@ M# V#  ]+  CF O# U#  \#  [+  [3  ]3  T#  Z+  Y#  BC S# ^+  \#  ]#  V3  [+  Y+  Z#  M3  U3  L  W#  Z#  Y#  Z+  U#  %C1 S# S3  #b Z3  W#  T#  X#  *C/ O# W  X#  Z#  X#  W3  T#  Y+  Y#  [#  V#  R  V#  X3  W#  T#  Y#  V#  RC{ @@< X#x  `3x  Z3x  ]#x  ]+x  BCx @@( U#  Z#  \#  R3  X#  ^#  S#  Z3  W#  Q#  KC O# V   X#  [#  T#  V#  Y#  R+  [#  X+  U#  ^#  Z#  ^#  Z#  'S U# W#  V#  X#  Y3  MC T# Z+  \#  Y  Z#  ]#  \#  ]#  Z#   C2 @@<  @xf c W#l =Ce c [#l C c \#l NC4 c ]+l EC c Wl RS c Y#l GCD @@ C C @@ DB @@ S+ Z+  `#  [;  [C X# T#  Z#  [#  X#  ]#  C M# X#  X#  X3  R#  Y#  S#  X#  Y#  W#  Y3  Y#  C' W# [#  O  W#  W#  W  [#  Y3  W#  /C W# V3  #C @@< `+x  Y#x  ,Cx @@<  @xf c N#l C c W#l "Cn @B EJ 6R @@ R# [3  \+  [+  W+  `#  =CH @@x @I @@$ W3 Y#  Y#  [#  `3  T#   C R3 U#  V  T3  CF V3 X;  Y#  V3  \#  Y#  Z#  X#  S#  U+  ];  W#  -C @@x @ @@$ S+ Y+  ]#  `3  X3  PC Q# V3  `#  ^3  9C C U# R3  L  U  V#  W#  Z#   Cg @@< X#x  W#x  [+x  \3x  ]#x  Sx @@( Y#  Z#  U#  Y#  W#  U#  S#  Y#  Cs W+ Y3  Y#  R#  [#  ^+  W#  W;  X+  V#  ZCN P3 Y#  Y#  ^#  X3  W#  ^#  Y#  [#  [#  f#  `#  ]3  # d#  ]3  5C T# T3  ]+  V#  Z;  LC3 X# _+  W#  ]#  W+  X#  Y+  V#  W3  S3  -C @@<  @xf c aZ Q+; V#; C; c aZ X#; 4C;w c aZ R; [+; AC; c aZ Z3; KC; c aZ S3; WS; c aZ V3; 2S; c aZ R#; Z#; 4C; c aZ U#; Z+; LC; c aZ V3; Y#; DC;7 c a W+; Y#; R;  C; @B 3B @@ W+ Z+  [+  W#  W  T#  R#  V3  YS  R# [#  [#  V3  W#  T#  S#  V#  X#  O  Y3  W3  R  T3  Z3  @C R Y  X  [#  N  S N X#  X#  S#  V#  #K V  U3  Y3  W3  +S N# U#  W#  HCQ U3 V#  R#  S#  Q#  U3  Z#  W#  Z3  X3  ^+  JC R# U3  X  Z#  \#  Y#  KC @@< ]3x  Zx  \3x  \#x  ]#x  ^+x  Z3x  e3x  f3x  ]3x  Cx @@( C> W#  W#  ]#  V3  U#  S#  V#  3Cw U3 U#  X#  S#  R  X3  \#   SG Q# Y#  X#  [#  U#  Y#  U#  )C] S3 V#  R#  ,S @@<  @xf c OC} c Ul J#l Ce Z#  7C @B C< C' @@ 2H IBq? @@ R# [+  _+  V#  Y#  X#  U#  %C Q O  R#  Y+  _#  R#  T#  V#  W#  V#  W+  X+  V#   C T# U#  S  P#  Z#  V#  X+  C V+ ^+  U  U#  TC @@ C C' @@ =B @@ T# U3  [#  S#  Z;  e+  c#  U#  `+  Y  #SP >Cs #C &CM +C "C %C0 0C 3C )C FC C DC )C 6SY #C@ 2S +C  C C $C #C| )C ,C CE C 9C  C <C PC C4 $C{ C [# "S  o] z]Update: Investigation of Bioterrorism-Related Anthrax Connecticut, 2001 CDC and state and local health departments continue investigating cases of bioterrorismrelated anthrax. This report revises the number of suspected cases and updates the investigation of a 94-year-old Connecticut (CT) resident who died from inhalational anthrax. As of December 5, a total of 22 cases of anthrax have been identified; 11 were confirmed as inhalational anthrax, and 11 (seven confirmed and four suspected) were cutaneous. A 54-year-old man who lived in Delaware and who worked at a postal facility in New Jersey (NJ) previously had been classified as having a suspected case of cutaneous anthrax. Additional laboratory findings indicate that the patients illness no longer meets the CDC surveillance case definition for anthrax (1). Initially, he was classified as having a suspected case because of a lesion on his left hand and elevated levels of antibody (IgG) to the protective antigen component of anthrax toxin. Subsequent biopsies of the skin lesion did not reveal Bacillus anthracis in the tissue, and additional confirmatory antibody tests on serum specimens were negative. The investigation in CT has not identified any additional cases of anthrax through prospective and retrospective surveillance. For prospective surveillance, hospitals, clinicians, postal facilities, and the state medical examiner have been asked to report daily any persons with clinical findings that might be related to anthrax, including sepsis and pneumonia. To date, 50 such patients have been reported. No evidence of anthrax was found in 43 patients and the remaining seven are being evaluated; preliminary investigations of the seven patients have not identified evidence of anthrax. Retrospective surveillance has included a review of all deaths since September 1 involving residents of Oxford and eight surrounding towns (Beacon Falls, Naugatuck, Ansonia, Derby, Woodbury, Shelton, Seymour, and Southbury [total population: 152,481]); 487 death certificates for persons who died during SeptemberNovember 2001 have been reviewed. Of the 131 deaths attributed to sepsis, pneumonia, sudden death, respiratory arrest, cardiac arrest, or undetermined cause, 66 occurred in hospitals. Of these, 52 had no apparent anthrax disease. For 14 persons who died soon after arrival to the hospital, review of hospital records revealed no evidence of anthrax, but information in the hospital record was insufficient to determine the specific cause of death, and postmortem examinations were not conducted. The source of exposure for the case of inhalational anthrax in a 94-year-old woman who lived in Oxford, CT, remains unknown. Multiple environmental samples collected from all places (e.g., the patients home, church, voting place, restaurants, and cars in which she traveled) the patient was known to have visited during the 60 days preceding illness onset were negative for B. anthracis by culture. Nasal swab specimens were negative from 16 persons epidemiologically linked to the case (e.g., persons who worked in the home and assisted with shopping). Environmental sampling was performed at the postal processing and distribution center in Wallingford, CT, that serves the towns of Oxford and Seymour and identified B. anthracis spores in three high-speed mail sorters. This facility receives mail from several postal distribution facilities known to have been contaminated by B. anthracis spores, including the postal center in Hamilton, NJ, which was the origination site for envelopes containing B. anthracis powder that were addressed to two U.S. senators. To evaluate potential crosscontamination of envelopes (i.e., an envelope contaminated from another B. anthracis-contaminated envelope or environmental surface), postal sorting records from the Wallingford facility are being examined to determine the timing and pathways of mail delivered to the CT patient and her local relatives and contacts. Sorting records in Hamilton indicated that an envelope addressed to a postal code adjacent to Oxford had been processed using the same automatic canceling machine at Hamilton <1 minute after one of the two B. anthracis powder-containing letters sent to a U.S. senator. This envelope was subsequently sorted at Wallingford and delivered to Seymour. The envelope was received at a residence 4 miles from the home of the CT patient; this envelope was recovered from the recipient and B. anthracis spores were detected on the outside of the envelope; none of the members of this household had clinical evidence of anthrax. No record of mail to the CT case-patient processed at Hamilton was found, and no B. anthracis spores have been recovered from envelopes found at her home. Reported by: N Lustig, MPH, Pomperaug Health District, Oxford; K Spargo, MPH, Naugatuck Valley Health District, Shelton; W Carver, MD, Office of the Chief Medical Examiner, M Cartter, MD, J Garcia, MD, DM Barden, MT (HHS), DR Mayo, ScD, KA Kelley, DrPH, J Hadler, MD, State Epidemiologist, Connecticut Dept of Public Health. G DiFerdinando, MD, E Bresnitz, MD, State Epidemiologist, New Jersey Dept of Health and Senior Svcs. L Hathcock, PhD, State Epidemiologist, Delaware Div of Public Health. EIS officers, CDC. Editorial Note: As of December 5, a total of 11 inhalational anthrax cases have been identified; direct exposure to a B. anthracis-containing envelope was likely in the first nine cases (2). The source of exposure to B. anthracis for the inhalational anthrax cases in CT and New York City (NYC) remain under investigation by public health and law enforcement officials. No direct exposure to B. anthracis-containing envelopes has been identified for these cases. Similar to the first nine cases of inhalational anthrax, exposure to B. anthracis might have occurred through the mail from exposure to an envelope containing B. anthracis powder. No direct exposure to envelopes containing B. anthracis powder has been identified for the inhalational cases in CT and NYC. In the absence of definitive evidence indicating how transmission occurred, infection from a cross-contaminated envelope is one hypothesis being considered by investigators. Cross-contamination could explain how B. anthracis spores were spread to some postal facilities that did not process the envelopes addressed to the U.S. senators. Approximately 85 million pieces of mail were processed on the days after the implicated envelopes passed through the NJ and the District of Columbia (DC) sorting facilities until they were closed. Both of these facilities had evidence of widespread environmental contamination with B. anthracis. Some of the pieces of mail that passed through these facilities could have been cross-contaminated and, in turn, could have contaminated mail processing equipment or other envelopes processed elsewhere. Despite the high volume of mail distributed to metropolitan areas around these facilities, active surveillance has not identified cases of inhalational anthrax among approximately 10.5 million residents in NJ, DC, Pennsylvania, Maryland, and Virginia or in postal workers since the initial cluster of cases associated with the processing of the implicated letters sent to the U.S. senators. The large population, the duration of active surveillance, and the absence of additional cases of inhalational anthrax indicate that if there is a risk for inhalational anthrax associated with exposure to mail crosscontaminated by the letters addressed to the U.S. senators, it is very low. Despite this very low risk, persons remaining concerned about their risk may want to take additional steps such as not opening suspicious mail; keeping mail away from your face when you open it and not blowing or sniffing mail or mail contents; washing your hands after you handle the mail; avoiding vigorous handling of mail, such as tearing or shredding mail before disposal; and discarding envelopes after opening mail. However, the effectiveness of these steps in reducing any residual risk is not known. Suspicious persons or situations should be reported to law enforcement authorities. Health-care providers should remain alert for persons with clinical presentations consistent with early anthrax (3), obtain appropriate diagnostic tests (e.g., blood cultures and chest radiograph) (4), and report suspicious illnesses to local or state public health authorities. Fatalities can be minimized by promptly initiating combination antimicrobial therapy (5). Recommendations for risk reduction for persons with potential occupational exposure are available (6). Public health surveillance for anthrax and research efforts to further define the risk associated with exposure to B. anthracis in the environment as a result of the bioterrorist attack is ongoing. CDC will continue to provide updates as new information becomes available. References 1. CDC. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR 2001;50:88993. 2. CDC. Update: investigation of bioterrorismrelated inhalational anthraxConnecticut, 2001. MMWR 2001;50:104951. 3. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorismrelated inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:93344. 4. CDC. Update: investigation of bioterrorismrelated anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR 2001;50:9418. 5. CDC. Update: investigation of bioterrorismrelated anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001;50:90919. 6. CDC. Interim recommendations for protecting workers from exposure to Bacillus anthracis in work sites in which mail is handled or processed. MMWR 2001;50:961. Public Health Dispatch Update: Unexplained Deaths Following Knee Surgery Minnesota, 2001 Since November 13, 2001, the Minnesota Department of Health (MDH), in collaboration with CDC, has been conducting an investigation of three patients who died unexpectedly within 1 week following knee surgery (1). Patient 1 had received a knee osteochondral allograft, and patients 2 and 3 had undergone total knee replacement surgery. Epidemiologic and microbiologic investigations have not linked the deaths of the three patients. Blood cultures obtained from patient 1 before his death grew a clostridial species that was identified subsequently at MDH and CDC as Clostridium sordellii by biochemical and molecular typing. Blood cultures from patients 2 and 3 did not yield growth of any bacteria. Molecular and special studies have not identified any Clostridium species in autopsy tissues from patients 2 and 3, and the cause of death in these patients remains unexplained. On the basis of investigative findings, MDH lifted a moratorium on elective knee surgery on November 25. As of December 4, neither surveillance in Minnesota by MDH nor enhanced case finding by CDC outside of Minnesota and follow-up of reports to CDC have identified any additional cases of C. sordellii infection associated with severe hemodynamic collapse or death in patients recently undergoing knee or large joint surgery. Because infection associated with contaminated graft tissue is a known but uncommon complication of allograft surgery (2), MDH, CDC, and the Food and Drug Administration have initiated an investigation to determine whether the osteochondral allograft might have been the source for the C. sordellii found in patient 1. Nonimplanted knee tissue from the same donor source as the allograft used in patient 1 was obtained by CDC from the same tissue bank. Preliminary cultures of this tissue have yielded growth of Clostridium species; biochemical and molecular testing to identify the species is under way. Reports of other allograft recipients infected with clostridial species have been received at CDC and are being investigated. Clinicians should consider possible clostridial infection in patients with evidence of infection following allograft implantation. Clinical evaluation should include looking for symptoms and signs of sepsis, including fever, hemodynamic compromise, and/or abdominal pain. In some patients, only local symptoms (e.g., knee pain) may be present during the early course of infection. Diagnostic evaluation should include two sets of blood cultures for both aerobes and anaerobes; these cultures should be incubated for 7 days. If appropriate, other specimens (e.g., knee aspirate or tissue) should be obtained and cultured aerobically and anaerobically. If appropriate, health-care providers should consider expanding empiric therapy to include anaerobic coverage. Consultation with an infectious disease physician might be helpful. Health-care providers should report cases of clostridial infection following allograft implantation to their state health department or CDCs Division of Healthcare Quality Promotion, telephone 800-893-0485. Reported by: KH LeDell, MPH, R Lynfield, MD, RN Danila, PhD, HF Hull, MD, State Epidemiologist, Minnesota Dept of Health. Div of Healthcare Quality Promotion, National Center for Infectious Diseases; and EIS officers, CDC. References 1. CDC. Unexplained deaths following knee surgeryMinnesota, November 2001. MMWR 2001;50:10356. 2. CDC. Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts. MMWR 2001;50:10813. Septic Arthritis Following Anterior Cruciate Ligament ReconstructionUsing Tendon Allografts Florida and Louisiana, 2000 In the United States, approximately 50,000 knee surgeries are performed each year for repairing anterior cruciate ligament (ACL) injuries (1). Tissue allografts frequently are used for ACL reconstruction, and septic arthritis is a rare complication of such procedures. This report describes four patients who acquired postsurgical septic arthritis probably associated with contaminated bone-tendon-bone allografts used for ACL reconstruction. Effective sterilization methods that do not functionally alter musculoskeletal tissue are needed to prevent allograft-related infections. Florida On April 5, 2000, at a surgical center, a girl aged 16 years had ACL reconstruction using a bone-tendon-bone allograft. On April 21 at a local orthopedic clinic, she sought medical care for swelling and redness of the left knee. On examination, septic arthritis was diagnosed, and she was treated with joint irrigation, a 6-week course of intravenous antimicrobial therapy, and removal of the allograft and screw. Cultures from the left knee aspirate yielded Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis. On April 7 at a surgical center, a man aged 40 years underwent ACL reconstruction using a bone-tendon-bone allograft. On April 24, he sought medical care for drainage from the knee. On examination, septic arthritis was diagnosed; his treatment was an 8-week course of antimicrobials and screw removal. P. aeruginosa was cultured from the surgical site. The allografts used for the two patients were supplied by a Texas tissue bank (tissue bank A) and were harvested from a common donor. Both patients initial ACL reconstruction procedures were performed on different days by different surgeons using different arthroscopic instruments but at the same surgical center. The local health department conducted an onsite investigation of the center and identified no breaches in infection-control procedures. At tissue bank A, the implicated allografts had been irradiated and processed using standard quality-control procedures. All other allografts used during the preceding 4 years at this surgical center had been supplied by a tissue bank other than tissue bank A; no postoperative infections were detected by orthopedic surgeons at follow-up visits among approximately 1,000 ACL reconstructions performed at this center during the 4-year period. P. aeruginosa isolates cultured from the surgical site infections of the two patients had genotypic patterns that were indistinguishable from each another by pulsed-field gel electrophoresis. Florida and Louisiana On October 9 at a surgical center in Florida, a woman aged 55 years had ACL reconstruction using a bone-tendon-bone allograft. On October 17, she was taken to an orthopedic clinic for purulent drainage from the left knee. On examination, septic arthritis was diagnosed, and she was treated with joint irrigation and 12 weeks of antimicrobial therapy. On July 11, 2001, the patient required a total knee arthroplasty. Citrobacter werkmanii/youngae and group B beta hemolytic streptococci grew from the knee aspirate. On October 19 in Louisiana, a woman aged 29 years had ACL reconstruction using a bone-tendon-bone allograft at a local surgical center. On November 7 at an orthopedic clinic, she presented with a temperature of 103 F (39.4 C) and septic arthritis. She was treated with joint irrigation and 13 weeks of antimicrobial therapy. Klebsiella oxytoca and Hafnia alvei were cultured from the knee aspirate. Both patients received allografts from the same Florida tissue bank (tissue bank B), and the allografts were from a common donor. When tissue bank B conducted a trace-back investigation and reviewed quality-control procedures, the implicated allografts had not received terminal sterilization with gamma irradiation. The same species of organisms isolated from the two recipients and Serratia liquefaciens were cultured from the donor allografts during tissue processing; other donor tissues were culture negative. No isolates from the donor or recipients were available for additional testing. Reported by: B Lutz, MD, Memorial Medical Center-Baptist Campus, New Orleans; R Ratard, MD, Louisiana Dept of Health and Hospitals. D Dodson, MD, West Palm Beach; JM Malecki, MD, Palm Beach County Health Dept; AC Morse, DO, Div of Sports Medicine, Florida Orthopedic Institute, Tampa; S Wiersma, MD, Florida Dept of Health. D Perrotta, PhD, Texas Dept of Health. Div of Healthcare Quality Promotion, National Center for Infectious Diseases; and an EIS Officer, CDC. Editorial Note: In the cases described in this report, clinicians suspected contaminated allografts because of the rarity of septic arthritis following arthroscopic interventions and the polymicrobial nature of these infections and worked with local public health authorities and tissue bank staff to link the infections to allografts of common donors. The epidemiologic and laboratory investigation related to tissue bank A indicated that the allografts were the source of the infection despite no apparent lapses in tissue processing. Cases related to tissue bank B were linked to allografts from a common donor that were released inadvertently before standard terminal sterilization procedures were conducted. In 1999, U.S. tissue banks distributed approximately 750,000 allografts for transplantation (2). Transmission of infectious agents (e.g., fungi, bacteria, and human immuno-deficiency virus [HIV]) caused by contaminated allografts has been described (35). The number of persons who develop septic arthritis caused by bacterially contaminated allografts is unknown. In addition, tissue banks, donors, and recipients often are located in different states, complicating detection of bacterial infections associated with contaminated allografts. The Food and Drug Administration (FDA) requires screening of tissue donors for HIV, hepatitis B and C, and other bloodborne pathogens. Reporting of infections resulting from contaminated allografts is not required. FDA has proposed regulations that would require reporting adverse reactions that involve the transmission of communicable diseases if fatal, life threatening, or results in permanent impairment. The American Association of Tissue Banks (AATB) publishes quality standards for procuring and processing tissue, and provides guidelines on donor screening, time limits for retrieval of soft tissues, and procedures for preservation (e.g., freezing or freeze-drying), sterilization, preparation, and evaluation, and labeling of tissue components (6). Gamma irradiation or ethylene oxide are used to sterilize allografts. Tissue banks use gamma irradiation for sterilization, but high doses of gamma irradiation may adversely affect the biomechanical properties of allografts (7). Ethylene oxide has limited ability to penetrate tissue and has been associated with adverse patient outcomes (8,9). Concern about possible sterilization-related complications has resulted in musculoskeletal tissues (e.g., bone-tendon-bone allografts) being processed aseptically but is not necessarily sterile. Although aseptic processing avoids contamination of tissue at the tissue bank, it does not eliminate contamination originating from the donor that might be inherent to the graft. AATB standards require that tissue banks establish a list of organisms which, when cultured from tissue, necessitate discarding, sterilization, or disinfection of harvested tissues (6). However, not all tissue is cultured, and AATB does not specify the organisms for which corrective actions should be taken (6). According to the Office of the Inspector General, approximately 44% of tissue banks identified were not accredited by AATB or inspected by Florida or New York (the two states that require licensing and inspection of tissue banks) (2), and this probably represents an underestimate of the tissue banks that are unaccredited or unlicensed (10). Tissue banks that lack accreditation and licensure are not required to comply with external quality requirements beyond donor screening for HIV and hepatitis (2). This report underscores the need for 1) standard practices for screening, disinfecting, sterilizing, or discarding potentially contaminated allografts; 2) mechanisms for certification and oversight of tissue banks and adherence to quality standards; 3) a system for reporting and investigating infections (bacterial, viral, or fungal) potentially transmitted through human tissues; and 4) the development of safe and effective sterilization methods for musculoskeletal tissue. When septic arthritis occurs after use of an allograft, allograft contamination should be suspected, especially when the infection is polymicrobial or associated with Gram-negative organisms. Clinicians should report infections involving allograft tissue to FDAs MedWatch system and through local and state health departments to CDCs Division of Healthcare Quality Promotion, National Center for Infectious Diseases, telephone 800-893-0485. References 1. American Academy of Orthopedic Surgeons. ACL reconstruction, October 2000. Available at http://orthoinfo.aaos.org/fact/thr_report.cfm?Thread_ID=216&topcategory=Knee. Accessed December 2001. 2. Office of the Inspector General. Oversight of tissue banking. Boston, Massachusetts: US Department of Health and Human Services, 2001:i17. 3. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, Jarvis WR. Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis 1998;27:68891. 4. Chang HJ, Christenson JC, Pavia AT, et al. Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. J Infect Dis 1996;173:65660. 5. Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992;326:72632. 6. American Association of Tissue Banks. Standards for tissue banking. McLean, Virginia: American Association of Tissue Banks, 1996:6774. 7. Gibbons MJ, Butler DL, Grood ES, Bylski-Austrow DI, Levy MS, Noyes FR. Effects of gamma irradiation on the initial mechanical and material properties of goat bone-patellar tendon-bone allografts. J Orthop Res 1991;9:20918. 8. Jackson DW, Windler GE, Simon TM. Intraarticular reaction associated with the use of freeze-dried, ethylene oxide-sterilized bone-patella tendon-bone allografts in the reconstruction of the anterior cruciate ligament. Am J Sports Med 1990;18:111. 9. Roberts TS, Drez D Jr, McCarthy W, Paine R. Anterior cruciate ligament reconstruction using freeze-dried, ethylene oxide-sterilized, bone-patellar tendon-bone allografts: two year results in thirty-six patients. Am J Sports Med 1991;19:3541. 10. Food and Drug Administration. Human cells, tissues, and cellular and tissue-based products: established registration and listing. Rockville, Maryland: US Department of Health and Human Services, Food and Drug Administration, 2001. Federal Register 2001;66:544769. Influenza Activity United States, 200102 Season In collaboration with the World Health Organization (WHO) and its collaborating laboratories, National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories, state and local health departments, and a network of sentinel physicians, CDC conducts surveillance to monitor influenza activity and to detect antigenic changes in circulating strains of influenza viruses. This report summarizes influenza activity in the United States* (1) during September 30November 24, 2001, when the viruses isolated most frequently were influenza A (H3N2). These viruses were well matched antigenically by the 200102 influenza A (H3N2) vaccine. Vaccine supplies are plentiful and influenza vaccine should continue to be offered during December and later. As of November 24, WHO and NREVSS collaborating laboratories in the United States tested 8,140 specimens for influenza viruses; 73 (0.9%) were positive. The percentage of positive influenza isolates identified each week is an indicator of the level of influenza activity, and for the weeks ending October 6 through November 24, the percentage of respiratory specimens testing positive for influenza viruses ranged from 0.4% to 1.7%. These percentages are low compared with the 24%33% testing positive at the peak of the 199899, 19992000, and 200001 seasons. Of the 73 influenza isolates reported since September 30, 70 (96%) were influenza A viruses and three (4%) were influenza B viruses. Of the 70 influenza A viruses identified, 45 (64%) have been subtyped; 44 were influenza A (H3N2) viruses and one was an influenza A (H1N1) virus. Influenza A (H3N2) isolates were identified in Alaska, Arizona, Colorado, Florida, New York, North Carolina, North Dakota, Texas, Utah, and Wisconsin. The influenza A (H1N1) isolate was identified in Washington, and unsubtyped influenza A isolates were identified in Alabama, Alaska, Hawaii, Louisiana, Minnesota, New York, Washington, and Wisconsin. Influenza B isolates were identified in Louisiana, Michigan, and Texas. Thirty-nine (52%) of the 73 influenza viruses isolated were identified in Alaska. CDC antigenically characterized 10 influenza isolates collected in September and 13 collected in October. They consisted of 20 influenza A (H3N2) viruses, two influenza A (H1N1) viruses, and one influenza B virus. The antigenically characterized influenza A (H3N2), influenza A (H1N1), and influenza B isolates were similar to the vaccine strains A/Panama/2007/99 (H3N2), A/New Caledonia/20/99 (H1N1), and B/Sichuan/379/99, respectively. During September 30November 24, the weekly percentage of patient visits for influenza-like illness (ILI) to approximately 650 U.S. sentinel physicians ranged from 1.0% to 1.4%. For the week ending November 24, the percentage of patient visits for ILI was 1.4%, which is less than the national baseline of 1.9%. During the same week, influenza activity, as reported by state epidemiologists, was regional in Alaska and sporadic in 25 states (Alabama, Arizona, California, Colorado, Connecticut, Georgia, Indiana, Iowa, Kansas, Kentucky, Maine, Michigan, Missouri, Nevada, New Mexico, New York, North Carolina, Ohio, Tennessee, Texas, Utah, Vermont, West Virginia, Wisconsin, and Wyoming), New York City, and District of Columbia; 23 states reported no influenza activity, and one state did not report. During the week ending November 24, the 122 Cities Mortality Reporting System attributed 6.1% of recorded deaths to pneumonia and influenza (P&I). This percentage was below the epidemic threshold** of 7.4% for that week. The percentage of P&I deaths has been below the epidemic threshold for each week since September 30. In November, two virologically confirmed institutional outbreaks caused by influenza A viruses were reported to CDC. On November 14, an elementary school in Fort Collins, Colorado, reported elevated and increasing absenteeism among its students. Of 675 students, 53 (8%) were absent on November 14, 96 (14%) were absent on November 15, and 110 (16%) were absent on November 16. Baseline absenteeism on November 1213 was 1820 students. Two of the three specimens submitted to the state laboratory for viral culture were positive for influenza A (H3N2). The school remained open and a letter was sent to parents describing influenza symptoms and requesting that sick children be kept at home. Use of influenza antiviral agents was left to the discretion of the childs health-care provider and family. Nursing homes in the Fort Collins area were advised of influenza activity in the community and a broadcast facsimile outlining antiviral treatments available for influenza was sent to all primary-care providers. On November 17, an influenza A outbreak was reported in a long-termcare facility with 160 residents located in the Hudson Valley region of New York; 14 residents and eight staff members had an influenza-like illness and four of six ill residents tested positive for influenza A by rapid antigen testing. On November 18, all residents began to receive antiviral medication and since then, no new cases of influenza-like illness in this facility have been reported. The facility received its order of influenza vaccine a week and a half before the outbreak and vaccinated residents on November 1216. Reported by: S Berns, Poudre School District; N Underwood, S Murray, A LeBailly, MD, Larimer County Dept of Health and Environment, Fort Collins; A Scott, K Gershman, MD, L Swanson, P Young, Colorado Dept of Public Health and Environment. C Waters, P Smith, MD, New York Dept of Health. Participating state and territorial epidemiologists and state public health laboratory directors. WHO collaborating laboratories. National Respiratory and Enteric Virus Surveillance System laboratories. Sentinel Physicians Influenza Surveillance System. Surveillance Systems Br, Div of Public Health Surveillance and Informatics, Epidemiology Program Office; Mortality Statistics Br, Div of Vital Statistics, National Center for Health Statistics; WHO Collaborating Center for Surveillance, Epidemiology, and Control of Influenza, Influenza Br and Respiratory and Enteric Virus Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC. Editorial Note: The four influenza surveillance system components indicated low levels of influenza activity in the United States during September 30November 24. The number of influenza viruses isolated this season is relatively low and it is too early to determine which strain(s) will predominate. However, two influenza A outbreaks were detected in November and influenza activity is expected to increase during the next few weeks to months. The viruses isolated most frequently have been influenza A (H3N2) viruses. The 200102 influenza vaccine strains are well matched to the influenza isolates that have been characterized antigenically this season. The best prevention against influenza is vaccination. Vaccine supplies are plentiful and are available for immediate shipment from the three U.S. licensed manufacturers. Manufacturers estimate that approximately 87 million doses of influenza vaccine will be produced this year compared with 76.8 million doses available during the 19992000 season and 70.4 million doses available during the 200001 season. By the end of November, approximately 74.2 million (85%) of the projected 87 million doses of vaccine will have been distributed. An additional 12.8 million doses are expected to be available in December. Health-care providers should continue to offer influenza vaccine during December and later because persons can benefit from vaccination after influenza activity has been detected in their community (2). The most important persons to be vaccinated are those in groups at increased risk for complications from influenza (i.e., persons aged >65 years and persons aged 6 months64 years with certain underlying medical conditions [3]), and health-care providers. In addition, household contacts of high-risk persons, healthy persons aged 5064 years, and anyone who wants to reduce the likelihood of becoming ill with influenza should be vaccinated. CDC collects and reports U.S. influenza surveillance data during OctoberMay. This information is updated weekly and is available through CDC voice information, 888-232-3228, fax information, 888-232-3299 (request document number 361100) or at http://www.cdc.gov/ncidod/diseases/flu/weekly.htm. References 1. CDC. Influenza activityUnited States, 19992000 season. MMWR 1999;48:103942. 2. CDC. Delayed influenza vaccine availability for the 200102 season and supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR 2001;50:5825. 3. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2001;50(no. RR-4). Notice to Readers Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus anthracis Contamination on Surfaces in Buildings Environmental sampling to ascertain the presence of Bacillus anthracis spores in buildings is an important tool for assessing risk for exposure. Similar to diagnostic testing, culture with positive identification of B. anthracis (CDC culture method) is the confirmatory test. Laboratory-based polymerase chain reaction (PCR) methods for detecting genetic material of B. anthracis can be used in preliminary assessments and as adjuncts to microbiologic methods. Although these tests are consistent with culture results, PCR methods are not approved by the Food and Drug Administration, and results should not be the basis for clinical decisions. Rapid-assay devices that can provide results within minutes are used for onsite detection of environmental contamination. Some of these devices are PCR-based assays, and others are immune-based assays for B. anthracis. CDC has not obtained validation data for rapid-assay devices. A recent CDC evaluation of B. anthracis contamination at the Brentwood postal facility in the District of Columbia included use of one onsite PCR-based device and CDC culture method. Of 107 samples analyzed using CDC culture method and the PCR-based device, 95 (89%) were negative by both methods. Of six samples identified as positive by CDC culture method, two were positive using the PCR-based device. Of eight samples identified as positive by the PCR-based device, two were positive by CDC culture method. Although these results indicate a poor agreement between results from the onsite PCR-based device and CDC culture method, this assessment was not intended as a formal validation test because of limited capacity to implement adequate quality-control measures and the small number of B. anthracis positive samples. The apparently poor agreement of the onsite PCR-based device could be attributed to several factors such as the concentration of spores on contaminated surfaces, sample collection and preparation procedures, sample splitting, and the methods used for removing the sample from collection material. Furthermore, PCR- or immune-based tests do not distinguish viable from nonviable spores and can produce positive scores for samples that culture methods would define as negative. As a result, these methods are not useful for evaluating the success of disinfection techniques that do not remove nonviable spores. Public health officials are urged to understand the limitations of onsite, rapid technologies for B. anthracis before using them for public health decision making. Until validation testing is complete and guidelines for effective use are developed, PCR- or immune-based assay results for B. anthracis should not be used alone, but should be confirmed with samples analyzed by culture methods to make public health decisions. Notice to Readers CDC Recognition of Members of MMWR Distribution Partnership The recent bioterrorist attacks represent a national emergency that requires action by all of those responsible for public health and safety. In October and November in response to these attacks, CDC developed guidelines for anthrax treatment, prophylaxis, and exposure management that required immediate dissemination to all health-care professionals. To expand its distribution, MMWR enlisted the assistance of various organizations, agencies, publications, and health-care plans in a distribution partnership. Participants in this partnership electronically distributed to their members and subscribers bioterrorism-related reports published in MMWR. As a result, millions of health-care professionals and the public were notified immediately about critical public health information within hours of its release by CDC. CDC appreciates this collective effort to protect public health and safety. Following are members of the MMWR distribution partnership: Alliance of Community Health Plans American Academy of Family Physicians American Academy of Orthopaedic Surgeons American Academy of Pediatrics American Association of Health Plans American Association of Poison Control Centers American Association of Public Health Laboratories American College of Emergency Physicians American College of Physicians, American Society of Internal Medicine American Hospital Association American Medical Association, Office of Specialty Society Relations Association of American Medical Colleges Association of State and Territorial Health Officials Blue Cross Blue Shield Association Council of State and Territorial Epidemiologists Employers Managed Health Care Association Environmental Protection Agency ePocrates, Inc. Federal Emergency Management Agency Federation of State Medical Boards International Association of Fire Chiefs Journal of the American Medical Association Kaiser Permanente MyDrugRep.com, Inc. National Association of County and City Health Officials New England Journal of Medicine National Institutes of Health, National Library of Medicine National Institute for Health Care Management Research and Education Foundation U.S. Department of State Washington Business Group on Health WebMD CDC invites other organizations and agencies to join this distribution partnership by contacting MMWR at mmwrq@cdc.gov. x] ] @] q@] ] m] ^JdnGMMdZmGMMdZmGMMdZmGMMdZmGMMdsZmGMMd ZmGMMdOZmGMMd ZmGMMdZmGMMd ZmGMMdoZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMd?ZmGMMdPZGMMdZnGMMdgZnGMMd ZnGMMd9ZnGMMdZnGMMdZnGMMd ZnGMMdZnGMMd ZnGMMdZnGMMd ZnGMMdOZnGMMd ZnGMMd5ZnGMMd ZnGMMdZnGMMd&ZmGMMd ZmGMMdZmGMMd ZmGMMdHZmGMMdZmGMMdUZmGMMdZmGMMdZmGMMdZmGMMdjZmGMMdZmGMMdwZmGMMd ZmGMMdZmGMMd PZGMMd PdGMMdHPdGMMdPdGMMdIPdGMMddnGMMdDdnGMMdZmGMMd,ZmGMMdZmGMMd3ZmGMMd<ZmGMMdZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMdZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMdQZmGMMdZmGMMdZmGMMdPZGMMdPdGMMd{dnGMMdZmGMMdZmGMMdZmGMMdZdGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMd2ZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMdZdGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMd ZmGMMdZmGMMdZmGMMdZmGMMdPZGMMdZnGMMdZnGMMd`ZmGMMdZmGMMdZmGMMdZmGMMd$ZmGMMdZmGMMdZmGMMdZmGMMdtZmGMMdZmGMMdRZmGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMdmZmGMMdZmGMMdZmGMMdZmGMMdZmGMMd PZGMMdPdGMMdPdGMMdPdGMMdPdGMMdPdGMMd3dnGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMdZmGMMd*ZmGMMdZmGMMde ZmGMMdPZGMMdZnGMMdZnGMMd/ZmGMMdZmGMMdZmGMMdZmGMMdXZmGMMdZmGMMdZmGMMd PZGMMdPdGMMddnGMMd@dnGMMddnGMMd)dnGMMd4ZmGMMdZmGMMdZmGMMd ZmGMMdZmGMMdZmGMMdyZmGMMd ZmGMMdZmGMMd ZmGMMd^ZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMdZmGMMd ZmGMMd~ZmGMMddnGMMddnGMMddnGMMddnGMMdZmGMMdZmGMMdZmGMMdZmGMMd ZmGMMdZmGMMdZmGMMd+ZmGMMdaZmGMMdZmGMMd6ZmGMMdZmGMMdZmGMMdJ](xKddd (xKddd<(xKddd((xKddd  (xKddd <(xKddd L(xKdddL(xKddd$(_<PddD[(xKddd(  (xKddd<(xKddd <(xKdddL(xKddd{](xKdddX (xKdddx$(xKddd (xKdddx$(xKddd (xKddd<(xKddd((xKddd (xKddd <(xKddd;(xKddd3](xKddd (xKddd<(xKddd((xKddd (xKddd <(xKdddL(xKddd$(_<Pdd{[(xKddd  (xKddd$(_<Pdd=[(xKdddN  (xKdddQ#   { 1\ v$;!  { 1   { 1 .wiPCd ..DOCM?810831080ADISTILL.PPDLetter.175lpi.2400dpi15.075.00.045.0175.0175.0175.0175.0XOnlyOne60.045.0 J @L L @M N O @O P @P P Q Q 1R R S S @T T cV V V @W X @X X X Y Y @Z Z Z [ [ @\ ]@     @    @     @         @  #@    @  r@  @     @     @   @  @     @ -  @   % % & @& & & @' ( @( N( ) @) ) * * @+ + , , @- - - . @. . / / 0 @0 0 1 1 2 @2 2 2 @3 4 @4 4 4 @5 5 6 6 1@7 7 8 8 @9 9 9 : @: : ; ; < @< < = = > @> > > @? @ @@ @ @ @A A B    @ @@ " C  @      @     @   @ $9$ij] @n]] /^ /^ &G^ S^ $9\^$-@\^-@ :^^Root Entry0/~PageMaker/p^////////////////////////i///////jklmnopqrstuvwxyz{|}~#  dfl^l^3l^l^T+MP2t60_88 88 hL&  , kZ 4&@ } @ Pd 0  @@ L4  & ^U N & &4   9 $7( MS6  B@ & >  ; G3Ld 26 kZ 3L  1 @ @  @   @} .+@EPSG:\mm Setup\logos\Cdc.eps.eps`F'l5(KL EPSG:\mm Setup\logos\Logoblack.eps.epsu;(u;(M DOCG:\MM\Mm 50 series (2001)\Mm5048\Original Text\Text.doc+,+$+DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 1.docm+n+n+!DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2a.docm+n+n+"DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2b.docm+n+n+#DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2c.docm+n+n+$DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 2d.docm+n+n+%DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 3a.docm+n+n+V&DOCG:\MM\Mm 50 series (2001)\Mm5048\End Tables\Table 3b.doc X X Y Y @Z Z Z [ [ @\ ]@     @    @     @         @  #@    @  r@  @     @     @   @  @     @ -  @   % % & @& & & @' ( @( N( ) @) ) * * @+ + , , @- - - . @. . / / 0 @0 0 1 1 2 @2 2 2 @3 4 @4 4 4 @5 5 6 6 1@7 7 8 8 @9 9 9 : @: : ; ; < @< < = = > @> > > @? @ @@ @ @ @A A B    @ @@ " C  @      @     @   @ $9$ij] @n]] /^ /^ &G^ S^ $9\^$-@\^-@ :^^D$d;P['aP (b$'